For
the fiscal year ended December 31, 2006
|
Commission
File No. 1-11083
|
DELAWARE
|
04-2695240
|
(State
of Incorporation)
|
(I.R.S.
Employer Identification No.)
|
COMMON
STOCK, $.01 PAR VALUE PER SHARE
|
NEW
YORK STOCK EXCHANGE
|
(Title
Of Class)
|
(Name
of Exchange on Which Registered)
|
3
|
||
3
|
||
24
|
||
34
|
||
34
|
||
34
|
||
34
|
||
34
|
||
34
|
||
35
|
||
36
|
||
65
|
||
66
|
||
132
|
||
132
|
||
132
|
||
132
|
||
132
|
||
141
|
||
141
|
||
141
|
||
141
|
||
141
|
||
141
|
||
151
|
EX-10.2
FORM
OF OMNIBUS AMENDMENT
|
|
EX-10.16
FORM
OF DEFERRED STOCK UNIT AWARD AGREEMENT
|
|
EX-10.21
FIFTH
AMENDMENT TO 401(K) RETIREMENT SAVINGS PLAN
|
|
EX-10.23
2006
GLOBAL EMPLOYEE STOCK OWNERSHIP PLAN
|
|
EX-10.24
FIRST
AMENDMENT TO 2006 GLOBAL EMPLOYEE STOCK OWNERSHIP PLAN
|
|
EX-10.46
GUIDANT
CORPORATION 1994 STOCK PLAN, AS AMENDED
|
|
EX-10.47
GUIDANT
CORPORATION 1996 NONEMPLOYEE DIRECTOR STOCK PLAN, AS
AMENDED
|
|
EX-10.48
GUIDANT
CORPORATION 1998 STOCK PLAN, AS AMENDED
|
|
EX-10.49
FORM
OF GUIDANT CORPORATION OPTION GRANT
|
|
EX-10.50
FORM
OF GUIDANT CORPORATION RESTRICTED STOCK GRANT
|
|
EX-10.51
GUIDANT
CORPORATION EMPLOYEE SAVINGS AND STOCK OWNERSHIP PLAN
|
|
EX-10.52
FIRST
AMENDMENT TO GUIDANT CORPORATION EMPLOYEE SAVINGS AND STOCK
OWNERSHIP
PLAN
|
|
EX-10.53
SECOND
AMENDMENT TO GUIDANT CORPORATION EMPLOYEE SAVINGS AND STOCK
OWNERSHIP
PLAN
|
|
EX-10.54
THIRD
AMENDMENT TO GUIDANT CORPORATION EMPLOYEE SAVINGS AND STOCK
OWNERSHIP
PLAN
|
|
EX-10.55
FOURTH
AMENDMENT TO GUIDANT CORPORATION EMPLOYEE SAVINGS AND STOCK
OWNERSHIP
PLAN
|
|
EX-10.56
FIFTH
AMENDMENT TO GUIDANT CORPORATION EMPLOYEE SAVINGS AND STOCK
OWNERSHIP
PLAN
|
EX-12
STATEMENT REGARDING COMPUTATION OF RATIOS OF EARNINGS TO FIXED
CHARGES
|
||
EX-21
LIST OF SUBSIDIARIES AS OF 2/28/2007
|
||
EX-23
CONSENT OF ERNST & YOUNG, LLP
|
||
EX-31.1
SECTION 302 CEO CERTIFICATION
|
||
EX-31.2
SECTION 302 CFO CERTIFICATION
|
||
EX-32.1
SECTION 906 CEO CERTIFICATION
|
||
EX-32.2
SECTION 906 CFO CERTIFICATION
|
||
· |
Implantable
defibrillator systems used to detect and treat abnormally fast
heart
rhythms (tachycardia) that could result in sudden cardiac death,
including
implantable cardiac resynchronization therapy defibrillator systems
used
to treat heart failure; and
|
· |
Implantable
pacemaker systems used to manage slow or irregular heart rhythms
(bradycardia), including implantable cardiac resynchronization
therapy
pacemaker systems used to treat heart
failure.
|
· |
spending
on new product development programs;
|
· |
regulatory
compliance and clinical research, particularly relating to our
next-generation stent and CRM platforms and other development
programs
acquired in connection with our business combinations;
and
|
· |
sustaining
engineering efforts which factor customer (or “post market”) feedback into
continuous improvement efforts for currently marketed products.
|
· |
the
VITALITY® family of defibrillators which provide a broad range of atrial
(upper chambers of the heart) and ventricular (lower chambers)
therapies
to serve patients’ various needs;
|
· |
cardiac
resynchronization therapy devices, like those in our CONTAK RENEWAL®
family of devices, which can help reduce mortality and
hospitalization;
|
· |
the
INSIGNIA® family of pacemakers which offer proprietary blended sensor
technology designed to measure patient workload through respiration
and
motion, providing rate response based on the patient’s activity; and
|
· |
the
LATITUDE® Patient Management System, comprised of the LATITUDE
Communicator, LATITUDE Website, CONTAK RENEWAL 3RF CRT-D and
ZOOM®
LATITUDE Programmer, which enables a physician or technician
to monitor a
patient’s device status and health data from home.
|
· |
The
recovery of the CRM market to historical growth rates and our
ability to
regain CRM market share and increase CRM net
sales;
|
· |
The
overall performance of and referring physician, implanting physician
and
patient confidence in our and other CRM products and technologies,
including our LATITUDE® Patient Management System and Frontier
™
CRM
technology;
|
· |
The
results of CRM clinical trials undertaken by us, our competitors
or other
third parties;
|
· |
Our
ability to launch various products utilizing the Frontier CRM
technology, our next generation CRM pulse generator platform,
in the U.S.
over the next 36 months and to expand our CRM market position through
reinvestment in our CRM products and
technologies;
|
· |
Our
ability to retain our CRM sales force and other key
personnel;
|
· |
Competitive
offerings in the CRM market and the timing of receipt of regulatory
approvals to market existing and anticipated CRM products and
technologies; and
|
· |
Our
ability to avoid disruption in the supply of certain components
or
materials or to quickly secure additional or replacement components
or
materials on a timely basis.
|
·
|
Volatility
in the coronary stent market, competitive offerings and the timing
of
receipt of regulatory approvals to market existing and anticipated
drug-eluting stent technology and other coronary and peripheral
stent
platforms;
|
·
|
Our
ability to launch our TAXUS® Express
2
™
coronary
stent system in Japan during the second half of 2007, and to
launch our
next-generation drug-eluting stent system, the TAXUS® Liberté™ coronary
stent system, in the U.S., subject to regulatory approval, and
to maintain
or expand our worldwide market leadership positions through reinvestment
in our drug-eluting stent program;
|
·
|
The
continued availability of our TAXUS stent system in sufficient
quantities
and mix, our ability to prevent disruptions to our TAXUS stent
system
manufacturing processes and to maintain or replenish inventory
levels
consistent with forecasted demand around the world as we transition
to
next-generation stent products;
|
· |
The
impact of concerns relating to late stent thrombosis on the size
of the
coronary stent market, distribution of share within the coronary
stent
market in the U.S. and around the world, the average number of
stents used
per procedure and average selling prices;
|
·
|
The
overall performance of and continued physician confidence in
our and other
drug-eluting stents, our ability to adequately address concerns
regarding
the risk of late stent thrombosis, and the results of drug-eluting
stent
clinical trials undertaken by us, our competitors or other third
parties;
|
·
|
Our
ability to sustain or increase the penetration rate of drug-eluting
stent
technology in the U.S. and our European and Inter-Continental
markets;
|
· |
Our
ability to take advantage of our position as one of two early
entrants in
the U.S. drug-eluting stent market, to anticipate competitor
products as
they enter the market and to respond to the challenges presented
as
additional competitors enter the U.S. drug-eluting stent market;
|
·
|
Our
ability to manage inventory levels, accounts receivable, gross
margins and
operating expenses relating to our drug-eluting stent systems
and other
product franchises and to react effectively to worldwide economic
and
political conditions;
|
· |
Our
ability to manage the launch of our PROMUS™ everolimus-eluting stent
system and the supply of this stent system in sufficient quantities
and
mix; and
|
· |
Our
ability to manage the mix of our PROMUS stent system revenue
relative to
our total drug-eluting stent revenue and maintain our overall
profitability as a percentage of
revenue.
|
·
|
Any
conditions imposed in resolving, or any inability to resolve,
our
outstanding warning letters or other FDA matters, as well as
risks
generally associated with our regulatory compliance quality systems
and
complaint handling;
|
· |
The
effect of our litigation, risk management practices, including
self-insurance, and compliance activities on our loss contingency,
legal
provision and cash flow;
|
·
|
The
impact of our stockholder derivative and class action, patent,
product
liability, contract and other litigation and other legal
proceedings;
|
·
|
The
ongoing, inherent risk of potential physician communications
or field
actions related to medical devices;
|
· |
Costs
associated with our incremental compliance and quality initiatives,
including Project Horizon; and
|
· |
The
availability and rate of third-party reimbursement for our products
and
procedures.
|
·
|
Our
ability to complete planned clinical trials successfully, to
obtain
regulatory approvals and to develop and launch products on a
timely basis
within cost estimates, including the successful completion of
in-process
projects from purchased research and
development;
|
·
|
Our
ability to manage research and development and other operating
expenses
consistent with our expected revenue growth;
|
·
|
Our
ability to fund and achieve benefits from our focus on internal
research
and development and external alliances as well as our ability
to
capitalize on opportunities across our businesses;
|
·
|
Our
ability to develop products and technologies successfully in
addition to
our drug-eluting stent and cardiac rhythm management
technologies;
|
·
|
Our
ability to develop next-generation products and technologies
within our
drug-eluting stent and cardiac rhythm management
business;
|
·
|
Our
failure to succeed at, or our decision to discontinue, any of
our growth
initiatives;
|
·
|
Our
ability to integrate the acquisitions and other strategic alliances
we
have consummated, including
Guidant;
|
·
|
Our
decision to exercise, or not to exercise, options to purchase
certain
companies party to our strategic alliances and our ability to
fund with
cash or common stock these and other acquisitions, or to fund
contingent
payments associated with these alliances;
|
·
|
The
timing, size and nature of strategic initiatives, market opportunities
and
research and development platforms available to us and the ultimate
cost
and success of these initiatives; and
|
·
|
Our
ability to successfully identify, develop and market new products
or the
ability of others to develop products or technologies that render
our
products or technologies noncompetitive or
obsolete.
|
·
|
Dependency
on international net sales to achieve growth;
|
·
|
Risks
associated with international operations, including compliance
with local
legal and regulatory requirements as well as reimbursement practices
and
policies; and
|
·
|
The
potential effect of foreign currency fluctuations and interest
rate
fluctuations on our net sales, expenses and resulting margins.
|
·
|
Our
ability to generate sufficient cash flow to fund operations and
capital
expenditures, as well as our strategic investments over the next
twelve
months and to maintain borrowing flexibility beyond the next
twelve
months;
|
·
|
Our
ability to access the public capital markets and to issue debt
or equity
securities on terms reasonably acceptable to us;
|
Our
ability to achieve a 21 percent effective tax rate, excluding certain
charges, during 2007 and to recover substantially all of our
deferred tax
assets;
|
· |
Our
ability to maintain investment-grade credit ratings and satisfy
our
financial covenants;
|
· |
Our
ability to generate sufficient cash flow to effectively manage
our debt
levels and minimize the impact of interest rate fluctuations
on our
floating-rate debt; and
|
·
|
Our
ability to better align expenses with future expected revenue
levels and
reallocate resources to support our future growth.
|
·
|
Risks
associated with significant changes made or to be made to our
organizational structure or to the membership of our executive
committee;
and
|
·
|
Risks
associated with our acquisition of Guidant Corporation, including,
among
other things, the indebtedness we have incurred and the integration
costs
and challenges we will continue to face.
|
(in
square feet)
|
Total
Space
|
Owned
|
Leased
|
|||
Domestic
|
6,255,900
|
4,353,965
|
1,901,935
|
|||
Foreign
|
1,986,444
|
1,484,822
|
501,622
|
|||
Total
|
8,242,344
|
5,838,787
|
2,403,557
|
|||
2006
|
High
|
Low
|
|||||
First
Quarter
|
$
|
26.48
|
$
|
20.90
|
|||
Second
Quarter
|
23.30
|
16.65
|
|||||
Third
Quarter
|
17.75
|
14.77
|
|||||
Fourth
Quarter
|
17.18
|
14.65
|
|||||
2005
|
|||||||
First
Quarter
|
$
|
35.19
|
$
|
28.67
|
|||
Second
Quarter
|
30.80
|
27.00
|
|||||
Third
Quarter
|
28.95
|
23.05
|
|||||
Fourth
Quarter
|
27.33
|
22.95
|
Year
Ended December 31,
|
2006
|
2005
|
2004
|
2003
|
2002
|
|||||||||||
Operating
Data
|
||||||||||||||||
Net
sales
|
$
|
7,821
|
$
|
6,283
|
$
|
5,624
|
$
|
3,476
|
$
|
2,919
|
||||||
Gross
profit
|
5,614
|
4,897
|
4,332
|
2,515
|
2,049
|
|||||||||||
Selling,
general and administrative expenses
|
2,675
|
1,814
|
1,742
|
1,171
|
1,002
|
|||||||||||
Research
and development expenses
|
1,008
|
680
|
569
|
452
|
343
|
|||||||||||
Royalty
expense
|
231
|
227
|
195
|
54
|
36
|
|||||||||||
Amortization
expense
|
530
|
152
|
112
|
89
|
72
|
|||||||||||
Litigation-related
charges (credits), net
|
780
|
75
|
15
|
(99
|
)
|
|||||||||||
Purchased
research and development
|
4,119
|
276
|
65
|
37
|
85
|
|||||||||||
Total
operating expenses
|
8,563
|
3,929
|
2,758
|
1,818
|
1,439
|
|||||||||||
Operating
(loss) income
|
(2,949
|
)
|
968
|
1,574
|
697
|
610
|
||||||||||
Loss
(income) before income taxes
|
(3,535
|
)
|
891
|
1,494
|
643
|
549
|
||||||||||
Net
(loss) income
|
(3,577
|
)
|
628
|
1,062
|
472
|
373
|
||||||||||
|
||||||||||||||||
Net
(loss) income per common share — basic
|
$
|
(2.81
|
)
|
$
|
0.76
|
$
|
1.27
|
$
|
0.57
|
$
|
0.46
|
|||||
Net
(loss) income per common share — assuming dilution
|
$
|
(2.81
|
)
|
$
|
0.75
|
$
|
1.24
|
$
|
0.56
|
$
|
0.45
|
|||||
|
||||||||||||||||
Weighted
average shares outstanding — assuming dilution
|
1,273.7
|
837.6
|
857.7
|
845.4
|
830.0
|
As
of December 31,
|
2006
|
2005
|
2004
|
2003
|
2002
|
|||||||||||
Balance
Sheet Data
|
||||||||||||||||
Cash,
cash equivalents and marketable securities
|
$
|
1,668
|
$
|
848
|
$
|
1,640
|
$
|
752
|
$
|
260
|
||||||
Working
capital
|
2,271
|
1,152
|
684
|
487
|
285
|
|||||||||||
Total
assets
|
31,096
|
8,196
|
8,170
|
5,699
|
4,450
|
|||||||||||
Borrowings
(long-term and short-term)
|
8,902
|
2,020
|
2,367
|
1,725
|
935
|
|||||||||||
Stockholders’
equity
|
15,298
|
4,282
|
4,025
|
2,862
|
2,467
|
|||||||||||
Book
value per common share
|
$
|
10.37
|
$
|
5.22
|
$
|
4.82
|
$
|
3.46
|
$
|
3.00
|
2006
versus 2005
|
2005
versus 2004
|
|||||||||||||||||||||
(in
millions)
|
2006
|
2005
|
2004
|
As
Reported
Currency
Basis
|
Constant
Currency
Basis
|
As
Reported
Currency
Basis
|
Constant
Currency
Basis
|
|||||||||||||||
United
States
|
$
|
4,840
|
$
|
3,852
|
$
|
3,502
|
26
|
%
|
26
|
%
|
10
|
%
|
10
|
%
|
||||||||
Europe
|
1,574
|
1,161
|
994
|
36
|
%
|
34
|
%
|
17
|
%
|
17
|
%
|
|||||||||||
Japan
|
594
|
579
|
613
|
3
|
%
|
8
|
%
|
(6
|
%)
|
(4
|
%)
|
|||||||||||
Inter-Continental
|
813
|
691
|
515
|
18
|
%
|
16
|
%
|
34
|
%
|
28
|
%
|
|||||||||||
International
|
2,981
|
2,431
|
2,122
|
23
|
%
|
22
|
%
|
15
|
%
|
13
|
%
|
|||||||||||
Worldwide
|
$
|
7,821
|
$
|
6,283
|
$
|
5,624
|
24
|
%
|
24
|
%
|
12
|
%
|
11
|
%
|
(in
millions)
|
2006
|
2005
|
2004
|
2006
versus 2005
|
2005
versus 2004
|
|||||||||||
Interventional
Cardiology
|
$
|
3,612
|
$
|
3,783
|
$
|
3,451
|
(5
|
%)
|
10
|
%
|
||||||
Peripheral
Interventions/ Vascular Surgery
|
666
|
715
|
656
|
(7
|
%)
|
9
|
%
|
|||||||||
Electrophysiology
|
134
|
132
|
130
|
2
|
%
|
2
|
%
|
|||||||||
Neurovascular
|
326
|
277
|
253
|
18
|
%
|
9
|
%
|
|||||||||
Cardiac
Surgery
|
132
|
N/A
|
N/A
|
N/A
|
N/A
|
|||||||||||
Cardiac
Rhythm Management
|
1,371
|
N/A
|
N/A
|
N/A
|
N/A
|
|||||||||||
Cardiovascular
|
6,241
|
4,907
|
4,490
|
27
|
%
|
9
|
%
|
|||||||||
Oncology
|
221
|
207
|
186
|
7
|
%
|
11
|
%
|
|||||||||
Endoscopy
|
754
|
697
|
641
|
8
|
%
|
9
|
%
|
|||||||||
Urology
|
371
|
324
|
261
|
15
|
%
|
24
|
%
|
|||||||||
Endosurgery
|
1,346
|
1,228
|
1,088
|
10
|
%
|
13
|
%
|
|||||||||
Neuromodulation
|
234
|
148
|
46
|
58
|
%
|
222
|
%
|
|||||||||
Worldwide
|
$
|
7,821
|
$
|
6,283
|
$
|
5,624
|
24
|
%
|
12
|
%
|
2006
|
2005
|
2004
|
|||||||||||||||||
(in
millions)
|
$
|
%
of Net Sales
|
$
|
%
of Net Sales
|
$
|
%
of Net Sales
|
|||||||||||||
Gross
profit
|
5,614
|
71.8
|
4,897
|
77.9
|
4,332
|
77.0
|
2006
|
2005
|
2004
|
|||||||||||||||||
(in
millions)
|
$
|
%
of Net Sales
|
$
|
%
of Net Sales
|
$
|
%
of Net Sales
|
|||||||||||||
Selling,
general and administrative expenses
|
2,675
|
34.2
|
1,814
|
28.9
|
1,742
|
31.0
|
|||||||||||||
Research
and development expenses
|
1,008
|
12.9
|
680
|
10.8
|
569
|
10.1
|
|||||||||||||
Royalty
expense
|
231
|
3.0
|
227
|
3.6
|
195
|
3.5
|
|||||||||||||
Amortization
expense
|
530
|
6.8
|
152
|
2.4
|
112
|
2.0
|
|
|
|
Percentage
Point
Increase (Decrease)
|
|||||||||||||
|
2006
|
2005
|
2004
|
2006
versus 2005
|
2005
versus 2004
|
|||||||||||
Reported
tax rate
|
1.2%
|
|
29.5%
|
|
28.9%
|
|
(28.3)
|
|
0.6
|
|||||||
Impact
of certain charges
|
(20.2
%)
|
5.5%
|
|
4.9%
|
|
(25.7)
|
|
0.6
|
(in
millions)
|
2006
|
2005
|
2004
|
|||||||
Cash
and cash equivalents
|
$
|
1,668
|
$
|
689
|
$
|
1,296
|
||||
Short-term
marketable securities
|
159
|
344
|
||||||||
Cash
provided by operating activities
|
1,845
|
903
|
1,804
|
|||||||
Cash
used for investing activities
|
9,312
|
551
|
1,622
|
|||||||
Cash
provided by (used for) financing activities
|
8,439
|
(954
|
)
|
439
|
||||||
EBITDA
2
|
(2,273
|
)
|
1,278
|
1,904
|
(in
millions)
|
2006
|
2005
|
||||||
Short-term
debt
|
$
|
7
|
$
|
156
|
||||
Long-term
debt
|
8,895
|
1,864
|
||||||
Gross
debt
|
8,902
|
2,020
|
||||||
Less:
cash, cash equivalents and marketable securities
|
1,668
|
848
|
||||||
Net
debt
|
$
|
7,234
|
$
|
1,172
|
(in
millions)
|
2006
|
2005
|
2004
|
|||||||
EBITDA
|
$
|
(2,273
|
)
|
$
|
1,278
|
$
|
1,904
|
|||
Interest
income
|
67
|
36
|
20
|
|||||||
Interest
expense
|
(435
|
)
|
(90
|
)
|
(64
|
)
|
||||
Income
taxes
|
(42
|
)
|
(263
|
)
|
(432
|
)
|
||||
Stock-based
compensation expense
|
(113
|
)
|
(19
|
)
|
(91
|
)
|
||||
Depreciation
and amortization
|
(781
|
)
|
(314
|
)
|
(275
|
)
|
||||
Net
(loss) income
|
$
|
(3,577
|
)
|
$
|
628
|
$
|
1,062
|
Payments
Due by Period
|
|||||||||||||||||||
(in
millions)
|
2008
|
2009
|
2010
|
2011
|
Thereafter
|
Total
|
|||||||||||||
Term
loan
|
$
|
650
|
$
|
650
|
$
|
1,700
|
$
|
2,000
|
$
|
5,000
|
|||||||||
Abbott
loan
|
900
|
900
|
|||||||||||||||||
Senior
notes
|
850
|
$
|
2,200
|
3,050
|
|||||||||||||||
$
|
650
|
$
|
650
|
$
|
1,700
|
$
|
3,750
|
$
|
2,200
|
$
|
8,950
|
Payments
Due by Period
|
||||||||||||||||||||||
(in
millions)
|
2007
|
2008
|
2009
|
2010
|
2011
|
Thereafter
|
Total
|
|||||||||||||||
Operating
leases
|
$
|
61
|
$
|
47
|
$
|
24
|
$
|
11
|
$
|
5
|
$
|
36
|
$
|
184
|
||||||||
Purchase
obligations
†
|
182
|
1
|
1
|
1
|
185
|
|||||||||||||||||
Minimum
royalty obligations
|
3
|
3
|
3
|
1
|
1
|
6
|
17
|
|||||||||||||||
Interest
payments
††
|
521
|
497
|
457
|
371
|
214
|
1,013
|
3,073
|
|||||||||||||||
|
$
|
767
|
$
|
548
|
$
|
485
|
$
|
384
|
$
|
220
|
$
|
1,055
|
$
|
3,459
|
† |
These
obligations related primarily to inventory commitments and capital
expenditures entered in the normal course of
business.
|
†† |
Interest
payment amounts related to the $5.0 billion five-year term loan
are
projected using market interest rates as of December 31, 2006.
Future
interest payments may differ from these projections based on changes
in
the market interest rates.
|
/s/
James R. Tobin
|
/s/
Lawrence C. Best
|
||
President
and Chief Executive Officer
|
Executive
Vice President and Chief Financial Officer
|
Year
Ended December 31,
|
2006
|
2005
|
2004
|
|||||||
Net
sales
|
$
|
7,821
|
$
|
6,283
|
$
|
5,624
|
||||
Cost
of products sold
|
2,207
|
1,386
|
1,292
|
|||||||
Gross
profit
|
5,614
|
4,897
|
4,332
|
|||||||
Selling,
general and administrative expenses
|
2,675
|
1,814
|
1,742
|
|||||||
Research
and development expenses
|
1,008
|
680
|
569
|
|||||||
Royalty
expense
|
231
|
227
|
195
|
|||||||
Amortization
expense
|
530
|
152
|
112
|
|||||||
Litigation-related
charges
|
780
|
75
|
||||||||
Purchased
research and development
|
4,119
|
276
|
65
|
|||||||
Total
operating expenses
|
8,563
|
3,929
|
2,758
|
|||||||
Operating
(loss) income
|
(2,949
|
)
|
968
|
1,574
|
||||||
Other
income (expense):
|
||||||||||
Interest
expense
|
(435
|
)
|
(90
|
)
|
(64
|
)
|
||||
Fair
value adjustment for sharing of proceeds feature of
Abbott stock purchase
|
(95
|
)
|
||||||||
Other,
net
|
(56
|
)
|
13
|
(16
|
)
|
|||||
(Loss)
income before income taxes
|
(3,535
|
)
|
891
|
1,494
|
||||||
Income
taxes
|
42
|
263
|
432
|
|||||||
Net
(loss) income
|
$
|
(3,577
|
)
|
$
|
628
|
$
|
1,062
|
|||
Net
(loss) income per common share — basic
|
$
|
(2.81
|
)
|
$
|
0.76
|
$
|
1.27
|
|||
Net
(loss) income per common share — assuming
dilution
|
$
|
(2.81
|
)
|
$
|
0.75
|
$
|
1.24
|
As
of December 31,
|
2006
|
2005
|
|||||
Assets
|
|||||||
Current
assets
|
|||||||
Cash
and cash equivalents
|
$
|
1,668
|
$
|
689
|
|||
Marketable
securities
|
159
|
||||||
Trade
accounts receivable, net
|
1,424
|
932
|
|||||
Inventories
|
749
|
418
|
|||||
Deferred
income taxes
|
583
|
152
|
|||||
Prepaid
expenses and other current assets
|
477
|
281
|
|||||
Total
current assets
|
$
|
4,901
|
$
|
2,631
|
|||
Property,
plant and equipment, net
|
1,726
|
1,011
|
|||||
Investments
|
596
|
594
|
|||||
Other
assets
|
237
|
225
|
|||||
Intangible
assets
|
|||||||
Goodwill
|
14,628
|
1,938
|
|||||
Technology
— core, net
|
6,973
|
1,099
|
|||||
Technology
— developed, net
|
897
|
209
|
|||||
Patents,
net
|
339
|
338
|
|||||
Other
intangible assets, net
|
799
|
151
|
|||||
Total
intangible assets
|
23,636
|
3,735
|
|||||
|
$
|
31,096
|
$
|
8,196
|
As
of December 31,
|
2006
|
2005
|
|||||
Liabilities
and Stockholders’ Equity
|
|||||||
Current
liabilities
|
|||||||
Commercial
paper
|
$
|
149
|
|||||
Current
debt obligations
|
$
|
7
|
7
|
||||
Accounts
payable
|
222
|
105
|
|||||
Accrued
expenses
|
1,845
|
1,124
|
|||||
Income
taxes payable
|
413
|
17
|
|||||
Other
current liabilities
|
143
|
77
|
|||||
Total
current liabilities
|
$
|
2,630
|
$
|
1,479
|
|||
Long-term
debt
|
8,895
|
1,864
|
|||||
Deferred
income taxes
|
2,784
|
262
|
|||||
Other
long-term liabilities
|
1,489
|
309
|
|||||
Commitments
and contingencies
|
|||||||
Stockholders’
equity
|
|||||||
Preferred
stock, $ .01 par value — authorized 50,000,000 shares, none issued and
outstanding
|
|||||||
Common
stock, $ .01 par value — authorized 2,000,000,000 shares and issued
1,486,403,445
shares at December 31, 2006; authorized 1,200,000,000 shares and
issued
844,565,292 shares at December 31, 2005
|
15
|
8
|
|||||
Additional
paid-in capital
|
15,792
|
1,658
|
|||||
Deferred
cost, ESOP
|
(58
|
)
|
|||||
Deferred
compensation
|
(98
|
)
|
|||||
Treasury
stock, at cost —
11,728,643
shares
at December 31, 2006 and 24,215,559 shares at December 31, 2005
|
(334
|
)
|
(717
|
)
|
|||
Retained
(deficit) earnings
|
(174
|
)
|
3,410
|
||||
Accumulated
other comprehensive income (loss)
|
|||||||
Foreign
currency translation adjustment
|
16
|
(71
|
)
|
||||
Unrealized
gain on available-for-sale securities, net
|
16
|
26
|
|||||
Unrealized
gain on derivative financial instruments, net
|
32
|
67
|
|||||
Unrealized
costs associated with certain retirement plans
|
(7
|
)
|
(1
|
)
|
|||
Total
stockholders’ equity
|
15,298
|
4,282
|
|||||
|
$
|
31,096
|
$
|
8,196
|
Common
Stock
|
Deferred
Cost, ESOP
|
||||||||||||||||||||||||||||||
Shares
Issued
|
Par
Value
|
Additional
Paid-In Capital
|
Deferred
Compensation
|
Shares
|
Amount
|
Treasury
Stock
|
Retained
Earnings
|
Accumulated
Other Comprehensive Income (Loss)
|
Comprehensive
Income (Loss)
|
||||||||||||||||||||||
Balance
at December 31, 2003
|
829,764,826
|
$
|
8
|
$
|
1,225
|
$
|
(111
|
)
|
$
|
1,789
|
$
|
(49
|
)
|
||||||||||||||||||
Comprehensive
income
|
|||||||||||||||||||||||||||||||
Net
income
|
1,062
|
$
|
1,062
|
||||||||||||||||||||||||||||
Other
comprehensive income (expense), net of
tax
|
|||||||||||||||||||||||||||||||
Foreign
currency translation adjustment
|
16
|
16
|
|||||||||||||||||||||||||||||
Net
change in equity investments
|
(48
|
)
|
(48
|
)
|
|||||||||||||||||||||||||||
Net
change in derivative financial
instruments
|
(3
|
)
|
(3
|
)
|
|||||||||||||||||||||||||||
Issuance
of common stock
|
14,800,466
|
132
|
149
|
(56
|
)
|
||||||||||||||||||||||||||
Issuance
of restricted stock, net of cancellations
|
1
|
$
|
(3
|
)
|
2
|
||||||||||||||||||||||||||
Repurchases
of common stock
|
(360
|
)
|
|||||||||||||||||||||||||||||
Tax
benefit related to stock options
|
185
|
||||||||||||||||||||||||||||||
Step-up
accounting adjustment for certain investments
|
(5
|
)
|
|||||||||||||||||||||||||||||
Stock-based
compensation expense for certain
modifications
|
90
|
||||||||||||||||||||||||||||||
Amortization
of deferred compensation
|
1
|
||||||||||||||||||||||||||||||
Balance
at December 31, 2004
|
844,565,292
|
8
|
1,633
|
(2
|
)
|
(320
|
)
|
2,790
|
(84
|
)
|
$
|
1,027
|
|||||||||||||||||||
Comprehensive
income
|
|||||||||||||||||||||||||||||||
Net
income
|
628
|
$
|
628
|
||||||||||||||||||||||||||||
Other
comprehensive income (expense), net of
tax
|
|||||||||||||||||||||||||||||||
Foreign
currency translation adjustment
|
(37
|
)
|
(37
|
)
|
|||||||||||||||||||||||||||
Net
change in equity investments
|
24
|
24
|
|||||||||||||||||||||||||||||
Net
change in derivative financial
instruments
|
118
|
118
|
|||||||||||||||||||||||||||||
Issuance
of common stock
|
(113
|
)
|
207
|
||||||||||||||||||||||||||||
Common
stock issued for acquisitions
|
(5
|
)
|
129
|
||||||||||||||||||||||||||||
Issuance
of restricted stock, net of cancellations
|
114
|
(115
|
)
|
1
|
|||||||||||||||||||||||||||
Repurchases
of common stock
|
(734
|
)
|
|||||||||||||||||||||||||||||
Tax
benefit related to stock options
|
28
|
||||||||||||||||||||||||||||||
Step-up
accounting adjustment for certain investments
|
(8
|
)
|
|||||||||||||||||||||||||||||
Amortization
of deferred compensation
|
1
|
19
|
|||||||||||||||||||||||||||||
Balance
at December 31, 2005
|
844,565,292
|
8
|
1,658
|
(98
|
)
|
(717
|
)
|
3,410
|
21
|
$
|
733
|
||||||||||||||||||||
Comprehensive
income
|
|||||||||||||||||||||||||||||||
Net
loss
|
(3,577
|
)
|
$
|
(3,577
|
)
|
||||||||||||||||||||||||||
Other
comprehensive income (expense), net
of
tax
|
|||||||||||||||||||||||||||||||
Foreign
currency translation adjustment
|
87
|
87
|
|||||||||||||||||||||||||||||
Net
change in equity investments
|
(10
|
)
|
(10
|
)
|
|||||||||||||||||||||||||||
Net
change in derivative financial
instruments
|
(35
|
)
|
(35
|
)
|
|||||||||||||||||||||||||||
Net
change in certain retirement amounts
|
(6
|
)
|
(6
|
)
|
|||||||||||||||||||||||||||
Issuance
of shares of common stock for Guidant acquisition
|
577,206,996
|
6
|
12,508
|
||||||||||||||||||||||||||||
Conversion
of outstanding Guidant stock options
|
450
|
||||||||||||||||||||||||||||||
Issuance
of shares of common stock to Abbott
|
64,631,157
|
1
|
1,399
|
||||||||||||||||||||||||||||
Issuance
of common stock
|
(238
|
)
|
383
|
||||||||||||||||||||||||||||
Tax
benefit related to stock options
|
7
|
||||||||||||||||||||||||||||||
Reversal
of deferred compensation in
accordance
with SFAS 123(R)
|
(98
|
)
|
98
|
||||||||||||||||||||||||||||
Stock-based
compensation expense, including amounts
capitalized
to inventory
|
115
|
||||||||||||||||||||||||||||||
Step-up
accounting adjustment for certain
investments
|
(7
|
)
|
|||||||||||||||||||||||||||||
Acquired
401(k) ESOP for legacy
Guidant
employees
|
3,794,965
|
$
|
(86
|
)
|
|||||||||||||||||||||||||||
401
(k) ESOP transactions
|
(9
|
)
|
(1,237,662
|
)
|
28
|
||||||||||||||||||||||||||
Balance
at December 31, 2006
|
1,486,403,445
|
$
|
15
|
$
|
15,792
|
2,557,303
|
$
|
(58
|
)
|
$
|
(334
|
)
|
$
|
(174
|
)
|
$
|
57
|
$
|
(3,541
|
)
|
Year
Ended December 31,
|
2006
|
2005
|
2004
|
|||||||
Operating
Activities
|
||||||||||
Net
(loss) income
|
$
|
(3,577
|
)
|
$
|
628
|
$
|
1,062
|
|||
Adjustments
to reconcile net (loss) income to cash provided by operating
activities:
|
||||||||||
Gain
on sale of equity investments
|
(9
|
)
|
(4
|
)
|
(36
|
)
|
||||
Write-downs
of investments
|
121
|
41
|
58
|
|||||||
Depreciation
and amortization
|
781
|
314
|
275
|
|||||||
Step-up
value of acquired inventory sold
|
267
|
|||||||||
Deferred
income taxes
|
(420
|
)
|
4
|
30
|
||||||
Fair-value
adjustment for sharing of proceeds feature of Abbott stock
purchase
|
95
|
|||||||||
Purchased
research and development
|
4,119
|
276
|
65
|
|||||||
Tax
benefit relating to stock options
|
28
|
185
|
||||||||
Stock-based
compensation expense
|
113
|
19
|
91
|
|||||||
Increase
(decrease) in cash flows from operating assets and liabilities,
excluding the effect of acquisitions:
|
||||||||||
Trade
accounts receivable
|
64
|
(24
|
)
|
(317
|
)
|
|||||
Inventories
|
(53
|
)
|
(77
|
)
|
(57
|
)
|
||||
Prepaid
expenses and other assets
|
79
|
(100
|
)
|
(73
|
)
|
|||||
Accounts
payable and accrued expenses
|
(1
|
)
|
(162
|
)
|
362
|
|||||
Income
taxes payable and other liabilities
|
234
|
(51
|
)
|
171
|
||||||
Other,
net
|
32
|
11
|
(12
|
)
|
||||||
Cash
provided by operating activities
|
1,845
|
903
|
1,804
|
|||||||
Investing
Activities
|
||||||||||
Property,
plant and equipment
|
||||||||||
Purchases
|
(341
|
)
|
(341
|
)
|
(274
|
)
|
||||
Proceeds
on disposals
|
18
|
19
|
||||||||
Marketable
securities
|
||||||||||
Purchases
|
(56
|
)
|
(660
|
)
|
||||||
Proceeds
from maturities
|
159
|
241
|
397
|
|||||||
Acquisitions
|
||||||||||
Payments
for the acquisition of Guidant
|
(15,394
|
)
|
||||||||
Cash
acquired in the acquisition of Guidant, including proceeds from
Guidant’s
sale of its vascular intervention and endovascular solutions
businesses
|
6,708
|
|||||||||
Payments
for acquisitions of other businesses, net of cash acquired
|
(178
|
)
|
(804
|
)
|
||||||
Payments
relating to prior year acquisitions
|
(397
|
)
|
(33
|
)
|
(107
|
)
|
||||
Strategic
alliances
|
||||||||||
Purchases
of publicly traded equity securities
|
(52
|
)
|
(23
|
)
|
||||||
Payments
for investments in privately held companies and acquisitions of
certain
technologies
|
(98
|
)
|
(156
|
)
|
(249
|
)
|
||||
Proceeds
from sales of privately held and publicly traded equity
securities
|
33
|
5
|
98
|
|||||||
Cash
used for investing activities
|
(9,312
|
)
|
(551
|
)
|
(1,622
|
)
|
||||
Financing
Activities
|
||||||||||
Debt
|
||||||||||
Net
payments on commercial paper
|
(149
|
)
|
(131
|
)
|
(723
|
)
|
||||
Payments
on notes payable, capital leases and long-term borrowings
|
(1,510
|
)
|
(508
|
)
|
(17
|
)
|
||||
Proceeds
from notes payable and long-term borrowings, net of debt issuance
costs
|
8,544
|
739
|
1,092
|
|||||||
Net
proceeds from (payments on) borrowings on revolving credit
facilities
|
3
|
(413
|
)
|
225
|
||||||
Equity
|
||||||||||
Repurchases
of common stock
|
(734
|
)
|
(360
|
)
|
||||||
Proceeds
from issuance of shares of common stock to Abbott
|
1,400
|
|||||||||
Proceeds
from issuances of shares of common stock
|
145
|
94
|
225
|
|||||||
Tax
benefit relating to stock options
|
7
|
|||||||||
Other,
net
|
(1
|
)
|
(1
|
)
|
(3
|
)
|
||||
Cash
provided by (used for) financing activities
|
8,439
|
(954
|
)
|
439
|
||||||
Effect
of foreign exchange rates on cash
|
7
|
(5
|
)
|
4
|
||||||
Net
increase (decrease) in cash and cash equivalents
|
979
|
(607
|
)
|
625
|
||||||
Cash
and cash equivalents at beginning of year
|
689
|
1,296
|
671
|
|||||||
Cash
and cash equivalents at end of year
|
$
|
1,668
|
$
|
689
|
$
|
1,296
|
||||
SUPPLEMENTAL
INFORMATION - Cash paid during the year for:
|
||||||||||
Income
taxes
|
$
|
40
|
$
|
350
|
$
|
72
|
||||
Interest
|
383
|
87
|
61
|
(in
millions)
|
2006
|
2005
|
|||||
Cash
and cash equivalents
|
$
|
1,668
|
$
|
689
|
|||
Marketable
securities
|
|||||||
Available-for-sale
|
159
|
||||||
$
|
1,668
|
$
|
848
|
(
in
millions)
|
Guidant
Retirement
Plan
|
Guidant
Excess
Benefit
Plan
|
Healthcare
Retirement
Benefit
Plan
|
|||||||
Projected
benefit obligation
|
$
|
90
|
$
|
30
|
$
|
30
|
||||
Fair
value of plan assets
|
82
|
|||||||||
Net
amount recognized in consolidated balance sheet
|
$
|
8
|
$
|
30
|
$
|
30
|
Guidant
Retirement
Plan
|
Guidant
Excess
Benefit
Plan
|
Healthcare
Retirement
Benefit
Plan
|
||||||||
Discount
rate
|
5.75
|
%
|
5.75
|
%
|
5.50
|
%
|
||||
Expected
return on plan assets
|
7.75
|
%
|
||||||||
Healthcare
cost trend rate
|
|
|
|
|
5.00
|
%
|
||||
Rate of compensation increase |
4.50
|
%
|
4.50 |
%
|
(in
millions)
|
2006
|
2005
|
|||||
Trade
accounts receivable
|
|||||||
Accounts
receivable
|
$
|
1,561
|
$
|
1,015
|
|||
Less:
allowances
|
137
|
83
|
|||||
|
$
|
1,424
|
$
|
932
|
|||
|
|||||||
Inventories
|
|||||||
Finished
goods
|
$
|
447
|
$
|
286
|
|||
Work-in-process
|
145
|
64
|
|||||
Raw
materials
|
157
|
68
|
|||||
|
$
|
749
|
$
|
418
|
|||
|
|||||||
Property,
plant and equipment
|
|||||||
Land
|
$
|
115
|
$
|
76
|
|||
Buildings
and improvements
|
827
|
625
|
|||||
Equipment,
furniture and fixtures
|
1,775
|
1,152
|
|||||
|
2,717
|
1,853
|
|||||
Less:
accumulated depreciation
|
991
|
842
|
|||||
|
$
|
1,726
|
$
|
1,011
|
|||
|
|||||||
Accrued
expenses
|
|||||||
Acquisition-related
obligations
|
$
|
428
|
$
|
369
|
|||
Legal
reserves
|
268
|
35
|
|||||
Payroll
and related liabilities
|
466
|
294
|
|||||
Other
|
683
|
426
|
|||||
|
$
|
1,845
|
$
|
1,124
|
|||
Other
long-term liabilities
|
|||||||
Legal
reserves
|
$
|
217
|
|||||
Other
accrued income taxes
|
1,041
|
$
|
267
|
||||
Other
|
231
|
42
|
|||||
$
|
1,489
|
$
|
309
|
2006
|
2005
|
||||||||||||
(in
millions)
|
Number
of Strategic Investments
|
Number
of Strategic Investments
|
|||||||||||
Available-for-sale
investments
|
|||||||||||||
Amortized
cost
|
$
|
120
|
$
|
103
|
|||||||||
Gross
unrealized gains
|
36
|
44
|
|||||||||||
Gross
unrealized losses
|
(10
|
)
|
(4
|
)
|
|||||||||
Fair
value
|
$
|
146
|
9
|
$
|
143
|
5
|
|||||||
Equity
method investments
|
|||||||||||||
Cost
|
$
|
123
|
$
|
94
|
|||||||||
Equity
in losses
|
(28
|
)
|
(9
|
)
|
|||||||||
Carrying
value
|
$
|
95
|
4
|
$
|
85
|
3
|
|||||||
Cost
method investments
|
|||||||||||||
Carrying
value
|
$
|
355
|
68
|
$
|
366
|
58
|
|||||||
$
|
596
|
81
|
$
|
594
|
66
|
· |
an
initial payment of $4.1 billion in cash at the Abbott transaction
closing;
|
· |
a
milestone payment of $250 million upon receipt of an approval from
the U.S. FDA within ten years after the Abbott transaction closing
to
market and sell an everolimus-eluting stent in the U.S.;
and
|
· |
a
milestone payment of $250 million upon receipt of an approval from
the
Japanese Ministry of Health, Labour and Welfare within ten years
after the Abbott transaction closing to market and sell an
everolimus-eluting stent in Japan.
|
December
31,
2006
|
April
21,
2006
|
||||||
BSX
stock price
|
$
|
17.18
|
$
|
22.49
|
|||
Expected
volatility
|
30.00
|
%
|
30.00
|
%
|
|||
Risk-free
interest rate
|
4.79
|
%
|
4.90
|
%
|
|||
Credit
spread
|
0.35
|
%
|
0.35
|
%
|
|||
Expected
dividend yield
|
0.00
|
%
|
0.00
|
%
|
|||
Contractual
term to expiration
|
1.8
years
|
2.5
years
|
|||||
Notional
shares
|
64,635,272
|
64,635,272
|
Consideration
to Guidant
|
||||
Cash
portion of consideration
|
$
|
14,527
|
||
Fair
value of Boston Scientific common stock
|
12,514
|
|||
Fair
value of Boston Scientific options exchanged for Guidant stock
options
|
450
|
|||
Buyout
of options for certain former employees
|
97
|
|||
27,588
|
||||
Other
acquisition-related costs
|
||||
Johnson
& Johnson termination fee
|
705
|
|||
Other
direct acquisition costs
|
65
|
|||
$
|
28,358
|
Expected
term (in years)
|
2.4
|
|||
Expected
volatility
|
30
|
%
|
||
Risk-free
interest rate
|
4.92
|
%
|
||
Stock
price on date of grant
|
$
|
22.49
|
||
Weighted-average
exercise price
|
$
|
13.11
|
Cash
|
$
|
6,708
|
||
Intangible
assets subject to amortization
|
7,719
|
|||
Goodwill
|
12,354
|
|||
Other
assets
|
2,255
|
|||
Purchased
research and development
|
4,169
|
|||
Current
liabilities
|
(1,803
|
)
|
||
Net
deferred income taxes
|
(2,549
|
)
|
||
Other
long-term liabilities
|
(495
|
)
|
||
$
|
28,358
|
Amount
Assigned
(in
millions)
|
Weighted
Average Amortization Period
(in
years)
|
Risk-Adjusted
Discount Rates used in Purchase Price Allocation
|
||||||||
Amortizable
intangible assets
|
||||||||||
Technology
- core
|
$
|
6,142
|
25
|
10%-16
%
|
|
|||||
Technology
- developed
|
885
|
6
|
10%
|
|
||||||
Customer
relationships
|
688
|
15
|
10%-13%
|
|
||||||
Other
|
4
|
10
|
10%
|
|
||||||
$
|
7,719
|
22
|
||||||||
Goodwill
|
$
|
12,354
|
||||||||
Purchased
research and development
|
4,169
|
13%-17%
|
|
· |
Implantable
cardioverter defibrillator systems used to detect and treat abnormally
fast heart rhythms (tachycardia) that could result in sudden cardiac
death, including implantable cardiac resynchronization therapy
defibrillator systems used to treat heart
failure;
|
· |
Implantable
pacemaker systems used to manage slow or irregular heart rhythms
(bradycardia), including implantable cardiac resynchronization
therapy
pacemaker systems used to treat heart failure;
and
|
· |
Cardiac
surgery systems used to perform cardiac surgical ablation, endoscopic
vein
harvesting and clampless beating-heart bypass
surgery.
|
|
|||||||
Year
Ended December 31,
|
|||||||
(in
millions, except per share data)
|
2006
|
2005
|
|||||
Unaudited
|
|||||||
Net
sales
|
$
|
8,533
|
$
|
8,739
|
|||
Net
loss
|
(3,916
|
)
|
(4,287
|
)
|
|||
Net
loss per share - basic
|
$
|
(2.66
|
)
|
$
|
(2.92
|
)
|
|
Net
loss per share - assuming dilution
|
$
|
(2.66
|
)
|
$
|
(2.92
|
)
|
(in
millions)
|
Purchase
Price Adjustments
|
Charges
Utilized in 2006
|
Balance
at December 31, 2006
|
|||||||
Workforce
reductions
|
$
|
190
|
$
|
(27
|
)
|
$
|
163
|
|||
Relocation
costs
|
15
|
(5
|
)
|
10
|
||||||
Contractual
commitments
|
30
|
(5
|
)
|
25
|
||||||
$
|
235
|
$
|
(37
|
)
|
$
|
198
|
2006
|
2005
|
||||||||||||
(in
millions)
|
Gross
Carrying Amount
|
Accumulated
Amortization
|
Gross
Carrying Amount
|
Accumulated
Amortization
|
|||||||||
Amortizable
intangible assets
|
|||||||||||||
Technology
- core
|
$
|
6,909
|
$
|
292
|
$
|
829
|
$
|
86
|
|||||
Technology
- developed
|
1,338
|
441
|
453
|
244
|
|||||||||
Patents
|
583
|
244
|
547
|
209
|
|||||||||
Customer
relationships
|
765
|
58
|
73
|
22
|
|||||||||
Other
intangible assets
|
214
|
122
|
208
|
108
|
|||||||||
$
|
9,809
|
$
|
1,157
|
$
|
2,110
|
$
|
669
|
||||||
Goodwill
|
$
|
14,628
|
$
|
1,938
|
|||||||||
Technology
- core
|
356
|
356
|
|||||||||||
$
|
14,984
|
$
|
2,294
|
|
Estimated
Amortization
Expense
(in
millions)
|
|||
2007
|
$
|
608
|
||
2008
|
566
|
|||
2009
|
545
|
|||
2010
|
533
|
|||
2011
|
439
|
(in
millions)
|
United
States
|
Europe
|
Japan
|
Inter-Continental
|
|||||||||
Balance
as of December 31, 2004
|
$
|
1,440
|
$
|
160
|
$
|
55
|
$
|
57
|
|||||
Purchase
price adjustments
|
(35
|
)
|
(4
|
)
|
(1
|
)
|
(2
|
)
|
|||||
Goodwill
acquired
|
19
|
3
|
3
|
9
|
|||||||||
Contingent
consideration
|
189
|
26
|
5
|
14
|
|||||||||
Balance
as of December 31, 2005
|
$
|
1,613
|
$
|
185
|
$
|
62
|
$
|
78
|
|||||
Purchase
price adjustments
|
(4
|
)
|
|||||||||||
Goodwill
acquired
|
7,642
|
3,700
|
387
|
625
|
|||||||||
Contingent
consideration
|
278
|
40
|
5
|
17
|
|||||||||
Balance
as of December 31, 2006
|
$
|
9,529
|
$
|
3,925
|
$
|
454
|
$
|
720
|
(in
millions)
|
2006
|
2005
|
|||||
Commercial
paper
|
$
149
|
||||||
Other
current debt obligations
|
$
|
7
|
7
|
||||
7
|
156
|
||||||
Term
loan
|
5,000
|
||||||
Abbott
loan
|
900
|
||||||
Senior
notes
|
3,050
|
1,850
|
|||||
Fair
value adjustment *
|
(12
|
)
|
14
|
||||
Discounts
|
(52
|
)
|
(7
|
)
|
|||
Other
|
9
|
7
|
|||||
8,895
|
1,864
|
||||||
$
|
8,902
|
$
|
2,020
|
* |
Represents
unamortized (losses) gains on interest rate swaps used to hedge
the fair
value of certain of our senior notes. See
Note
G - Financial Instruments
for further discussion regarding the treatment of our interest
rate
swaps.
|
Payments
Due by Period
|
|||||||||||||||||||
(in
millions)
|
2008
|
2009
|
2010
|
2011
|
Thereafter
|
Total
|
|||||||||||||
Term
loan
|
$
|
650
|
$
|
650
|
$
|
1,700
|
$
|
2,000
|
$
|
5,000
|
|||||||||
Abbott
loan
|
900
|
900
|
|||||||||||||||||
Senior
notes
|
850
|
$
|
2,200
|
3,050
|
|||||||||||||||
$
|
650
|
$
|
650
|
$
|
1,700
|
$
|
3,750
|
$
|
2,200
|
$
|
8,950
|
Amount
(in
millions)
|
Issuance
Date
|
Maturity
Date
|
Semi-annual
Coupon
Rate
|
||||||||||
January
2011 Notes
|
$
|
250
|
November
2004
|
January
2011
|
4.25%
|
|
|||||||
June
2011 Notes
|
600
|
June
2006
|
June
2011
|
6.0%
|
|
||||||||
June
2014 Notes
|
600
|
June
2004
|
June
2014
|
5.45%
|
|
||||||||
November
2015 Notes
|
400
|
November
2005
|
November
2015
|
5.5%
|
|
||||||||
June
2016 Notes
|
600
|
June
2006
|
June
2016
|
6.4%
|
|
||||||||
January
2017 Notes
|
250
|
November
2004
|
January
2017
|
5.125%
|
|
||||||||
November
2035 Notes
|
350
|
November
2005
|
November
2035
|
6.25%
|
|
||||||||
2006
|
2005
|
||||||||||||
(in
millions)
|
Carrying
Amount
|
Fair
Value
|
Carrying
Amount
|
Fair
Value
|
|||||||||
Assets
|
|||||||||||||
Foreign
exchange contracts
|
$
|
71
|
$
|
71
|
$
|
176
|
$
|
176
|
|||||
Interest
rate swap contracts
|
21
|
21
|
|||||||||||
Liabilities
|
|||||||||||||
Long-term
debt
|
$
|
8,895
|
$
|
8,862
|
$
|
1,862
|
$
|
1,859
|
|||||
Foreign
exchange contracts
|
27
|
27
|
55
|
55
|
|||||||||
Interest
rate swap contracts
|
11
|
11
|
7
|
7
|
(in
millions)
|
|
|||
2007
|
$
|
61
|
||
2008
|
47
|
|||
2009
|
24
|
|||
2010
|
11
|
|||
2011
|
5
|
|||
Thereafter
|
36
|
|||
$
|
184
|
(in
millions)
|
2006
|
2005
|
2004
|
|||||||
Domestic
|
$
|
(4,535
|
)
|
$
|
(126
|
)
|
$
|
353
|
||
Foreign
|
1,000
|
1,017
|
1,141
|
|||||||
$
|
(3,535
|
)
|
$
|
891
|
$
|
1,494
|
(in
millions)
|
2006
|
2005
|
2004
|
|||||||
Current
|
||||||||||
Federal
|
$
|
251
|
$
|
136
|
$
|
233
|
||||
State
|
53
|
37
|
20
|
|||||||
Foreign
|
158
|
86
|
149
|
|||||||
$
|
462
|
$
|
259
|
$
|
402
|
|||||
Deferred
|
||||||||||
Federal
|
$
|
(421
|
)
|
$
|
(25
|
)
|
$
|
73
|
||
State
|
(24
|
)
|
(1
|
)
|
4
|
|||||
Foreign
|
25
|
30
|
(47
|
)
|
||||||
(420
|
)
|
4
|
30
|
|||||||
$
|
42
|
$
|
263
|
$
|
432
|
2006
|
2005
|
2004
|
|
U.S.
federal statutory income tax rate
|
(35.0%)
|
35.0%
|
35.0%
|
State
income taxes, net of federal benefit
|
0.5%
|
3.0%
|
1.1%
|
Effect
of foreign taxes
|
(6.1%)
|
(31.9%)
|
(12.4%)
|
Non-deductible
acquisition expenses
|
40.8%
|
9.9%
|
1.5%
|
Research
credit
|
(0.6%)
|
(1.6%)
|
(1.4%)
|
Valuation
allowance
|
2.2%
|
(0.7%)
|
(0.6%)
|
Tax
liability release on unremitted earnings
|
(3.8%)
|
||
Legal
settlement
|
10.2%
|
1.8%
|
|
Extraordinary
dividend from subsidiaries
|
(0.7%)
|
4.1%
|
|
Sale
of intangible assets
|
3.3%
|
5.9%
|
|
Other,
net
|
(0.1%)
|
0.4%
|
(0.2%)
|
1.2%
|
29.5%
|
28.9%
|
(in
millions)
|
2006
|
2005
|
|||||
Deferred
tax assets
|
|||||||
Inventory
costs, intercompany profit and related reserves
|
$
|
241
|
$
|
142
|
|||
Tax
benefit of net operating loss, capital loss and tax
credits
|
188
|
154
|
|||||
Reserves
and accruals
|
291
|
125
|
|||||
Restructuring
and acquisition-related charges, including purchased research
and
development
|
108
|
144
|
|||||
Litigation
and product liability reserves
|
114
|
||||||
Investment
write-down
|
78
|
||||||
Stock-based
compensation expense
|
57
|
||||||
Other
|
5
|
53
|
|||||
1,082
|
618
|
||||||
Less:
valuation allowance on deferred tax assets
|
97
|
17
|
|||||
$
|
985
|
$
|
601
|
||||
Deferred
tax liabilities
|
|||||||
Property,
plant and equipment
|
$
|
76
|
$
|
10
|
|||
Intangible
assets
|
3,053
|
453
|
|||||
Unremitted
earnings of subsidiaries
|
133
|
||||||
Litigation
settlement
|
24
|
24
|
|||||
Unrealized
gains on available-for-sale securities
|
10
|
14
|
|||||
Unrealized
gains on derivative financial instruments
|
19
|
39
|
|||||
Other
|
4
|
38
|
|||||
3,186
|
711
|
||||||
$
|
(2,201
|
)
|
$
|
(110
|
)
|
(in
millions)
|
||||
Cost
of products sold
|
$
|
15
|
||
Selling,
general and administrative expenses
|
74
|
|||
Research
and development expenses
|
24
|
|||
Loss
before income taxes
|
113
|
|||
Income
tax benefit
|
32
|
|||
Net
loss
|
$
|
81
|
||
Net
loss per common share - basic
|
$
|
0.06
|
||
Net
loss per common share - assuming dilution
|
$
|
0.06
|
Year
Ended
December
31,
|
|||||||
(in
millions, except per share data)
|
2005
|
2004
|
|||||
|
|||||||
Net
income, as reported
|
$
|
628
|
$
|
1,062
|
|||
Add:
Stock-based employee compensation expense included in net income,
net of
related tax effects
|
13
|
62
|
|||||
Less:
Total stock-based employee compensation expense determined under
fair
value based method for all awards, net of related tax
benefits
|
(74
|
)
|
(67
|
)
|
|||
Pro
forma net income
|
$
|
567
|
$
|
1,057
|
|||
Net
income per common share
|
|||||||
Basic
|
|||||||
Reported
|
$
|
0.76
|
$
|
1.27
|
|||
Pro
forma
|
$
|
0.69
|
$
|
1.26
|
|||
Assuming
dilution
|
|||||||
Reported
|
$
|
0.75
|
$
|
1.24
|
|||
Pro
forma
|
$
|
0.68
|
$
|
1.24
|
Year
Ended December 31,
|
||||||||||
2006
|
2005
|
2004
|
||||||||
Options
granted (in thousands)
|
5,438
|
7,983
|
2,101
|
|||||||
Weighted-average
exercise price
|
$
|
21.48
|
$
|
30.12
|
$
|
39.72
|
||||
Weighted-average
grant-date fair value
|
$
|
7.61
|
$
|
12.18
|
$
|
14.36
|
||||
Black-Scholes
Assumptions
|
||||||||||
Expected
volatility
|
30
|
%
|
37
|
%
|
47
|
%
|
||||
Expected
term (in years)
|
5
|
5
|
5
|
|||||||
Risk-free
interest rate
|
4.26%
- 5.18
|
%
|
3.37%
- 4.47
|
%
|
2.24%
- 4.05
|
%
|
Options
(in
thousands)
|
Weighted
Average
Exercise
Price
|
Weighted
Average
Remaining
Contractual
Life
(in years)
|
Aggregate
Intrinsic
Value
(in
millions)
|
||||||||||
Outstanding
at January 1, 2004
|
66,103
|
$
|
15
|
||||||||||
Granted
|
2,101
|
40
|
|||||||||||
Exercised
|
(18,296
|
)
|
11
|
||||||||||
Cancelled/forfeited
|
(880
|
)
|
18
|
||||||||||
Outstanding
at December 31, 2004
|
49,028
|
$
|
18
|
||||||||||
Granted
|
7,983
|
30
|
|||||||||||
Exercised
|
(5,105
|
)
|
12
|
||||||||||
Cancelled/forfeited
|
(1,621
|
)
|
28
|
||||||||||
Outstanding
at December 31, 2005
|
50,285
|
$
|
20
|
||||||||||
Guidant
converted options
|
39,649
|
13
|
|||||||||||
Granted
|
5,438
|
21
|
|||||||||||
Exercised
|
(10,548
|
)
|
11
|
||||||||||
Cancelled/forfeited
|
(1,793
|
)
|
25
|
||||||||||
Outstanding
at December 31, 2006
|
83,031
|
$
|
18
|
5
|
$
|
233
|
|||||||
Exercisable
at December 31, 2006
|
68,718
|
$
|
16
|
4
|
$
|
231
|
|||||||
Expected
to vest as of December 31, 2006
|
80,802
|
$
|
18
|
5
|
$
|
232
|
Non-Vested
Stock
Award
Units
(in
thousands)
|
Weighted
Average
Grant-
Date
Fair
Value
|
||||||
Balance
at January 1, 2006
|
3,834
|
$
|
30
|
||||
Granted
|
6,580
|
23
|
|||||
Vested
|
(52
|
)
|
32
|
||||
Forfeited
|
(487
|
)
|
28
|
||||
Balance
at December 31, 2006
|
9,875
|
$
|
26
|
Stock
price on date of grant
|
$
|
24.42
|
||
Expected
volatility
|
30
|
%
|
||
Expected
term (in years)
|
3.84
|
|||
Risk-free
rate
|
4.64
|
%
|
Unrecognized
Compensation
Cost
(in
millions)*
|
Weighted
Average
Remaining
Vesting
Period
(in
years)
|
||||||
Stock
options
|
$
|
63
|
|||||
Non-vested
stock awards
|
131
|
||||||
$
|
194
|
3.3
|
2006
|
2005
|
2004
|
||||||||
Shares
issued
|
2,765,000
|
1,445,000
|
1,004,000
|
|||||||
Range
of purchase prices
|
|
$14.20
- $14.31
|
|
$20.82
- $22.95
|
$30.22
- $30.81
|
(in
millions, except per share data)
|
2006
|
2005
|
2004
|
|||||||
Basic
|
||||||||||
Net
(loss) income
|
$
|
(3,577
|
)
|
$
|
628
|
$
|
1,062
|
|||
Weighted
average shares outstanding
|
1,273.7
|
825.8
|
838.2
|
|||||||
Net
(loss) income per common share
|
$
|
(2.81
|
)
|
$
|
0.76
|
$
|
1.27
|
|||
Assuming
dilution
|
||||||||||
Net
(loss) income
|
$
|
(3,577
|
)
|
$
|
628
|
$
|
1,062
|
|||
Weighted
average shares outstanding
|
1,273.7
|
825.8
|
838.2
|
|||||||
Net
effect of common stock equivalents
|
11.8
|
19.5
|
||||||||
Total
|
1,273.7
|
837.6
|
857.7
|
|||||||
Net
(loss) income per common share
|
$
|
(2.81
|
)
|
$
|
0.75
|
$
|
1.24
|
(
in
millions)
|
United
States
|
Europe
|
Japan
|
Inter-
Continental
|
Total
|
|||||||||||
2006
|
||||||||||||||||
Net
sales
|
$
|
4,840
|
$
|
1,529
|
$
|
630
|
$
|
783
|
$
|
7,782
|
||||||
Depreciation
|
70
|
12
|
4
|
6
|
92
|
|||||||||||
Segment
income
|
2,273
|
767
|
337
|
382
|
3,759
|
|||||||||||
2005
|
||||||||||||||||
Net
sales
|
$
|
3,852
|
$
|
1,152
|
$
|
579
|
$
|
675
|
$
|
6,258
|
||||||
Depreciation
|
18
|
5
|
3
|
4
|
30
|
|||||||||||
Segment
income
|
1,815
|
644
|
308
|
332
|
3,099
|
|||||||||||
2004
|
||||||||||||||||
Net
sales
|
$
|
3,502
|
$
|
982
|
$
|
602
|
$
|
497
|
$
|
5,583
|
||||||
Depreciation
|
10
|
5
|
3
|
3
|
21
|
|||||||||||
Segment
income
|
1,753
|
557
|
343
|
232
|
2,885
|
(in
millions)
|
2006
|
2005
|
2004
|
|||||||
Net
sales
|
||||||||||
Total
net sales allocated to reportable segments
|
$
|
7,782
|
$
|
6,258
|
$
|
5,583
|
||||
Foreign
exchange
|
39
|
25
|
41
|
|||||||
$
|
7,821
|
$
|
6,283
|
$
|
5,624
|
|||||
Depreciation
|
||||||||||
Total
depreciation allocated to reportable segments
|
$
|
92
|
$
|
30
|
$
|
21
|
||||
Manufacturing
operations
|
76
|
89
|
113
|
|||||||
Depreciation
included in special charges
|
17
|
|||||||||
Corporate
expenses and foreign exchange
|
66
|
43
|
29
|
|||||||
$
|
251
|
$
|
162
|
$
|
163
|
|||||
(Loss)
income before income taxes
|
||||||||||
Total
operating income allocated to reportable segments
|
$
|
3,759
|
$
|
3,099
|
$
|
2,885
|
||||
Manufacturing
operations
|
(617
|
)
|
(449
|
)
|
(396
|
)
|
||||
Corporate
expenses and foreign exchange
|
(920
|
)
|
(409
|
)
|
(462
|
)
|
||||
Purchase
accounting adjustments
|
(4,453
|
)
|
(276
|
)
|
(65
|
)
|
||||
Acquisition-related
and other costs
|
||||||||||
Integration
costs
|
(61
|
)
|
||||||||
CRM
technology offering charge
|
(31
|
)
|
||||||||
Certain
retirement benefits
|
(17
|
)
|
(110
|
)
|
||||||
Business
optimization charges
|
(19
|
)
|
(39
|
)
|
||||||
TriVascular
AAA program cancellation costs, including amortization
expense
|
13
|
|||||||||
Litigation-related
charges
|
(780
|
)
|
(75
|
)
|
||||||
Amortization
and stock-based compensation expense
|
(620
|
)
|
(161
|
)
|
(203
|
)
|
||||
(2,949
|
)
|
968
|
1,574
|
|||||||
Other
income (expense)
|
(586
|
)
|
(77
|
)
|
(80
|
)
|
||||
$
|
(3,535
|
)
|
$
|
891
|
$
|
1,494
|
(in
millions)
|
2006
|
2005
|
2004
|
|||||||
Net
sales
|
||||||||||
Interventional
Cardiology
|
$
|
3,612
|
$
|
3,783
|
$
|
3,451
|
||||
Cardiac
Rhythm Management
|
1,371
|
N/A
|
N/A
|
|||||||
Other
|
1,258
|
1,124
|
1,039
|
|||||||
Cardiovascular
|
6,241
|
4,907
|
4,490
|
|||||||
Endosurgery
|
1,346
|
1,228
|
1,088
|
|||||||
Neuromodulation
|
234
|
148
|
46
|
|||||||
Worldwide
|
$
|
7,821
|
$
|
6,283
|
$
|
5,624
|
||||
Long-lived
assets
|
||||||||||
United
States
|
$
|
1,343
|
$
|
795
|
$
|
660
|
||||
Ireland
|
199
|
140
|
149
|
|||||||
Other
foreign countries
|
184
|
76
|
61
|
|||||||
$
|
1,726
|
$
|
1,011
|
$
|
870
|
Three
Months Ended
|
March
31,
|
June
30,
|
Sept
30,
|
Dec
31,
|
|||||||||
2006
|
|||||||||||||
Net
sales
|
$
|
1,620
|
$
|
2,110
|
$
|
2,026
|
$
|
2,065
|
|||||
Gross
profit
|
1,246
|
1,433
|
1,396
|
1,539
|
|||||||||
Operating
income (loss)
|
497
|
(3,925
|
)
|
195
|
284
|
||||||||
Net
income (loss)
|
332
|
(4,262
|
)
|
76
|
277
|
||||||||
Net
income (loss) per common share - basic
|
$
|
0.40
|
$
|
(3.21
|
)
|
$
|
0.05
|
$
|
0.19
|
||||
Net
income (loss) per common share - assuming dilution
|
$
|
0.40
|
$
|
(3.21
|
)
|
$
|
0.05
|
$
|
0.19
|
||||
2005
|
|||||||||||||
Net
sales
|
$
|
1,615
|
$
|
1,617
|
$
|
1,511
|
$
|
1,540
|
|||||
Gross
profit
|
1,271
|
1,260
|
1,168
|
1,198
|
|||||||||
Operating
income (loss)
|
513
|
326
|
(336
|
)
|
465
|
||||||||
Net
income (loss)
|
358
|
205
|
(269
|
)
|
334
|
||||||||
Net
income (loss) per common share - basic
|
$
|
0.43
|
$
|
0.25
|
$
|
(0.33
|
)
|
$
|
0.41
|
||||
Net
income (loss) per common share - assuming dilution
|
$
|
0.42
|
$
|
0.24
|
$
|
(0.33
|
)
|
$
|
0.40
|
DIRECTORS
|
||
John
E. Abele
|
69
|
Director,
Founder
|
Ursula
M. Burns
|
48
|
Director,
President, Business Group Operations and Corporate Senior Vice
President,
Xerox Corporation
|
Nancy-Ann
DeParle
|
50
|
Director,
Managing Director, CCMP Capital Advisors, LLC
|
Joel
L. Fleishman
|
72
|
Director,
Professor of Law and Public Policy, Duke University
|
Marye
Anne Fox, Ph.D.
|
59
|
Director,
Chancellor of the University of California, San Diego
|
Ray
J. Groves
|
71
|
Director,
Retired Chairman and Chief Executive Officer, Ernst &
Young
|
Kristina
M. Johnson
|
49
|
Director,
Dean of the Pratt School of Engineering, Duke
University
|
Ernest
Mario, Ph.D.
|
68
|
Director,
Chairman, Reliant Pharmaceuticals, Inc.
|
N.J.
Nicholas, Jr.
|
67
|
Director,
Private Investor
|
Pete
M. Nicholas
|
65
|
Director,
Founder, Chairman of the Board
|
John
E. Pepper
|
68
|
Director,
Chief Executive Officer, National Underground Railroad Freedom
Center
|
Uwe
E. Reinhardt, Ph.D.
|
69
|
Director,
Professor of Political Economy and Economics and Public Affairs,
Princeton
University
|
Senator
Warren B. Rudman
|
76
|
Director,
Former U.S. Senator, Of Counsel, Paul, Weiss, Rifkind, Wharton,
&
Garrison LLP
|
James
R. Tobin
|
62
|
President,
Chief Executive Officer and Director
|
EXECUTIVE
OFFICERS
|
||
Donald
Baim, M.D.
|
57
|
Senior
Vice President, Chief Medical and Scientific Officer
|
Mark
Bartell
|
46
|
Senior
Vice President, Global Sales & Marketing for CRM
|
Lawrence
C. Best
|
57
|
Executive
Vice President-Finance & Administration and Chief Financial
Officer
|
Brian
R. Burns
|
42
|
Senior
Vice President, Quality
|
Fredericus
A. Colen
|
54
|
Executive
Vice President, Operations and Technology, CRM and Chief Technology
Officer
|
Paul
Donovan
|
51
|
Senior
Vice President, Corporate Communications
|
Jim
Gilbert
|
49
|
Group
President, Cardiovascular
|
Jeffrey
H. Goodman
|
59
|
Executive
Vice President, International
|
William
H. (Hank) Kucheman
|
57
|
Senior
Vice President and Group President of Interventional
Cardiology
|
Paul
A. LaViolette
|
49
|
Chief
Operating Officer
|
William
McConnell
|
57
|
Senior
Vice President, Administration, CRM
|
Stephen
F. Moreci
|
55
|
Senior
Vice President and Group President, Endosurgery
|
Kenneth
J. Pucel
|
40
|
Executive
Vice President, Operations
|
Lucia
L. Quinn
|
53
|
Executive
Vice President, Human Resources
|
Paul
W. Sandman
|
59
|
Executive
Vice President, Secretary and General
Counsel
|
EXHIBIT
NO.
|
|
TITLE
|
|
|
|||
2.1
|
|
Agreement
and Plan of Merger, dated as of January 25, 2006, among Boston
Scientific
Corporation, Galaxy Merger Sub, Inc. and Guidant Corporation (Exhibit
2.1,
Current Report on Form 8-K, dated January 25,2006, File No.
1-11083).
|
|
3.1
|
|
Second
Restated Certificate of Incorporation of the Company, as amended
(Exhibit
3.1, Annual Report on Form 10-K for the year ended December 31,
1993,
Exhibit 3.2, Annual Report on Form 10-K for the year ended December
31,
1994, Exhibit 3.3, Annual Report on Form 10-K for the year ended
December
31, 1998, and Exhibit 3.4, Annual Report on Form 10-K for the year
ended
December 31, 2003, File No. 1-11083).
|
|
3.2
|
|
Restated
By-laws of the Company (Exhibit 3.2, Registration No.
33-46980).
|
|
3.4
|
|
Certificate
of Amendment of the Second Restated Certificate of Incorporation
(Exhibit
3.1, Quarterly Report on Form 10-Q for the quarter ended September
30,
2006, File No. 1-11083).
|
|
4.1
|
|
Specimen
Certificate for shares of the Company
’
s
Common
Stock (Exhibit 4.1, Registration No. 33-46980).
|
|
4.2
|
|
Description
of Capital Stock contained in Exhibits 3.1, 3.2 and 3.3.
|
|
4.3
|
|
Indenture
dated as of June 25, 2004 between the Company and JPMorgan Chase
Bank
(formerly The Chase Manhattan Bank) (Exhibit 4.1, Current Report
on Form
8-K dated June 25, 2004, File No. 1-11083).
|
|
4.4
|
|
Indenture
dated as of November 18, 2004 between the Company and J.P. Morgan
Trust
Company, National Association, as Trustee (Exhibit 4.1, Current
Report on
Form 8-K dated November 18, 2004, File No. 1-11083).
|
|
4.5
|
|
Form
of First Supplemental Indenture dated as of April 21, 2006 (Exhibit
99.4,
Current Report on Form 8-K dated April 21, 2006, File No.
1-11083).
|
4.6
|
|
Form
of Second Supplemental Indenture dated as of April 21, 2006 (Exhibit
99.6,
Current Report on Form 8-K dated April 21, 2006, File No.
1-11083).
|
|
4.7
|
|
5.45%
Note due June 15, 2014 in the aggregate principal amount of $500,000,000
(Exhibit 4.2, Current Report on Form 8-K dated June 25, 2004, File
No.
1-11083).
|
|
4.8
|
|
5.45%
Note due June 15, 2014 in the aggregate principal amount of $100,000,000
(Exhibit 4.3, Current Report on Form 8-K dated June 25, 2004, File
No.
1-11083).
|
|
4.9
|
|
Form
of Global Security for the 5.125% Notes due 2017 (Exhibit 4.3,
Current
Report on Form 8-K dated November 18, 2004, File No.
1-11083).
|
|
4.10
|
|
Form
of Global Security for the 4.250% Notes due 2011 (Exhibit 4.2,
Current
Report on Form 8-K dated November 18, 2004, File No.
1-11083).
|
|
4.11
|
|
Form
of Global Security for the 5.50% Notes due 2015, and form of Notice
to the
holders thereof (Exhibit 4.1, Current Report on Form 8-K dated
November
17, 2005 and Exhibit 99.5, Current Report on Form 8-K dated April
21,
2006, File No. 1-11083).
|
|
4.12
|
|
Form
of Global Security for the 6.25% Notes due 2035, and form of Notice
to
holders thereof (Exhibit 4.2, Current Report on Form 8-K dated
November
17, 2005 and Exhibit 99.7, Current Report on Form 8-K dated April
21,
2006, File No. 1-11083).
|
|
4.13
|
|
Indenture
dated as of June 1, 2006 between the Company and JPMorgan Chase
Bank,
N.A., as Trustee (Exhibit 4.1, Current Report on Form 8-K dated
June 9,
2006, File No. 1-11083).
|
|
4.14
|
|
Form
of Global Security for the 6.00% Notes due 2011 (Exhibit 4.2,
Current
Report on Form 8-K dated June 9, 2006, File No. 1-11083).
|
|
4.15
|
|
Form
of Global Security for the 6.40% Notes due 2016 (Exhibit 4.3,
Current
Report on Form 8-K dated June 9, 2006, File No. 1-11083).
|
10.1
|
|
Form
of Credit and Security Agreement dated as of August 16, 2002 among
Boston
Scientific Funding Corporation, the Company, Blue Ridge Asset Funding
Corporation, Victory Receivables Corporation The Bank of Tokyo-Mitsubishi
Ltd., New York Branch and Wachovia Bank, N.A., as amended (Exhibit
10.1,
Quarterly Report on Form 10-Q for the quarter ended September 30,
2002,
Exhibit 10.1, Quarterly Report on Form 10-Q for quarter ended March
31,
2003, Exhibit 10.01, Quarterly Report on Form 10-Q for quarter
ended
September 30, 2003, Exhibit 10.1, Quarterly Report on Form 10-Q
for the
quarter ended March 31, 2004, Exhibit 10.1, Quarterly Report on
Form 10-Q
for the quarter ended June 30, 2004, and Exhibit 10.1, Quarterly
Report on
Form 10-Q for the quarter ended September 30, 2004, Exhibit 10.1,
Current
Report on Form 8-K dated August 12, 2005, Exhibit 10.7, Current
Report on
Form 8-K dated March 20, 2006, Exhibit 10.1, Quarterly Report on
Form 10-Q
for quarter ended June 30, 2006, File No. 1-11083).
|
|
*10.2
|
|
Form
of Omnibus Amendment dated as of December 21, 2006 among the Company,
Boston Scientific Funding Corporation, Variable Funding Capital
Company
LLC, Victory Receivables Corporation and The Bank of Tokyo-Mitsubishi
UFJ,
Ltd., New York Branch (Amendment No. 1 to Receivable Sale Agreement
and Amendment No. 9 to Credit and Security Agreement).
|
|
10.3
|
|
Form
of Receivables Sale Agreement dated as of August 16, 2002 between
the
Company and each of its Direct or Indirect Wholly-Owned Subsidiaries
that
Hereafter Becomes a Seller Hereunder, as the Sellers, and Boston
Scientific Funding Corporation, as the Buyer (Exhibit 10.2, Quarterly
Report on Form 10-Q for the quarter ended September 30, 2002, File
No.
1-11083).
|
|
10.4
|
|
Form
of Credit Agreement dated as of April 21, 2006 among the Company,
BSC
International Holding Limited, Merrill Lynch Capital Corporation,
Bear
Stearns Corporate Lending Inc., Deutsche Bank Securities Inc.,
Wachovia
Bank, National Association, Bank of America, N.A., Banc of America
Securities LLC, Merrill Lynch & Co. and Merrill Lynch, Pierce, Fenner
& Smith Incorporated (Exhibit 99.1, Current Report on Form 8-K dated
April 21, 2006, File No. 1-11083).
|
|
10.5
|
|
License
Agreement among Angiotech Pharmaceuticals, Inc., Cook Incorporated
and the
Company dated July 9, 1997, and related Agreement dated December
13, 1999
(Exhibit 10.6, Annual Report on Form 10-K for the year ended December
31,
2002, File No. 1-11083).
|
|
10.6
|
|
Amendment
between Angiotech Pharmaceuticals, Inc. and the Company dated
November 23,
2004 modifying July 9, 1997 License Agreement among Angiotech
Pharmaceuticals, Inc., Cook Incorporated and the Company (Exhibit
10.1,
Current Report on Form 8-K dated November 23, 2004, File No.
1-11083).
|
|
10.7
|
|
Form
of Offer Letter between Boston Scientific and Donald S. Baim,
M.D.
(Exhibit 10.1, Current Report on Form 8-K dated July 27, 2006,
File No.
1-11083).
|
|
10.8
|
|
Form
of Stock Option Agreement dated as of July 25, 2006 between Boston
Scientific and Donald S. Baim, M.D. (Exhibit 10.2, Current Report
on Form
8-K dated July 27, 2006, File No. 1-11083).
|
10.20
|
|
Boston
Scientific Corporation 401(k) Retirement Savings Plan, as Amended
and
Restated, Effective January 1, 2001, and amended (Exhibit 10, 12,
Annual
Report on Form 10-K for the year ended December 31, 2002, Exhibit
10.12,
Annual Report on Form 10-K for the year ended December 31, 2003,
Exhibit
10.1, Current Report on Form 8-K dated September 24, 2004 and Exhibit
10.52, Annual Report on Form 10-K for year ended December 31, 2005,
File
No. 1-11083).
|
|
*10.21
|
|
Form
of Fifth Amendment to Boston Scientific Corporation 401(k) Retirement
Savings Plan, effective as of January 1, 2006.
|
|
10.22
|
|
Boston
Scientific Corporation Global Employee Stock Ownership Plan, as
Amended
and Restated (Exhibit 10.18, Annual Report on Form 10-K for the
year ended
December 31, 1997, Exhibit 10.21, Annual Report on Form 10-K for
the year
ended December 31, 2000, Exhibit 10.22, Annual Report on Form 10-K
for the
year ended December 31, 2000 and Exhibit 10.14, Annual Report on
Form 10-K
for the year ended December 31, 2003, File No. 1-11083).
|
|
*10.23
|
|
Boston
Scientific Corporation 2006 Global Employee Stock Ownership
Plan.
|
|
*10.24
|
|
First
Amendment of the Boston Scientific Corporation 2006 Global Employee
Stock
Ownership Plan.
|
|
10.25
|
|
Boston
Scientific Corporation Deferred Compensation Plan, Effective January
1,
1996 (Exhibit 10.17, Annual Report on Form 10-K for the year ended
December 31, 1996, File No. 1-11083).
|
|
10.26
|
|
Boston
Scientific Corporation 1992 Non-Employee Directors' Stock Option
Plan, as
amended (Exhibit 10.2, Annual Report on Form 10-K for the year
ended
December 31, 1996, Exhibit 10.3, Annual Report on Form 10-K for
the year
ended December 31, 2000 and Exhibit 10.1, Current Report on Form
8-K dated
December 31, 2004, File No.1-11083).
|
|
10.27
|
|
Boston
Scientific Corporation 2003 Long-Term Incentive Plan, as amended
(Exhibit
10.17, Annual Report on Form 10-K for the year ended December 31,
2003 and
Exhibit 10.3, Current Report on Form 8-K dated May 9, 2005, File
No.
1-11083).
|
|
10.28
|
|
Boston
Scientific Corporation 2000 Long Term Incentive Plan, as amended
(Exhibit
10.20, Annual Report on Form 10-K for the year ended December 31,
1999,
Exhibit 10.18, Annual Report on Form 10-K for the year ended December
31,
2001, Exhibit 10.1, Current Report on Form 8-K dated December 22,
2004 and
Exhibit 10.3, Current Report on Form 8-K dated May 9, 2005, File
No.
1-11083).
|
|
10.29
|
|
Boston
Scientific Corporation 1995 Long-Term Incentive Plan, as amended
(Exhibit
10.1, Annual Report on Form 10-K for the year
|
|
ended December 31, 1996, Exhibit 10.5, Annual Report on Form 10-K for the year ended December 31, 2001, Exhibit 10.1, Current Report on Form 8-K dated December 22, 2004 and Exhibit 10.3, Current Report on Form 8-K dated May 9, 2005, File No. 1-11083). | |||
10.30
|
|
Boston
Scientific Corporation 1992 Long-Term Incentive Plan, as amended
(Exhibit
10.1, Annual Report on Form 10-K for the year ended December 31,
1996,
Exhibit 10.2, Annual Report on Form 10-K for the year ended December
31,
2001, Exhibit 10.1, Current Report on Form 8-K dated December 22,
2004 and
Exhibit 10.3, Current Report on Form 8-K dated May 9, 2005, File
No.
1-11083).
|
|
10.31
|
|
Form
of Deferred Stock Unit Agreement between Lucia L. Quinn and Boston
Scientific Corporation dated May 31, 2005 (Exhibit 10.1, Current
Report on
Form 8-K dated May 31, 2005, File No. 1-11083).
|
|
10.32
|
|
Form
of Boston Scientific Corporation Excess Benefit Plan (Exhibit 10.1,
Current Report on Form 8-K dated June 29, 2005, File No.
1-11083).
|
|
10.33
|
|
Form
of Trust Under the Boston Scientific Corporation Excess Benefit
Plan
(Exhibit 10.2, Current Report on Form 8-K dated June 29, 2005,
File No.
1-11083).
|
|
10.34
|
|
Form
of Non-Qualified Stock Option Agreement dated July 1, 2005 (Exhibit
10.1,
Current Report on Form 8-K dated July 1, 2005, File No.
1-11083).
|
|
10.35
|
|
Form
of Deferred Stock Unit Award Agreement dated July 1, 2005 (Exhibit
10.2,
Current Report on Form 8-K dated July 1, 2005, File No.
1-11083).
|
|
10.36
|
|
Form
of 2006 Performance Incentive Plan (Exhibit 10.1, Current Report
on Form
8-K dated June 30, 2006, File No. 1-11083).
|
|
10.37
|
|
Form
of 2007 Performance Incentive Plan, as amended (Exhibit 10.2, Current
Report on Form 8-K dated February 20, 2007, File No.
1-11083).
|
|
10.38
|
|
Form
of Non-Qualified Stock Option Agreement (Executive) (Exhibit 10.1,
Current
Report on Form 8-K dated May 12, 2006, File No. 1-11083).
|
|
10.39
|
|
Form
of Deferred Stock Unit Award Agreement (Executive) (Exhibit 10.2,
Current
Report on Form 8-K dated May 12, 2006, File No. 1-11083).
|
|
10.40
|
|
Form
of Non-Qualified Stock Option Agreement (Special) (Exhibit 10.3,
Current
Report on Form 8-K dated May 12, 2006, File No. 1-11083).
|
|
10.41
|
|
Form
of Deferred Stock Unit Award Agreement (Special) (Exhibit 10.4,
Current
Report on Form 8-K dated May 12, 2006, File No. 1-11083).
|
|
10.42
|
|
Target
Therapeutics, Inc. 1988 Stock Option Plan, as amended (Exhibit
10.2,
Quarterly Report of Target Therapeutics, Inc. on Form 10-Q for
the quarter
ended September 30, 1996, File No. 0-19801 and Exhibit 10.1, Current
Report on Form 8-K dated December 31, 2004, File No.
1-11083).
|
|
10.43
|
|
Embolic
Protection Incorporated 1999 Stock Plan, as amended (Exhibit 10.1,
Registration Statement on Form S-8, Registration No. 333-61060
and Exhibit
10.1, Current Report on Form 8-K dated December 31, 2004, File
No.
1-11083).
|
|
10.44
|
|
Quanam
Medical Corporation 1996 Stock Plan, as amended (Exhibit 10.3,
Registration Statement on Form S-8, Registration No. 333-61060
and Exhibit
10.1, Current Report on Form 8-K dated December 31, 2004, File
No.
1-11083).
|
|
10.45
|
|
RadioTherapeutics
Corporation 1994 Stock Incentive Plan, as amended (Exhibit 10.1,
Registration Statement on Form S-8, Registration No. 333-76380
and Exhibit
10.1, Current Report on Form 8-K dated December 31, 2004, File
No.
1-11083).
|
|
*10.46
|
|
Guidant
Corporation 1994 Stock Plan, as amended.
|
|
*10.47
|
|
Guidant
Corporation 1996 Nonemployee Director Stock Plan, as
amended.
|
|
*10.48
|
|
Guidant
Corporation 1998 Stock Plan, as amended.
|
|
*10.49
|
|
Form
of Guidant Corporation Option Grant.
|
|
*10.50
|
|
Form
of Guidant Corporation Restricted Stock Grant.
|
|
*10.51
|
|
The
Guidant Corporation Employee Savings and Stock Ownership Plan.
|
|
*10.52
|
|
First
Amendment of the Guidant Corporation Employee
Savings
and Stock Ownership Plan.
|
|
*10.53
|
|
Second
Amendment of the Guidant Corporation Employee Savings and Stock
Ownership
Plan.
|
|
*10.54
|
|
Third
Amendment of the Guidant Corporation Employee Savings and Stock
Ownership
Plan.
|
|
*10.55
|
|
Fourth
Amendment of the Guidant Corporation Employee Savings and Stock
Ownership
Plan.
|
|
*10.56
|
|
Fifth
Amendment of the Guidant Corporation Employee Savings and Stock
Ownership
Plan.
|
|
10.57
|
|
Settlement
Agreement effective September 21, 2005 among Medinol Ltd., Jacob
Richter
and Judith Richter and Boston Scientific Corporation, Boston Scientific
Limited and Boston Scientific Scimed, Inc. (Exhibit 10.1, Current
Report
on Form 8-K dated September 21, 2005, File No. 1-11083).
|
|
10.58
|
|
Transaction
Agreement, dated as of January 8, 2006, as amended, between Boston
Scientific Corporation and Abbott Laboratories (Exhibit 10.47,
Exhibit
10.48, Exhibit 10.49 and Exhibit 10.50, Annual Report on Form 10-K
for
year ended December 31, 2005, Exhibit 10.1, Current Report on Form
8-K
dated April 7, 2006, File No. 1-11083).
|
|
10.59
|
Purchase
Agreement between Guidant Corporation and Abbott Laboratories dated
April
21, 2006, as amended (Exhibit 10.2 and Exhibit 10.3, Quarterly
Report on
Form 10-Q for the quarter ended June 30, 2006, File No.
1-11083)
|
||
10.60
|
Promissory
Note between BSC International Holding Limited (“Borrower”) and Abbott
Laboratories (“Lender”) dated April 21, 2006 (Exhibit 10.4, Quarterly
Report on Form 10-Q for the quarter ended June 30, 2006, File
No.
1-11083)
|
||
10.61
|
Subscription
and Stockholder Agreement between Boston Scientific Corporation
and Abbott
Laboratories dated April 21, 2006, as amended (Exhibit 10.5 and
Exhibit
10.6, Quarterly Report on Form 10-Q for the quarter ended June
30, 2006,
File No. 1-11083)
|
||
10.62
|
Decision
and Order of the Federal Trade Commission in the matter of Boston
Scientific Corporation and Guidant Corporation finalized August
3, 2006
(Exhibit 10.5, Quarterly Report on Form 10-Q for the quarter
ended
September 30, 2006, File No. 1-11083)
|
||
10.63
|
|
Boston
Scientific Executive Allowance Plan (Exhibit 10.53, Annual Report
on Form
10-K for year ended December 31, 2005, File No. 1-11083).
|
|
10.64
|
|
Boston
Scientific Executive Retirement Plan (Exhibit 10.54, Annual Report
on Form
10-K for year ended December 31, 2005, File No. 1-11083).
|
|
10.65
|
|
Form
of Deferred Stock Unit Agreement between James R. Tobin and the
Company
dated February 28, 2006 (2003 Long-Term Incentive Plan) (Exhibit
10.56, Annual Report on Form 10-K for year ended December 31, 2005,
File
No. 1-11083).
|
|
10.66
|
|
Form
of Deferred Stock Unit Agreement between James R. Tobin and the
Company
dated February 28, 2006 (2000 Long-Term Incentive Plan) (Exhibit
10.57, Annual Report on Form 10-K for year ended December 31, 2005,
File
No. 1-11083).
|
|
11
|
|
Statement
regarding computation of per share earnings (included in Note M
to the
Company's 2006 consolidated financial statements for the year ended
December 31, 2006 included in Item 8).
|
|
*12
|
|
Statement
regarding computation of ratios of earnings to fixed
charges.
|
|
14
|
|
Code
of Conduct (Exhibit 14, Annual Report on Form 10-K for the year ended
December 31, 2005, File No. 1-11083).
|
|
*21
|
|
List
of the Company
’
s
subsidiaries as of February 28, 2007.
|
|
*23
|
|
Consent
of Independent Auditors, Ernst & Young, LLP.
|
|
*31.1
|
|
Certification
of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley
Act of 2002.
|
|
*31.2
|
|
Certification
of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley
Act of 2002.
|
|
*32.1
|
|
Certification
of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002.
|
|
*32.2
|
|
Certification
of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002.
|
BOSTON
SCIENTIFIC CORPORATION
|
||
|
|
|
Dated:
March 1, 2007
|
By: | /s/ LAWRENCE C. BEST |
Lawrence C. Best |
||
Chief
Financial Officer
|
Dated:
March 1, 2007
|
|
/s/
JOHN E. ABELE
John
E. Abele
Director,
Founder
|
Dated:
March 1, 2007
|
|
/s/
LAWRENCE C. BEST
Lawrence
C. Best
Executive
Vice President, Finance and
Administration
and Chief
Financial
Officer (Principal Financial
And
Accounting Officer)
|
Dated:
March 1, 2007
|
|
/s/
URSULA M. BURNS
Ursula
M. Burns
Director
|
Dated:
March 1, 2007
|
|
/s/
NANCY-ANN DePARLE
Nancy-Ann
DeParle
Director
|
Dated:
March 1, 2007
|
|
/s/
JOEL L. FLEISHMAN
Joel
L. Fleishman
Director
|
Dated:
March 1, 2007
|
|
/s/
MARYE ANNE FOX
Marye
Anne Fox, Ph.D.
Director
|
Dated:
March 1, 2007
|
|
/s/
RAY J. GROVES
Ray
J. Groves
Director
|
Dated:
March 1, 2007
|
|
/s/
KRISTINA M. JOHNSON
Kristina
M. Johnson
Director
|
Dated:
March 1, 2007
|
|
/s/
ERNEST MARIO
Ernest
Mario, Ph.D.
Director
|
|
|
|
|
/s/
N.J. NICHOLAS, JR.
N.J.
Nicholas, Jr.
Director
|
Dated:
March 1, 2007
|
|
/s/
PETE M. NICHOLAS
Pete
M. Nicholas
Director,
Founder, Chairman of the Board
|
Dated:
March 1, 2007
|
|
/s/
JOHN E. PEPPER
John
E. Pepper
Director
|
Dated:
March 1, 2007
|
|
/s/
UWE E. REINHARDT
Uwe
E. Reinhardt, Ph.D.
Director
|
Dated:
March 1, 2007
|
|
/s/
WARREN B. RUDMAN
Warren
B. Rudman
Director
|
Dated:
March 1, 2007
|
|
/s/
JAMES R. TOBIN
James
R. Tobin
Director,
President and
Chief
Executive Officer
(Principal
Executive Officer)
|
Year
Ended December 31,
|
Balance
at
Beginning
of
Year
|
Balance
Assumed from Guidant
|
Charges
to Costs and Expenses
|
Deductions
to Allowances for Uncollectible Amounts (a)
|
Charges
to Other Accounts (b)
|
Balance
at
End
of Year
|
|||||||||||||
Allowances
for uncollectible
|
|||||||||||||||||||
amounts
and sales returns:
|
|||||||||||||||||||
2006
|
$
|
83
|
15
|
12
|
(7
|
) |
19
|
$
|
122
|
||||||||||
2005
|
$
|
80
|
9
|
(8
|
) |
2
|
$
|
83
|
|||||||||||
2004
|
$
|
61
|
14
|
(4
|
) |
9
|
$
|
80
|
BOSTON
SCIENTIFIC FUNDING CORPORATION
Name:
Title:
|
VICTORY
RECEIVABLES CORPORATION
By
:
Name
:
Title
:
By:
Name:
Title:
THE
BANK OF
TOKYO
-MITSUBISHI
UFJ, LTD.,
NEW
YORK
BRANCH,
as Victory Agent
By:
Name:
Title:
|
PARTICIPANT:
Signature
_____________________________
<<Employee
Name>>
|
BOSTON SCIENTIFIC CORPORATION
James R. Tobin
President and Chief Executive
Officer
|
First
Plan Year in which the automatic compensation reduction authorization
is
in effect:
|
2%
of Compensation
|
Second
Plan Year in which the automatic compensation reduction authorization
is
in effect:
|
3%
of Compensation
|
Third
Plan Year in which the automatic compensation reduction authorization
is
in effect:
|
4%
of Compensation
|
Fourth
Plan Year in which the automatic compensation reduction authorization
is
in effect:
|
5%
of Compensation
|
Fifth
Plan Year and future Plan Years in which the automatic compensation
reduction authorization is in effect:
|
6%
of Compensation"
|
BOSTON
SCIENTIFIC CORPORATION
By:
___________________________
Title:
___________________________
Date:
___________________________
|
BOSTON
SCIENTIFIC CORPORATION
By:
Its:
|
|
ATTEST:
By:
Its:
|
GUIDANT CORPORATION 1994 STOCK PLAN
The Guidant Corporation 1994 Stock Plan ("1994 Plan") authorizes the Compensation Committee ("Committee") of the Board of Directors of Guidant Corporation to provide employees and consultants of Guidant Corporation and its subsidiaries with certain rights to acquire shares of Guidant Corporation common stock ("Guidant Stock"). The Company believes that this incentive program will benefit the Company's shareholders by allowing the Company to attract, motivate, and retain employees and consultants and by causing employees and consultants, through stock-based incentives, to contribute materially to the growth and success of the Company. For purposes of the 1994 Plan, the term "Company" shall mean Guidant Corporation and its subsidiaries, unless the context requires otherwise.
1. Administration.
The 1994 Plan shall be administered and interpreted by the Committee consisting of not less than three persons appointed by the Board of Directors of the Company from among its members. A person may serve on the Committee only if he or she (i) is a nonemployee director as defined in Rule 16b-3(b)(3) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and (ii) satisfies the requirements of an "outside director" for purposes of Section 162(m) of the Internal Revenue Code of 1986, as amended (the "Code"). The Committee shall determine the fair market value of Guidant Stock for purposes of the 1994 Plan. The Committee may, subject to the provisions of the 1994 Plan, from time to time establish such rules and regulations as it deems appropriate for the proper administration of the Plan. The Committee's decisions shall be final, conclusive, and binding with respect to the interpretation and administration of the 1994 Plan and any Grant made under it. Except to the extent expressly prohibited by the 1994 Plan or applicable law, the Committee may delegate to one or more of its members, or to one or more agents, such responsibility or duties as it deems desirable.
2. Grants.
Incentives under the 1994 Plan shall consist of incentive stock options, nonqualified stock options, performance awards, and restricted stock grants (collectively, "Grants"). All Grants shall be subject to the terms and conditions set out herein and to such other terms and conditions which are not inconsistent with the 1994 Plan as the Committee deems appropriate. The Committee shall approve the form and provisions of each Grant. Grants under a particular section of the 1994 Plan need not be uniform and Grants under two or more sections may be combined in one instrument.
3. Eligibility for Grants.
Grants may be made to any employee (including any officer) or consultant of the Company ("Eligible Person"). The Committee shall select the persons to receive Grants ("Grantees") from among the Eligible Persons and determine the number of shares subject to any particular Grant.
4. Shares Available for Grant.
(a) Shares Subject to Issuance or Transfer. Subject to adjustment as provided in Section 4(b), the aggregate number of shares of Guidant Stock that may be issued or transferred under the 1994 Plan is 7,000,000. The shares may be authorized but unissued shares or treasury shares. The number of shares available for Grants at any given time shall be 7,000,000, reduced by the aggregate of all shares previously issued or transferred and of shares which may become subject to issuance or transfer under then-outstanding Grants. Payment in cash in lieu of shares shall be deemed to be an issuance of the shares for purposes of determining the number of shares available for Grants under the 1994 Plan as a whole or to any individual Grantee.
(b) Adjustment Provisions. If any subdivision or combination of shares of Guidant Stock or any stock dividend, reorganization, recapitalization, or consolidation or merger with Guidant Corporation as the surviving corporation occurs, or if additional shares or new or different shares or other securities of the Company or any other issuer are distributed with respect to the shares of Guidant Stock through a spin-off, exchange offer, or other extraordinary distribution, the Committee shall make such adjustments as it determines appropriate in the number of shares of Guidant Stock that may be issued or transferred in the future under Sections 4(a) and 5(f). The Committee shall also adjust as it determines appropriate the number of shares and Option Price in outstanding Grants made before the event.
5. Stock Options.
The Committee may grant options qualifying as incentive stock options under the Code ("Incentive Stock Options"), and nonqualified options (collectively, "Stock Options"). The following provisions are applicable to Stock Options:
(a) Option Price. The Committee shall determine the price at which Guidant Stock may be purchased by the Grantee under a Stock Option ("Option Price") which, except in the case of substitute grants as described in Section 10(b), shall be not less than the fair market value of Guidant Stock on the date the Stock Option is granted (the "Grant Date"). In the Committee's discretion, the Grant Date of a Stock Option may be established as the date on which Committee action approving the Stock Option is taken or any later date specified by the Committee.
(b) Option Exercise Period. The Committee shall determine the option exercise period of each Stock Option. The period shall not exceed ten years from the Grant Date.
(c) Exercise of Option. A Grantee may exercise a Stock Option by delivering a notice of exercise to the Company or its representative as designated by the Committee, either with or without accompanying payment of the Option Price. The notice of exercise, once delivered, shall be irrevocable.
(d) Satisfaction of Option Price. The Grantee shall pay or cause to be paid the Option Price in cash, or with the Committee's permission, by delivering shares of Guidant Stock already owned by the Grantee and having a fair market value on the date of exercise equal to the Option Price, or a combination of cash and shares. In addition, the Committee may permit the exercise of an option by delivery of written notice, subject to the Company's receipt of a third-party payment in full in cash for the Option Price prior to the issuance of shares of Guidant Stock, in the manner and subject to the procedures as may be established by the Committee. Unless the Committee establishes a shorter period which is set forth in the Stock Option, the Grantee shall pay the Option Price not later than 30 days after the date of a statement from the Company following exercise setting forth the Option Price, fair market value of Guidant Stock on the exercise date, the number of shares of Guidant Stock that may be delivered in payment of the Option Price, and the amount of withholding tax due, if any. If the Grantee fails to pay the Option Price within the specified period, the Committee shall have the right to take whatever action it deems appropriate, including voiding the option exercise. The Company shall not issue or transfer shares of Guidant Stock upon exercise of a Stock Option until the Option Price and any required withholding tax are fully paid.
(e) Share Withholding. With respect to any nonqualified option, the Committee may, in its discretion and subject to such rules as the Committee may adopt, permit or require the Grantee to satisfy, in whole or in part, any withholding tax obligation which may arise in connection with the exercise of the nonqualified option by having the Company withhold shares of Guidant Stock having a fair market value equal to the amount of the withholding tax.
(f) Limits on Individual Grants. No individual Grantee may be granted Stock Options under the 1994 Plan for more than 700,000 shares of Guidant Stock during any three consecutive calendar years.
(g) Limits on Incentive Stock Options. The aggregate fair market value of the stock covered by Incentive Stock Options granted under the 1994 Plan or any other stock option plan of the Company or any subsidiary or parent of the Company that become exercisable for the first time by any employee in any calendar year shall not exceed $100,000. The aggregate fair market value will be determined at the Grant Date. An Incentive Stock Option shall not be granted to any Eligible Person who, on the Grant Date, owns stock possessing more than 10% of the total combined voting power of all classes of stock of the Company or any subsidiary or parent of the Company.
6. Performance Awards.
The Committee may grant Performance Awards which shall be denominated at the time of grant either in shares of Guidant Stock ("Stock Performance Awards") or in dollar amounts ("Dollar Performance Awards"). Payment under a Stock Performance Award or a Dollar Performance Award shall be made, at the discretion of the Committee, in shares of Guidant Stock ("Performance Shares"), or in cash or in any combination thereof, if the financial performance of the Company or any subsidiary, division, or other unit of the Company ("Business Unit") selected by the Committee for the Award Period (as defined below). The following provisions are applicable to Performance Awards:
(a) Award Period. The Committee shall determine and include in the Grant the period of time (which shall be four or more consecutive fiscal quarters) for which a Performance Award is made ("Award Period"). Grants of Performance Awards need not be uniform with respect to the length of the Award Period. Award Periods for different Grants may overlap. A Performance Award may not be granted for a given Award Period after one half (1/2) or more of such period has elapsed.
(b) Performance Goals and Payment. Before a Grant is made, the Committee shall establish objectives ("Performance Goals") that must be met by the Business Unit during the Award Period as a condition to payment being made under the Performance Award. The Performance Goals, which must be set out in the Grant, may include earnings per share, return on assets, return on shareholders' equity, divisional income, net income, or any other financial measurement established by the Committee. The Committee shall also set forth in the Grant the number of Performance Shares or the amount of payment to be made under a Performance Award if the Performance Goals are met or exceeded, including the fixing of a maximum payment.
(c) Computation of Payment. After an Award Period, the financial performance of the Business Unit during the period shall be measured against the Performance Goals. If the Performance Goals are not met, no payment shall be made under a Performance Award. If the Performance Goals are met or exceeded, the Committee shall determine the number of Performance Shares or the amount of payment to be made under a Performance Award in accordance with the grant for each Grantee. The Committee, in its sole discretion, may elect to pay part or all of the Performance Award in cash in lieu of issuing or transferring Performance Shares. The cash payment shall be based on the fair market value of Guidant Stock on the date of payment. The Company shall promptly notify each Grantee of the number of Performance Shares and the amount of cash, if any, he or she is to receive.
(d) Revisions for Significant Events. At any time before payment is made, the Committee may revise the Performance Goals and the computation of payment if unforeseen events occur during an Award Period which have a substantial effect on the Performance Goals and which in the sole discretion of the Committee make the application of the Performance Goals unfair unless a revision is made.
(e) Requirement of Employment. To be entitled to receive payment under a Performance Award, a Grantee who is an employee of the Company must remain in the employment of the Company to the end of the Award Period, except that the Committee may provide for partial or complete exceptions to this requirement as it deems equitable in its sole discretion.
7. Restricted Stock Grants.
The Committee may issue or transfer shares of Guidant Stock to a Grantee under a Restricted Stock Grant. Upon the issuance or transfer, the Grantee shall be entitled to vote the shares and to receive any dividends paid. The following provisions are applicable to Restricted Stock Grants:
(a) Requirement of Employment. If the employment of a Grantee who is an employee of the Company terminates during the period designated in the Grant as the "Restriction Period," the Restricted Stock Grant terminates and the shares of Guidant Stock must be returned immediately to the Company. However, the Committee may provide for partial or complete exceptions to this requirement as it deems equitable.
(b) Restrictions on Transfer and Legend on Stock
Certificate. During the Restriction Period, a Grantee may not
sell, assign, transfer, pledge, or otherwise dispose of the
shares of Guidant Stock except to a Successor Grantee under
Section 10(a). Each certificate for shares issued or transferred
under a Restricted Stock Grant shall contain a restricted legend
or be held in escrow by the Company until the expiration of the
Restriction Period.
(c) Lapse of Restrictions. All restrictions imposed under
the Restricted Stock Grant shall lapse (i) upon the expiration of
the Restriction Period if all conditions, including those stated
in Sections 7(a) and (b) have been met or (ii) as provided under
Section 9(a)(ii). The Grantee shall then be entitled to delivery
of the certificate.
8. Amendment and Termination of the 1994 Plan.
(a) Amendment. The Company's Board of Directors may amend or terminate the 1994 Plan, subject to shareholder approval to the extent necessary for the continued applicability of Rule 16b- 3 under the Exchange Act, but no amendment shall withdraw from the Committee the right to select Grantees under Section 3.
(b) Termination of 1994 Plan. The 1994 Plan shall terminate on May 31, 2000, unless terminated earlier by the Board or unless extended by the Board.
(c) Termination and Amendment of Outstanding Grants. A termination or amendment of the 1994 Plan that occurs after a Grant is made shall not result in the termination or amendment of the Grant unless the Grantee consents or unless the Committee acts under Section 11(e). The termination of the 1994 Plan shall not impair the power and authority of the Committee with respect to outstanding Grants. Whether or not the 1994 Plan has terminated, an outstanding Grant may be terminated or amended under Section 11(e) or may be amended (i) by agreement of the Company and the Grantee consistent with the 1994 Plan or (ii) by action of the Committee provided that the amendment is consistent with the 1994 Plan and is found by the Committee not to materially impair the rights of the Grantee under the Grant.
9. Change of Control.
(a) Effect on Grants. Unless the Committee shall otherwise expressly provide in the agreement relating to a Grant, upon the occurrence of a Change of Control (as defined below):
(i) In the case of Stock Options, (A) each outstanding Stock
Option that is not then fully exercisable shall automatically
become fully exercisable until the termination of the option
exercise period of the Stock Option (as modified by subsection
(i)(B) that follows, and (B) in the event the Grantee's
employment is terminated within two years after a Change of
Control, his or her outstanding Stock Options at that date of
termination shall be immediately exercisable for a period of
three months following such termination, provided, however, that,
to the extent the Stock Option by its terms otherwise permits a
longer option exercise period after such termination, such longer
period shall govern, and provided further that in no event shall
a Stock Option be exercisable more than 10 years after the Grant
Date;
(ii) The Restriction Period on all outstanding Restricted Stock Grants shall automatically expire and all restrictions imposed under such Restricted Stock Grants shall immediately lapse; and
(iii) Each Grantee of a Performance Award for an Award Period that has not been completed at the time of the Change of Control shall be deemed to have earned a minimum Performance Award equal to the product of (A) such Grantee's maximum award opportunity for such Performance Award and (B) a fraction, the numerator of which is the number of full and partial months that have elapsed since the beginning of such Award Period to the date on which the Change of Control occurs, and the denominator of which is the total number of months in such Award Period.
(b) Change of Control. For purposes of the 1994 Plan, a Change of Control shall mean the happening of any of the following events:
(i) The acquisition by any "person," as that term is used in Sections 13(d) and 14(d) of the Exchange Act (other than (A) the Company, (B) any subsidiary of the Company, (C) any employee or directors' benefit plan or stock plan of the Company or a subsidiary of the Company, or any trustee or fiduciary with respect to any such plan when acting in that capacity, or (D) any person who acquires such shares pursuant to a transaction or series of transactions approved prior to such transaction(s) by the Board of Directors of the Company) of "beneficial ownership" as defined in Rule 13d-3 under the Exchange Act, directly or indirectly, of 20% or more of the shares of the Company's capital stock the holders of which have general voting power under ordinary circumstances to elect at least a majority of the Board of Directors of the Company (or which would have such voting power but for the application of the Indiana Control Share Statute) ("Voting Stock");
(ii) the first day on which less than two-thirds of the total membership of the Board of Directors of the Company shall be Continuing Directors (as that term is defined in Article 6(f) of the Company's Articles of Incorporation;
(iii) approval by the shareholders of the Company of a merger, share exchange, or consolidation of the Company (a "Transaction"), other than a Transaction which would result in the Voting Stock of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) more than 50% of the Voting Stock of the Company or such surviving entity immediately after such Transaction; or
(iv) approval by the shareholders of the Company of a complete liquidation of the Company or a sale or disposition of all or substantially all the assets of the Company.
10. Eligible Persons Resident Outside the United States.
The following provisions shall apply to each Eligible Person who is resident outside the United States:
(a) Determination of Eligible Locations. The Committee shall determine whether it is feasible or desirable under local law, custom and practice to make Grants at each location outside the United States. In making this determination as of any Grant Date, the Committee may differentiate among classes of individuals (including expatriates, third country nationals or international assignees) and locations within a particular country.
(b) Special Terms Applicable to Grants. In order to facilitate the making of Grants under this Section 10, the Committee may provide for such special terms for Grants to Grantees who are foreign nationals or who are employed outside the United States as the Committee may consider necessary or desirable to accommodate differences in local law, policy or custom, or to take advantage of special tax or social insurance regimes applicable in a particular jurisdiction. The Committee may approve such supplements, restatements or alternate versions of the Plan as it may consider necessary or desirable for such purposes, without thereby affecting the terms of the Plan as in effect for any other purpose. Without limiting the generality of the foregoing, the Committee may adopt special sub-plans applicable to individuals in particular jurisdictions (e.g., French or U.K. qualified plans), may provide for accelerated vesting with restrictions on the shares received under a Grant, and may condition Grants on acknowledgments or agreements by Grantees tailored to local law.
(c) No Acquired Rights. Nothing in the 1994 Plan or in this Section 10 shall confer upon any individual in any country the right to receive (or to continue to receive) any Grant, any form of Grant or to receive any benefit in lieu of a Grant hereunder, nor to have any special tax treatment apply to any Grant.
11. General Provisions.
(a) Transfer of Grants. Only a Grantee or his or her authorized legal representative or valid transferee may exercise rights under a Grant. Such persons may not transfer those rights. Except as set forth below, the rights under a Grant may not be disposed of by transfer, alienation, pledge, encumbrance, assignment, or any other means, whether voluntary, involuntary, or by operation of law, and any such attempted disposition shall be void. Notwithstanding the foregoing and solely to the extent permitted by the Committee in an agreement relating to a Grant, rights under a Grant (other than pursuant to an Incentive Stock Option) may be transferred to members of a Grantee's immediate family, charitable institutions, or trusts or partnerships whose beneficiaries are any of the foregoing, or to such other persons or entities as may be approved by the Committee, in each case subject to the condition that the Committee be satisfied that such transfer is being made for estate or tax planning purposes or for donative purposes without consideration being received therefor. In addition, when a Grantee dies, the personal representative or other person entitled to succeed to the rights of the Grantee may exercise the rights. A successor to the rights under a Grant pursuant to the foregoing ("Successor Grantee") must furnish proof satisfactory to the Company of his or her right to receive the Grant, whether as a result of a transfer from the Grantee, under the Grantee's will or under the applicable laws of descent and distribution.
(b) Substitute Grants. The Committee may make a Grant to an employee of another corporation who becomes an Eligible Person by reason of a corporate merger, consolidation, acquisition of stock or property, reorganization or liquidation involving the Company in substitution for a stock option, performance award, or restricted stock grant granted by such other corporation ("Substituted Stock Incentive"). The terms and conditions of the substitute Grant may vary from the terms and conditions required by the 1994 Plan and from those of the Substituted Stock Incentives. The Committee shall prescribe the exact provisions of the substitute Grants, preserving to the extent the Committee deems practical the provisions of the Substituted Stock Incentives. The Committee shall also determine the number of shares of Guidant Stock to be taken into account under Section 4.
(c) Subsidiaries. The term "subsidiary" means a corporation of which Guidant owns directly or indirectly 50% or more of the voting power.
(d) Fractional Shares. Fractional shares shall not be issued or transferred under a Grant, but the Committee may pay cash in lieu of a fraction or round the fraction.
(e) Compliance with Law. The 1994 Plan, the exercise of Grants, and the obligations of the Company to issue or transfer shares of Guidant Stock under Grants shall be subject to all applicable laws and regulations and to approvals by any governmental or regulatory agency as may be required. The Committee may revoke any Grant if it is contrary to law or modify a Grant to bring it into compliance with any valid and mandatory law or governmental regulation. The Committee may also adopt rules regarding the withholding of taxes on payment to Grantees.
(f) Ownership of Stock. A Grantee or Successor Grantee shall have no rights as a stockholder of the Company with respect to any shares of Guidant Stock covered by a Grant until the shares are issued or transferred to the Grantee or Successor Grantee on the Company's books.
(g) No Right to Employment. The 1994 Plan and the Grants under it shall not confer upon any Grantee the right to continue in the employment of the Company or affect in any way the right of the Company to terminate the employment of a Grantee at any time, with or without notice or cause.
(h) Foreign Jurisdictions. The Committee may adopt, amend, and terminate such arrangements, not inconsistent with the intent of the 1994 Plan, as it may deem necessary or desirable to make available tax or other benefits of the laws of foreign jurisdictions to Grantees who are subject to such laws.
(i) Governing Law. The 1994 Plan and all Grants made under it shall be governed by and interpreted in accordance with the laws of the State of Indiana, regardless of the laws that might otherwise govern under applicable Indiana conflict-of-laws principles.
(j) Effective Date of the 1994 Plan. The 1994 Plan shall become effective on October 17, 1994.
***
GUIDANT CORPORATION
1996 NONEMPLOYEE DIRECTORS STOCK PLAN, AS AMENDED
ARTICLE I
PURPOSE
1.1 This Guidant Corporation 1996 Nonemployee Directors Stock Plan is intended to advance the interests of Guidant Corporation and its shareholders by attracting, retaining and motivating the performance of nonemployee directors of Guidant Corporation and to encourage and enable such directors to acquire and retain a proprietary interest in Guidant Corporation by ownership of its stock.
ARTICLE II
DEFINITIONS
2.1 "Board" means the Board of Directors of the Company.
2.2 "Code" means the Internal Revenue Code of 1986, as amended.
2.3 "Common Stock" means the Company's common stock.
2.4 "Company" means Guidant Corporation.
2.5 "Date of Grant" means the date on which an option is granted in accordance with Section 3.3 or Section 5.1 hereof or a Restricted Stock Award is granted in accordance with Section 6.1 hereof.
2.6 "Disability" means a permanent and total disability within the meaning of Section 22(e)(3) of the Code.
2.7 "Exchange Act" means the Securities Exchange Act of 1934, as amended.
2.8 "Fair Market Value" means the average of the highest and lowest sale prices of a share of Common Stock on the New York Stock Exchange (NYSE) on the date as of which fair market value is to be determined or, in the absence of any reported sales of Common Stock on such date, on the first preceding date on which any such sale shall have been reported. If Common Stock is not listed on the NYSE on the date as of which fair market value is to be determined, the Board shall determine in good faith the fair market value in whatever manner it considers appropriate.
2.9 "Grant" means the Options and Restricted Stock Awards granted to a Grantee under the Plan.
2.10 "Grantee" means a person to whom an Option or a Restricted Stock Award has been granted under the Plan.
2.11 "Nonemployee Director" means any member of the Board who is not an employee of the Company.
2.12 "Option" means a stock option granted under the Plan.
2.13 "Option Price" means the price at which each share of Common Stock subject to an Option may be purchased, determined in accordance with Section 3.3 or Section 5.2 hereof.
2.14 "Plan" means this Guidant Corporation 1996 Nonemployee Directors Stock Plan, as amended.
2.15 "Restricted Stock Award" means an award of Common Stock granted under the Plan and subject to the restrictions set forth herein.
2.16 "Restricted Stock Notice" means a notification by the Company to a Grantee pursuant to which Common Stock will be issued or transferred to a Grantee under the Plan.
2.17 "Rule 16b-3" means Rule 16b-3 under the Securities Exchange Act of 1934, as amended.
2.18 "Stock Option Notice" means a notification by the Company to a Grantee pursuant to which a Grantee may purchase Common Stock under the Plan.
ARTICLE III
ADMINISTRATION; GRANTS
3.1 Board Authority. Subject to the express provisions of the Plan, the Board shall have discretionary authority to interpret the Plan, to prescribe, amend and rescind rules and regulations relating to it, to determine the details and provisions of each Stock Option Notice and Restricted Stock Notice, and to make all the determinations necessary or advisable in the administration of the Plan. All such actions and determinations by the Board shall be conclusively binding for all purposes and upon all persons. The Board shall not be liable for any action or determination made in good faith with respect to the Plan, any Option or Restricted Stock Award or any Stock Option Notice or Restricted Stock Notice entered into hereunder.
3.2 Annual Retainer Grants. Commencing with the 2003 annual meeting of the Company's shareholders and on the date of each annual meeting thereafter, each Nonemployee Director who is a member of the Board immediately following each such
annual meeting shall receive, as determined by the Board, a grant of (i) an Option to purchase shares of Common Stock in accordance with the provisions of Article V hereof and (ii) a Restricted Stock Award in accordance with the provisions of Article VI hereof.
3.3 Discretionary Option Grants. The Board may make discretionary Grants of Options to any Nonemployee Director in accordance with the provisions of this Section 3.3. The Board shall select the persons who will receive Options under this Section 3.3 from among the Nonemployee Directors and determine the number of shares subject to any particular Option. The Option Price of each share of Common Stock subject to an Option under this Section 3.3 shall be 100 percent of the Fair Market Value of a share of Common Stock on the Date of Grant. The Board shall determine the exercise period of each Option granted under this Section 3.3, which shall not exceed ten years from the Date of Grant. Such exercise period shall be set forth in the related Stock Option Notice which shall be prepared and delivered as provided in the last sentence of Section 5.1 hereof. A Grantee may exercise an Option granted under this Section 3.3 in the manner and in accordance with the provisions set forth in Section 5.5 hereof.
ARTICLE IV
SHARES OF STOCK SUBJECT TO PLAN
4.1 Number of Shares. Subject to adjustment pursuant to the provisions of this Article IV, the maximum number of shares of Common Stock which may be issued and sold hereunder shall be 250,000(1) shares. Shares of Common Stock issued and sold under the Plan may be either authorized but unissued shares or shares held in the Company's treasury. Shares of Common Stock covered by an Option that shall have been exercised shall not again be available for grant. If an Option shall terminate for any reason without being wholly exercised, the number of shares to which such Option termination relates shall again be available for grant hereunder. Shares of Common Stock covered by a Restricted Stock Award for which the restrictions have lapsed shall not again be available for grant. If a Restricted Stock Award shall terminate for any reason prior to the time its restrictions shall have lapsed, the number of shares to which such Restricted Stock Award relates shall again be available for grant hereunder.
4.2 Antidilution. If any subdivision or combination of shares of Common Stock or any stock dividend, reorganization, recapitalization, or consolidation or merger with the Company as the surviving corporation occurs, or if additional shares or new or different shares or other securities of the Company or any other issuer are distributed with respect to the shares of Common Stock through a spin-off, exchange offer, or other extraordinary distribution, the Board shall make such adjustments as it determines appropriate in the number of shares of Common Stock that may be issued or transferred in the future under Articles III, V and VI. The Board shall also adjust as it determines appropriate the number of shares and Option Price in outstanding Grants made before the event.
ARTICLE V
ANNUAL RETAINER OPTIONS
5.1 Grant of Option. Commencing with the 2003 annual meeting of the Company's shareholders and on the date of each annual meeting thereafter, each Nonemployee Director who is a member of the Board immediately following each such annual meeting shall receive a grant of an Option to purchase Common Stock as determined in accordance with Section 3.2 hereof. The Company shall deliver to the Grantee a Stock Option Notice which shall set forth such terms and conditions of the Option as may be determined by the Board to be consistent with the Plan, and which may include additional provisions and restrictions that are not inconsistent with the Plan.
5.2 Option Price. The Option Price of each share of Common Stock subject to an Option shall be 100 percent of the Fair Market Value of a share of Common Stock on the Date of Grant.
5.3 Vesting; Term of Option. An Option granted under Section 5.1 hereof shall vest and become fully exercisable on the first date following the Date of Grant on which is held the annual meeting of the shareholders of the Company, provided that the Grantee is a member of the Board immediately preceding such annual meeting. In the event of the Grantee's death or Disability, an Option shall become fully vested and immediately exercisable. The period during which a vested Option may be exercised shall be ten years from the Date of Grant, subject to Section 5.4 hereof.
5.4 Termination of Option. A vested Option granted under Section 5.1 hereof may be exercised prior to the Termination Date. The Termination Date shall be the earliest to occur of (i) ten years from the Date of Grant; (ii) the day of resignation or removal from the Board, except by reason of (a) death, (b) retirement from the Board, or (c) Disability; (iii) the corresponding calendar day in the sixtieth month following (a) the date the Grantee retires from the Board or (b) the day on which the Grantee's seat on the Board is terminated by reason of Disability, or on the last day of that sixtieth month if there is no corresponding day in that month; or (iv) the corresponding calendar day in the sixtieth month following the date of death of the Grantee while an active member of the Board or on the last day of that sixtieth month if there is no corresponding day in that month.
5.5 Option Exercise. A Grantee may exercise an Option by delivering notice of exercise to the Company or its representative as designated by the Board, either with or without accompanying payment of the Option Price. The notice of exercise, once delivered, shall be irrevocable. The Grantee shall pay or cause to be paid the Option Price in cash, or with the Board's permission, by delivering shares of Common Stock already owned by the Grantee and having a fair market value on the date of exercise equal to the Option Price, or a combination of cash and shares. In addition, the Board may permit the exercise of an Option by delivery of written notice, subject to the Company's receipt of a third-party payment in full in cash for the Option Price prior to the issuance of Common Stock, in the manner and subject to the procedures as may be established by the Board. Unless the Board establishes a
shorter period which is set forth in the Stock Option Notice, the Grantee shall pay the Option Price not later than 30 days after the date of a statement from the Company following exercise setting forth the Option Price, fair market value of Common Stock on the exercise date, the number of shares of Common Stock that may be delivered in payment of the Option Price, and the amount of withholding tax due, if any. If the Grantee fails to pay the Option Price within the specified period, the Board shall have the right to take whatever action it deems appropriate, including voiding the Option exercise. The Company shall not issue or transfer shares of Common Stock upon exercise of an Option until the Option Price is fully paid.
ARTICLE VI
RESTRICTED STOCK AWARDS
6.1 Restricted Stock Award. Commencing with the 2003 annual meeting of the Company's shareholders and on the date of each annual meeting thereafter, each Nonemployee Director who is a member of the Board immediately following each such annual meeting shall receive a grant of a Restricted Stock Award determined in accordance with Section 3.2 hereof. The Company shall deliver to the Grantee a Restricted Stock Notice which shall set forth such terms and conditions of the Restricted Stock Award as may be determined by the Board to be consistent with the Plan, and which may include additional provisions and restrictions that are not inconsistent with the Plan. Upon the issuance or transfer of a Restricted Stock Award, the Grantee shall be entitled to vote the shares and to receive any dividends paid thereon.
6.2 Restriction Period. The rights of a Grantee in respect of a Restricted Stock Award shall be subject to a "Restriction Period" (after which restrictions shall lapse), which shall mean a period commencing on the Date of Grant and ending on the first date following the Date of Grant on which is held the annual meeting of the shareholders of the Company, provided that the Grantee is a member of the Board immediately preceding such annual meeting.
6.3 Requirement of Service. If the Grantee's service as a member of the Board is terminated for any reason during the Restriction Period, the Restricted Stock Award shall terminate and the shares of Common Stock must be returned immediately to the Company; provided, however, the Restriction Period for any Restricted Stock Award shall expire and all restrictions shall lapse upon the Grantee's death or Disability.
6.4 Restrictions on Transfer and Legend on Stock Certificate. During
the Restriction Period, a Grantee may not sell, assign, transfer, pledge, or
otherwise dispose of the shares of Common Stock except in accordance with
Section 9.1 hereof. Each certificate for shares issued or transferred under a
Restricted Stock Award shall be held in escrow by the Company until the
expiration of the Restriction Period.
6.5 Lapse of Restrictions. All restrictions imposed under the Restricted Stock Award shall lapse (i) upon the expiration of the Restriction Period if all conditions stated in
Sections 6.3 and 6.4 have been met or (ii) as provided under Section 7.1(b). The Grantee shall then be entitled to delivery of the certificate.
ARTICLE VII
CHANGE OF CONTROL
7.1 Effect of Grants. Unless the Board shall otherwise expressly provide in the agreement relating to a Grant, upon the occurrence of a Change of Control (as defined below):
(a) Each outstanding Option that is not then fully exercisable shall automatically become immediately and fully exercisable and shall remain exercisable until the termination of the Option exercise period applicable to the Option under Section 3.3 or Article V as the case may be; and
(b) The Restriction Period on an outstanding Restricted Stock Award shall automatically expire and all restrictions imposed under such Restricted Stock Award shall immediately lapse.
7.2 Change of Control. For purposes of the Plan, a Change of Control shall mean the happening of any of the following events:
(a) The acquisition by any "person," as that term is used in Sections 13(d) and 14(d) of the Exchange Act (other than (i) the Company, (ii) any subsidiary of the Company, (iii) any employee or directors' benefit plan or stock plan of the Company or a subsidiary of the Company, or any trustee or fiduciary with respect to any such plan when acting in that capacity, or (iv) any person who acquires such shares pursuant to a transaction or series of transactions approved prior to such transaction(s) by the Board) of "beneficial ownership," as defined in Rule 13d-3 under the Exchange Act, directly or indirectly, of 20% or more of the shares of the Company's capital stock, the holders of which have general voting power under ordinary circumstances to elect at least a majority of the Board (or which would have such voting power but for the application of the Indiana Control Share Statute) ("Voting Stock");
(b) the first day on which less than two-thirds of the total membership of the Board shall be Continuing Directors (as that term is defined in Article 6(f) of the Company's Amended and Restated Articles of Incorporation);
(c) approval by the shareholders of the Company of a merger, share exchange, or consolidation of the Company (a "Transaction"), other than a Transaction which would result in the Voting Stock of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) more than 50% of the Voting Stock of the Company or such surviving entity immediately after such Transaction; or
(d) approval by the shareholders of the Company of a complete liquidation of the Company or a sale or disposition of all or substantially all the assets of the Company.
For purposes hereof, the term "subsidiary" means a corporation of which the Company owns directly or indirectly 50% or more of the voting power.
ARTICLE VIII
EFFECTIVE DATE, TERMINATION AND AMENDMENT
8.1 Effective Date. The Plan shall become effective after its adoption by the Board and on the date of its approval by the affirmative votes of the shareholders of the Company present, or represented, and entitled to vote at a meeting duly held in accordance with applicable state law and the Articles of Incorporation and By-laws of the Company.
8.2 Termination. The Plan shall terminate on the date following the date of the 2006 Annual Meeting of Shareholders of the Company. The Board may, in its sole discretion and at any earlier date, terminate the Plan. Notwithstanding the foregoing, no termination of the Plan shall in any manner affect any Grant theretofore granted without the consent of the Grantee or the permitted transferee of the Grant.
8.3 Amendment. The Board may at any time and from time to time and in
any respect, amend or modify the Plan; provided, however, that, solely to the
extent necessary to comply with Rule 16b-3 (i) the Board may not act more than
once every six months to amend the provisions of the Plan relating to the
determination of the amount, price or timing of any Grant under the Plan; and
(ii) the approval of the Company's shareholders will be required for any
amendment that (a) changes the class of persons eligible for the Grants, (b)
increases (other than as described in Section 4.2 hereof) the maximum number of
shares of Common Stock subject to grant under the Plan, as specified in Section
4.1 hereof, or (c) materially increases the benefits accruing to Grantees under
the Plan, within the meaning of Rule 16b-3. Any such approval shall be by the
affirmative votes of the shareholders of the Company present, or represented,
and entitled to vote at a meeting duly held in accordance with applicable state
law and the Articles of Incorporation and By-laws of the Company.
Notwithstanding the foregoing, no amendment or modification of the Plan shall in
any manner affect any Grant theretofore granted without the consent of the
Grantee or the permitted transferee of the Grant.
ARTICLE IX
MISCELLANEOUS
9.1 Nontransferability of Grant. No Grant shall be transferred by a Grantee other than by will or the laws of descent and distribution. No transfer of a Grant by the Grantee by will or by laws of descent and distribution shall be effective to bind the Company unless the Company shall have been furnished with written notice thereof and an authenticated copy of
the will and/or such other evidence as the Board may deem necessary to establish the validity of the transfer. During the lifetime of the Grantee, the Grant shall be exercisable only by such Grantee, except that, in the case of a Grantee who is legally incapacitated, the Grant shall be exercisable by the Grantee's guardian or legal representative.
9.2 Rights as Shareholder. A Grantee or the permitted transferee of a Grant shall have no rights as a shareholder with respect to any shares subject to such Grant prior to the purchase of such shares by exercise of an Option, or with respect to a Restricted Stock Award prior to the lapse of the restrictions, except as provided herein or in the applicable Stock Option Notice or Restricted Stock Notice. Nothing contained herein, or in the Stock Option Notice or Restricted Stock Notice relating to any Grant shall create an obligation on the part of the Company to repurchase any shares of Common Stock purchased hereunder.
9.3 Service on Board. Nothing in the Plan, in the grant of any Option or Restricted Stock Award or in any Stock Option Notice or Restricted Stock Notice shall confer upon any Nonemployee Director the right to continue service as a member of the Board.
9.4 Compliance with Law. The Plan, the exercise of Grants, and the obligations of the Company to issue or transfer shares of Common Stock under Grants shall be subject to all applicable laws and regulations and to approvals by any governmental or regulatory agency as may be required. The Board may revoke any Grant if it is contrary to law or modify a Grant to bring it into compliance with any valid and mandatory law or government regulation.
9.5 Section 83(b) Election. If a Grantee shall make an election pursuant to Section 83(b) of the Code with respect to a Restricted Stock Award, the Grantee shall, within 30 days following the Date of Grant, furnish to the Company a copy of such election.
9.6 Plan Binding on Successors. The Plan shall be binding upon the Company, its successors and assigns, and the Grantee, the Grantee's executor, administrator and permitted transferee.
9.7 Construction and Interpretation. Whenever used herein, nouns in the singular shall include the plural, and the masculine pronoun shall include the feminine gender. Headings of Articles and Sections hereof are inserted for convenience and reference and constitute no part of the Plan.
9.8 Severability. If any provision of the Plan or any Stock Option Notice or Restricted Stock Notice shall be determined to be illegal or unenforceable by any court of law in any jurisdiction, the remaining provisions hereof and thereof shall be severable and enforceable in accordance with their terms, and all provisions shall remain enforceable in any other jurisdiction.
9.9 Governing Law. The validity and construction of this Plan and of any Stock Option Notice or Restricted Stock Notice shall be governed by the laws of the State of Indiana.
GUIDANT CORPORATION
1998 STOCK PLAN, AS AMENDED
The Guidant Corporation 1998 Stock Plan, as amended, ("1998 Plan") authorizes the Management Development and Compensation Committee ("Committee") of the Board of Directors of Guidant Corporation to provide employees and consultants of Guidant Corporation and its subsidiaries with certain rights to acquire shares of Guidant Corporation common stock ("Guidant Stock"). The Company believes that this incentive program will benefit the Company's shareholders by allowing the Company to attract, motivate, and retain employees and consultants and by causing employees and consultants, through stock-based incentives, to contribute materially to the growth and success of the Company. For purposes of the 1998 Plan, the term "Company" shall mean Guidant Corporation and its subsidiaries, unless the context requires otherwise.
1. ADMINISTRATION.
The 1998 Plan shall be administered and interpreted by the Committee consisting of not less than three persons appointed by the Board of Directors of the Company from among its members. A person may serve on the Committee only if he or she (i) is a nonemployee director as defined in Rule 16b-3(b)(3) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and (ii) satisfies the requirements of an "outside director" for purposes of Section 162(m) of the Internal Revenue Code of 1986, as amended (the "Code"). The Committee shall determine the fair market value of Guidant Stock for purposes of the 1998 Plan. The Committee may, subject to the provisions of the 1998 Plan, from time to time establish such rules and regulations as it deems appropriate for the proper administration of the Plan. The Committee's decisions shall be final, conclusive, and binding with respect to the interpretation and administration of the 1998 Plan and any Grant made under it. Except to the extent expressly prohibited by the 1998 Plan or applicable law, the Committee may delegate to one or more of its members, or to one or more agents, such responsibility or duties as it deems desirable.
2. GRANTS.
Incentives under the 1998 Plan shall consist of incentive stock options, nonqualified stock options, performance awards, and restricted stock grants (collectively, "Grants"). All Grants shall be subject to the terms and conditions set out herein and to such other terms and conditions which are not inconsistent with the 1998 Plan as the Committee deems appropriate. The Committee shall approve the form and provisions of each Grant. Grants under a particular section of the 1998 Plan need not be uniform and Grants under two or more sections may be combined in one instrument.
3. ELIGIBILITY FOR GRANTS.
Grants may be made to any employee (including any officer) or consultant of the Company ("Eligible Person"). The Committee shall select the persons to receive Grants ("Grantees") from among the Eligible Persons and determine the number of shares subject to any particular Grant.
4. SHARES AVAILABLE FOR GRANT.
(a) Shares Subject to Issuance or Transfer. Subject to adjustment as provided in Section 4(b), the aggregate number of shares of Guidant Stock that may be issued or transferred under the 1998 Plan is
22,500,000(1); provided, however, that the aggregate number of such shares that may be issued or transferred as Restricted Stock Grants under the 1998 Plan is 5,000,000. The shares may be authorized but unissued shares or treasury shares. The number of shares available for Grants at any given time shall be 22,500,000 (5,000,000 in the case of Restricted Stock Grants), reduced by the aggregate of all shares previously issued or transferred and of shares which may become subject to issuance or transfer under then-outstanding Grants. Payment in cash in lieu of shares shall be deemed to be an issuance of the shares for purposes of determining the number of shares available for Grants under the 1998 Plan as a whole or to any individual Grantee.
(b) Adjustment Provisions. If any subdivision or combination of shares of Guidant Stock or any stock dividend, reorganization, recapitalization, or consolidation or merger with Guidant Corporation as the surviving corporation occurs, or if additional shares or new or different shares or other securities of the Company or any other issuer are distributed with respect to the shares of Guidant Stock through a spin-off, exchange offer, or other extraordinary distribution, the Committee shall make such adjustments as it determines appropriate in the number of shares of Guidant Stock that may be issued or transferred in the future under Sections 4(a), 5(f) and 6(f). The Committee shall also adjust as it determines appropriate the number of shares and Option Price in outstanding Grants made before the event.
5. STOCK OPTIONS.
The Committee may grant options qualifying as incentive stock options under the Code ("Incentive Stock Options"), and nonqualified options (collectively, "Stock Options"). The following provisions are applicable to Stock Options:
(a) Option Price. The Committee shall determine the price at which Guidant Stock may be purchased by the Grantee under a Stock Option ("Option Price") which, except in the case of substitute grants as described in Section 11(b), shall be not less than the fair market value of Guidant Stock on the date the Stock Option is granted (the "Grant Date"). In the Committee's discretion, the Grant Date of a Stock Option may be established as the date on which Committee action approving the Stock Option is taken or any later date specified by the Committee.
(b) Option Exercise Period. The Committee shall determine the option exercise period of each Stock Option. The period shall not exceed ten years from the Grant Date.
(c) Exercise of Option. A Grantee may exercise a Stock Option by delivering a notice of exercise to the Company or its representative as designated by the Committee, either with or without accompanying payment of the Option Price. The notice of exercise, once delivered, shall be irrevocable.
(d) Satisfaction of Option Price. The Grantee shall pay or cause to be paid the Option Price in cash, or with the Committee's permission, by delivering shares of Guidant Stock already owned by the Grantee and having a fair market value on the date of exercise equal to the Option Price, or a combination of cash and shares. In addition, the Committee may permit the exercise of an option by delivery of written notice, subject to the Company's receipt of a third-party payment in full in cash for the Option Price prior to the issuance of shares of Guidant Stock, in the manner and subject to the procedures as may be established by the Committee. Unless the Committee establishes a shorter period which is set forth in the Stock Option, the Grantee shall pay the Option Price not later than 30 days after the date of a statement from the Company following
exercise setting forth the Option Price, fair market value of Guidant Stock on the exercise date, the number of shares of Guidant Stock that may be delivered in payment of the Option Price, and the amount of withholding tax due, if any. If the Grantee fails to pay the Option Price within the specified period, the Committee shall have the right to take whatever action it deems appropriate, including voiding the option exercise. The Company shall not issue or transfer shares of Guidant Stock upon exercise of a Stock Option until the Option Price and any required withholding tax are fully paid.
(e) Share Withholding. With respect to any nonqualified option, the Committee may, in its discretion and subject to such rules as the Committee may adopt, permit or require the Grantee to satisfy, in whole or in part, any withholding tax obligation which may arise in connection with the exercise of the nonqualified option by having the Company withhold shares of Guidant Stock having a fair market value equal to the amount of the withholding tax.
(f) Limits on Individual Grants. No individual Grantee may be granted Stock Options under the 1998 Plan for more than 700,000 shares of Guidant Stock during any one calendar year.
(g) Limits on Incentive Stock Options. The aggregate fair market value of the stock covered by Incentive Stock Options granted under the 1998 Plan or any other stock option plan of the Company or any subsidiary or parent of the Company that become exercisable for the first time by any employee in any calendar year shall not exceed $100,000. The aggregate fair market value will be determined at the Grant Date. An Incentive Stock Option shall not be granted to any Eligible Person who, on the Grant Date, owns stock possessing more than 10% of the total combined voting power of all classes of stock of the Company or any subsidiary or parent of the Company.
6. PERFORMANCE AWARDS.
The Committee may grant Performance Awards which shall be denominated
at the time of grant either in shares of Guidant Stock ("Stock Performance
Awards") or in dollar amounts ("Dollar Performance Awards"). Payment under a
Stock Performance Award or a Dollar Performance Award shall be made, at the
discretion of the Committee, in shares of Guidant Stock ("Performance Shares"),
or in cash or in any combination thereof, if the financial performance of the
Company or any subsidiary, division, or other unit of the Company ("Business
Unit") selected by the Committee meets certain financial goals established by
the Committee for the Award Period (as defined below). Performance Awards may be
granted by the Committee in a manner designed to qualify for exemption under
Section 162(m) of the Code ("Section 162(m) Awards") or in a manner that is not
intended to so qualify. The following provisions are applicable to Performance
Awards:
(a) Award Period. The Committee shall determine and include in the Grant the period of time (which shall be four or more consecutive fiscal quarters) for which a Performance Award is made ("Award Period"). Grants of Performance Awards need not be uniform with respect to the length of the Award Period. Award Periods for different Grants may overlap. A Performance Award may not be granted for a given Award Period after one half (1/2) or more of such period has elapsed, except as provided in Section 6(g).
(b) Performance Criteria and Payment. Before a Grant is made, the Committee shall establish objectives with respect to designated business performance criteria ("Performance Criteria") that must be met by the Business Unit during the Award Period as a condition to payment being made under the Performance Award. The Performance Criteria and the applicable goals with respect to such criteria shall be set out in the Grant. In the case of Section 162(m) Awards, the Performance
Criteria shall be limited to earnings per share, return on assets, return on shareholders' equity, divisional income, net income, total shareholder return, stock price goals, cash flow, operating earnings, return on capital, or economic value added, in each case as may be applied on an absolute or relative to peer group basis. In the case of non-Section 162(m) Awards, the Performance Criteria may include any of the foregoing or any other financial measurement established by the Committee. The Committee shall also set forth in the Grant the number of Performance Shares or the amount of payment to be made under a Performance Award if the Performance Criteria are met or exceeded, including the fixing of a maximum payment, subject to Section 6(f).
(c) Computation of Payment. After an Award Period, the financial performance of the Business Unit during the period shall be measured against the Performance Criteria. If the Performance Criteria are not met, no payment shall be made under a Performance Award. If the Performance Criteria are met or exceeded, the Committee shall certify that fact in writing prior to payment of the Performance Award and shall determine the number of Performance Shares or the amount of payment to be made under a Performance Award in accordance with the Grant for each Grantee. The Committee, in its sole discretion, may elect to pay part or all of the Performance Award in cash in lieu of issuing or transferring Performance Shares. The cash payment shall be based on the fair market value of Guidant Stock on the date of payment. The Company shall promptly notify each Grantee of the number of Performance Shares and the amount of cash, if any, he or she is to receive.
(d) Revisions for Significant Events. At any time before payment is made, the Committee may revise the Performance Criteria and the computation of payment if unforeseen events occur during an Award Period which have a substantial effect on the Performance Criteria and which in the sole discretion of the Committee make the application of the Performance Criteria unfair unless a revision is made; provided, however, that any such revision that would result in an increase in the amount payable under Section 162(m) Awards shall be made only on a non-discretionary basis upon the occurrence of objective events specified in the Grant.
(e) Requirement of Employment. To be entitled to receive payment under a Performance Award, a Grantee who is an employee of the Company must remain in the employment of the Company through the date of the award payment, except that the Committee may provide for partial or complete exceptions to this requirement as it deems equitable in its sole discretion.
(f) Maximum Payment. In case of a Performance Award that is designated as a Section 162(m) Award, no individual may receive Performance Award payments in respect of Stock Performance Awards in excess of 30,000 shares of Guidant Stock in any calendar year or payments in respect of Dollar Performance Awards in excess of $2,000,000 in any calendar year. For purposes of determining the maximum payment under this subsection, payment in cash of all or part of a Stock Performance Award will be deemed an issuance of the number of shares with respect to which such cash payment is made. No individual may receive both a Stock Performance Award and a Dollar Performance Award for the same Award Period.
(g) Section 162(m) Requirements. In the case of a Performance Award that is designated as a Section 162(m) Award, the Committee shall make all determinations necessary to establish the Performance Award within 90 days of the beginning of the Award Period, including, without limitation, the designation of the Participants to whom Performance Awards are made, the Performance Criteria applicable to the Grant and the performance goals that relate to such criteria, and the dollar amounts or number of shares of Guidant Stock payable upon achieving the applicable performance goals. As and to the extent required by Section 162(m) of the Code, the
terms of a Section 162(m) Award must state, in terms of an objective formula or standard, the method of computing the amount of compensation payable under the Performance Award and must preclude discretion to increase the amount of compensation payable under the Performance Award.
7. RESTRICTED STOCK GRANTS.
The Committee may issue or transfer shares of Guidant Stock to a Grantee under a Restricted Stock Grant. Upon the issuance or transfer, the Grantee shall be entitled to vote the shares and to receive any dividends paid. The following provisions are applicable to Restricted Stock Grants:
(a) Requirement of Employment. If the employment of a Grantee who is an employee of the Company terminates during the period designated in the Grant as the "Restriction Period," the Restricted Stock Grant terminates and the shares of Guidant Stock must be returned immediately to the Company. However, the Committee may provide for partial or complete exceptions to this requirement as it deems equitable.
(b) Restrictions on Transfer and Legend on Stock Certificate. During the Restriction Period, a Grantee may not sell, assign, transfer, pledge, or otherwise dispose of the shares of Guidant Stock except to a Successor Grantee under Section 11(a). Each certificate for shares issued or transferred under a Restricted Stock Grant shall contain a restricted legend or be held in escrow by the Company until the expiration of the Restriction Period.
(c) Lapse of Restrictions. All restrictions imposed under the
Restricted Stock Grant shall lapse (i) upon the expiration of the
Restriction Period if all conditions, including those stated in
Sections 7(a) and (b) have been met or (ii) as provided under Section
9(a)(ii). The Grantee shall then be entitled to delivery of the
certificate.
8. AMENDMENT AND TERMINATION OF THE 1998 PLAN.
(a) Amendment. The Board may at any time and from time to time and
in any respect, amend or modify the Plan; provided, however, that no amendment
or modification of the 1998 Plan shall be effective without the consent of the
Company's shareholders that would: (i) change the class of Eligible Persons
under the 1998 Plan, (ii) increase the number of shares of Guidant Stock
available for Grants or for Restricted Stock Grants, as provided in Section
4(a), (iii) allow the grant of Stock Options at an exercise price below fair
market value, or (iv) allow the re-pricing of Stock Options. In addition, the
Board may seek the approval of any amendment or modification by the Company's
shareholders to the extent it deems necessary or advisable in its sole
discretion for purposes of compliance with Section 162(m) or Section 422 of the
Code, the listing requirements of the New York Stock Exchange or for any other
purpose. No amendment or modification of the 1998 Plan shall in any manner
affect any outstanding Grant without the consent of the Grantee or the permitted
transferee of the Grant.
(b) Termination of 1998 Plan. The 1998 Plan shall terminate on May 31, 2007, unless terminated earlier by the Board or unless extended by the Board.
(c) Termination and Amendment of Outstanding Grants. A termination or amendment of the 1998 Plan that occurs after a Grant is made shall not result in the termination or amendment of the Grant unless the Grantee consents or unless the Committee acts under Section 11(e). The termination of the 1998 Plan shall not impair the power and authority of the Committee with respect to outstanding Grants. Whether or not the 1998 Plan has terminated, an outstanding Grant may be terminated or amended under Section 11(e) or may be amended (i) by agreement of the Company and the Grantee consistent with the
1998 Plan or (ii) by action of the Committee provided that the amendment is consistent with the 1998 Plan and is found by the Committee not to materially impair the rights of the Grantee under the Grant.
9. CHANGE OF CONTROL.
(a) Effect on Grants. Unless the Committee shall otherwise expressly provide in the agreement relating to a Grant, upon the occurrence of a Change of Control (as defined below):
(i) In the case of Stock Options, each outstanding Stock Option that is not then fully exercisable shall automatically become fully exercisable;
(ii) The Restriction Period on all outstanding Restricted Stock Grants shall automatically expire and all restrictions imposed under such Restricted Stock Grants shall immediately lapse; and
(iii) Each Grantee of a Performance Award for an Award Period that has not been completed at the time of the Change of Control shall be deemed to have earned a Performance Award equal to such Grantee's maximum award opportunity during such Award Period for such Performance Award.
(b) Change of Control. For purposes of the 1998 Plan, a Change of Control shall mean the happening of any of the following events:
(i) The acquisition by any "person," as that term is used in Sections 13(d) and 14(d) of the Exchange Act (other than (A) the Company, (B) any subsidiary of the Company, (C) any employee or directors' benefit plan or stock plan of the Company or a subsidiary of the Company, or any trustee or fiduciary with respect to any such plan when acting in that capacity, or (D) any person who acquires such shares pursuant to a transaction or series of transactions approved prior to such transaction(s) by the Board of Directors of the Company) of "beneficial ownership" as defined in Rule 13d-3 under the Exchange Act, directly or indirectly, of 20% or more of the shares of the Company's capital stock the holders of which have general voting power under ordinary circumstances to elect at least a majority of the Board of Directors of the Company (or which would have such voting power but for the application of the Indiana Control Share Statute) (Voting Stock);
(ii) the first day on which less than two-thirds of the total membership of the Board of Directors of the Company shall be Continuing Directors (as that term is defined in Article 6(f) of the Company's Articles of Incorporation;
(iii) approval by the shareholders of the Company of a merger, share exchange, or consolidation of the Company (a "Transaction"), other than a Transaction which would result in the Voting Stock of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) more than 50% of the Voting Stock of the Company or such surviving entity immediately after such Transaction; or
(iv) approval by the shareholders of the Company of a complete liquidation of the Company or a sale or disposition of all or substantially all the assets of the Company.
10. ELIGIBLE PERSONS RESIDENT OUTSIDE THE UNITED STATES.
The following provisions shall apply to each Eligible Person who is resident outside the United States:
(a) Determination of Eligible Locations. The Committee shall determine whether it is feasible or desirable under local law, custom and practice to make Grants at each location outside the United States. In making this determination as of any Grant Date, the Committee may differentiate among classes of individuals (including expatriates, third country nationals or international assignees) and locations within a particular country.
(b) Special Terms Applicable to Grants. In order to facilitate the making of Grants under this Section 10, the Committee may provide for such special terms for Grants to Grantees who are foreign nationals or who are employed outside the United States as the Committee may consider necessary or desirable to accommodate differences in local law, policy or custom, or to take advantage of special tax or social insurance regimes applicable in a particular jurisdiction. The Committee may approve such supplements, restatements or alternate versions of the Plan as it may consider necessary or desirable for such purposes, without thereby affecting the terms of the Plan as in effect for any other purpose. Without limiting the generality of the foregoing, the Committee may adopt special sub-plans applicable to individuals in particular jurisdictions (e.g., French or U.K. qualified plans), may provide for accelerated vesting with restrictions on the shares received under a Grant, and may condition Grants on acknowledgments or agreements by Grantees tailored to local law.
(c) No Acquired Rights. Nothing in the 1998 Plan or in this Section 10 shall confer upon any individual in any country the right to receive (or to continue to receive) any Grant, any form of Grant or to receive any benefit in lieu of a Grant hereunder, nor to have any special tax treatment apply to any Grant.
11. GENERAL PROVISIONS.
(a) Transfer of Grants. Only a Grantee or his or her authorized legal representative or valid transferee may exercise rights under a Grant. Such persons may not transfer those rights. Except as set forth below, the rights under a Grant may not be disposed of by transfer, alienation, pledge, encumbrance, assignment, or any other means, whether voluntary, involuntary, or by operation of law, and any such attempted disposition shall be void. Notwithstanding the foregoing and solely to the extent permitted by the Committee in an agreement relating to a Grant, rights under a Grant (other than pursuant to an Incentive Stock Option) may be transferred to members of a Grantee's immediate family, charitable institutions, or trusts or partnership whose beneficiaries are any of the foregoing, or to such other persons or entities as may be approved by the Committee, in each case subject to the condition that the Committee be satisfied that such transfer is being made for estate or tax planning purposes or for donative purposes without consideration being received therefor. In addition, when a Grantee dies, the personal representative or other person entitled to succeed to the rights of the Grantee may exercise the rights. A successor to the rights under a Grant pursuant to the foregoing ("Successor Grantee") must furnish proof satisfactory to the Company of his or her right to receive the Grant, whether as a result of a transfer from the Grantee, under the Grantees will or under the applicable laws of descent and distribution.
(b) Substitute Grants. The Committee may make a Grant to an employee of another corporation who becomes an Eligible Person by reason of a corporate merger, consolidation, acquisition of stock or property, reorganization or liquidation involving the Company in substitution for a stock option, performance award, or restricted stock grant granted by such other corporation ("Substituted Stock
Incentive"). The terms and conditions of the substitute Grant may vary from the
terms and conditions required by the 1998 Plan and from those of the Substituted
Stock Incentives. The Committee shall prescribe the exact provisions of the
substitute Grants, preserving to the extent the Committee deems practical the
provisions of the Substituted Stock Incentives. The Committee shall also
determine the number of shares of Guidant Stock to be taken into account under
Section 4.
(c) Subsidiaries. The term "subsidiary" means a corporation of which Guidant owns directly or indirectly 50% or more of the voting power.
(d) Fractional Shares. Fractional shares shall not be issued or transferred under a Grant, but the Committee may pay cash in lieu of a fraction or round the fraction.
(e) Compliance with Law. The 1998 Plan, the exercise of Grants, and the obligations of the Company to issue or transfer shares of Guidant Stock under Grants shall be subject to all applicable laws and regulations and to approvals by any governmental or regulatory agency as may be required. The Committee may revoke any Grant if it is contrary to law or modify a Grant to bring it into compliance with any valid and mandatory law or governmental regulation. The Committee may also adopt rules regarding the withholding of taxes on payment to Grantees.
(f) Ownership of Stock. A Grantee or Successor Grantee shall have no rights as a stockholder of the Company with respect to any shares of Guidant Stock covered by a Grant until the shares are issued or transferred to the Grantee or Successor Grantee on the Company's books.
(g) No Right to Employment. The 1998 Plan and the Grants under it shall not confer upon any Grantee the right to continue in the employment of the Company or affect in any way the right of the Company to terminate the employment of a Grantee at any time, with or without notice or cause.
(h) Foreign Jurisdictions. The Committee may adopt, amend, and terminate such arrangements, not inconsistent with the intent of the 1998 Plan, as it may deem necessary or desirable to make available tax or other benefits of the laws of foreign jurisdictions to Grantees who are subject to such laws.
(i) Governing Law. The 1998 Plan and all Grants made under it shall be governed by and interpreted in accordance with the laws of the State of Indiana, regardless of the laws that might otherwise govern under applicable Indiana conflict-of-laws principles.
(j) Effective Date of the 1998 Plan. The 1998 Plan shall become effective upon approval by the Company's shareholders.
GUIDANT CORPORATION
NONQUALIFIED STOCK OPTION
This Nonqualified Stock Option ("Stock Option") has been granted on ___ (the "Grant Date") by Guidant Corporation, an Indiana corporation (the "Company"), with its principal offices in Indianapolis, Indiana, to
RECITALS
Under the Guidant Corporation 1998 Stock Plan ("1998 Plan"), the Management Development and Compensation Committee of the Company's Board of Directors (the "Committee") has determined the form of this Stock Option and selected the Grantee, an Eligible Person, to receive this Stock Option under the 1998 Plan. The applicable terms of the 1998 Plan are incorporated in this Stock Option by reference, including the definition of terms contained in the 1998 Plan. In this Stock Option, the term "Company" means Guidant Corporation and its subsidiaries, unless the context requires otherwise.
OPTION
Pursuant to the terms of the 1998 Plan, the Company grants to the Grantee the right to purchase shares of Guidant Stock from the Company by one or more exercises of this Stock Option under the following terms and conditions:
SECTION 1. Number of Shares. Subject to adjustment as provided in Section 3, the Grantee may purchase a total of ______ shares of Guidant Stock. This Stock Option is a nonqualified stock option and is not intended to satisfy the requirements of Section 422 of the Internal Revenue Code.
SECTION 2. Option Price. Subject to adjustment as provided in Section 3, the Option Price shall be $_____ per share of Guidant Stock, which has been determined by the Committee to be the Fair Market Value of Guidant Stock on the Grant Date.
SECTION 3. Adjustments to Number of Shares and Option Price. If any subdivision or combination of shares of Guidant Stock, or any stock dividend, capital reorganization, recapitalization, or consolidation or merger with the Company as the surviving corporation occurs, or if additional shares or new or different shares or other securities of the Company or
EXHIBIT 10.49
any other issuer are distributed with respect to shares of Guidant Stock through a spin-off, exchange offer, or other extraordinary distribution, the Committee shall make those adjustments it determines appropriate in its discretion, in the number of shares still subject to purchase under this Stock Option or to the Option Price or both. If an adjustment would result in a fractional share, then upon exercise of this Stock Option and payment of the Option Price the Committee may in its discretion either pay cash for the fractional right or round the fraction.
SECTION 4. Option Exercise Period. This Stock Option may be exercised from the Commencement Date to and including the Termination Date ("Option Exercise Period").
The Commencement Date shall be the Grant Date.
The Termination Date shall be the earliest to occur of a., b., c. or d below:
a. ___________,
b. the day of Termination of Employment (as defined below), except by reason of (i) death, (ii) retirement from the Company as a Retired Employee, or (iii) Disability,
c. the corresponding calendar day in the sixtieth month following the day on which the Grantee becomes a Retired Employee, or on which the Grantee's employment is terminated by reason of Disability, or on the last day of that sixtieth month if there is no corresponding day in that month, or
d. the corresponding calendar day in the sixtieth month following the date of death of the Grantee while in the active service of the Company, or on the last day of that sixtieth month if there is no corresponding day in that month.
"Termination of Employment" means the cessation, for any reason, of the relation of employer and employee between the Grantee and the Company. The Committee's determination whether the Grantee's employment has been terminated by reason of Disability or whether a leave of absence constitutes a Termination of Employment shall be final and binding on the Grantee. This Stock Option shall not confer upon the Grantee the right to continue in the employment of the Company or affect in any way the right of the Company to terminate the employment of the Grantee at any time, with or without notice or cause.
A Retired Employee shall be a person whose employment with the Company has terminated upon or after the earliest of (i) the day upon which the person's age plus years of service with the Company, including any predecessor company of the Company, equals 80, and the person is eligible to receive transition benefits under The Guidant Retirement Plan, (ii) the day the person has attained at least 55 years of age and has at least 10 years of service with the Company, including any predecessor company of the Company, (iii) the day the person attains 65 years of age, or (iv) as the Committee otherwise determines.
EXHIBIT 10.49
SECTION 5. Limitations on Right to Exercise Stock Option. The right to exercise this Stock Option during the Option Exercise Period shall be subject to the following limitations:
a. During the lifetime of the Grantee, only the Grantee or a guardian or legal representative acting for the Grantee under judicial authority may exercise this Stock Option.
b. After the death of the Grantee, this Stock Option may be exercised only by a successor grantee who has become entitled to exercise by will or the laws of descent and distribution and who has furnished proof satisfactory to the Company of his or her right to exercise. The term "Grantee" includes a successor grantee where applicable.
c. The Grantee may not exercise this Stock Option with respect to a fractional share or with respect to less than twenty-five (25) shares of Guidant Stock unless the exercise covers the entire balance of the shares of Guidant Stock subject to purchase. This number is not subject to an adjustment under Section 3.
d. The Grantee's right to exercise this Stock Option and the Company's obligation to issue or transfer shares are subject to all stock exchange requirements, to all applicable laws, and to approvals by any governmental or regulatory agency as may be required.
SECTION 6. Non-Transfer of Stock Option. Neither this Stock Option nor any right under it is transferable except by will or applicable laws of descent and distribution.
SECTION 7. Exercise of Stock Option. The Grantee may exercise this Stock Option by delivering a notice of exercise to the Company's stock option processor, as designated from time to time. The notice of exercise, once delivered, shall be irrevocable. The Option Price shall be paid on or about the time of the notice of exercise, as shall be directed by the Company's stock option processor. The notice of exercise must specify the number of shares of Guidant Stock covered by the exercise and state the number of shares of Guidant stock, if any, being tendered in exchange. Upon receipt of the notice of exercise, the stock option processor shall send to the Grantee a statement of the Option Price, the fair market value of Guidant Stock on the exercise date, the number of shares of Guidant Stock that may be delivered in payment of the Option Price, and the amount of withholding tax due, if any. Shares will be issued or transferred only to the Grantee or the Grantee and another as joint tenants with right of survivorship.
SECTION 8. Ownership of Guidant Stock and Delivery of Certificate. The Committee may, from time to time, establish alternative procedures for paying the Option Price. The Company will not issue or transfer shares of Guidant Stock upon exercise of this Stock Option until the Option Price is fully paid and the Grantee shall have no rights as a shareholder as to shares covered by an exercise until the shares are issued or transferred on the Company's books. At the time the Grantee becomes the owner of the shares covered by the exercise, he or she shall cease to be the owner of any shares tendered in payment of the Option Price.
EXHIBIT 10.49
SECTION 9. Withholding Tax. Before delivering a certificate for shares of Guidant Stock issued or transferred under this Stock Option, the Company may, by notice to the Grantee, require that the Grantee pay to the Company the amount of federal, state, or local taxes, if any, required by law to be withheld.
SECTION 10. Notices and Payments. Any notices to be given by the Grantee under this Stock Option shall be in writing, and any notice or payment shall be deemed to have been given or made only upon receipt by the Company or the Company's stock option processor at such address as may be communicated in writing to the Grantee from time to time. Any notice or communication by the Company under this Stock Option shall be in writing and shall be deemed to have been given if mailed or delivered to the Grantee at the address listed in the records of the Company or at such address as specified in writing to the Company by the Grantee.
SECTION 11. Waiver. The waiver by the Company of any provision of this Stock Option shall not operate as, or be construed to be, a waiver of the same or any other provision of this Stock Option at any subsequent time for any other purpose.
SECTION 12. Revocation or Modification of Stock Option. This Stock Option shall be irrevocable except that the Company shall have the right under Section 11(e) of the 1998 Plan to revoke this Stock Option at any time if it is contrary to law or to modify this Stock Option to bring it into compliance with any valid and mandatory law or government regulation.
SECTION 13. Section Headings. The section headings in this Stock Option are for convenience of reference only and shall not be deemed a part of, or germane to, the interpretation or construction of this Stock Option.
SECTION 14. Determinations by Committee. Determinations by the Committee shall be final and conclusive with respect to the interpretation of the 1998 Plan and this Stock Option.
SECTION 15. Change of Control. The provisions of Section 9(a)(i) of the 1998 Plan apply to this Stock Option.
SECTION 16. Rights as a Shareholder. The Grantee or the permitted transferee of this Stock Option shall have no rights as a shareholder with respect to any shares subject to this Stock Option prior to the purchase of such shares by exercise of this Stock Option, except as provided in the 1998 Plan. Nothing in the 1998 Plan or this Stock Option shall create an obligation on the part of the Company to repurchase any shares of Guidant stock purchased hereunder.
SECTION 17. Effective Date. The effective date of this Stock Option shall be the Grant Date.
SECTION 18. Governing Law. The validity and construction of this Stock Option shall be governed by the laws of the State of Indiana.
EXHIBIT 10.49
IN WITNESS WHEREOF, the Company has caused this Stock Option to be executed and granted in Indianapolis, Indiana.
GUIDANT CORPORATION
GUIDANT CORPORATION
RESTRICTED STOCK GRANT
This Restricted Stock Grant ("Restricted Stock Grant") has been granted effective ___ (the "Date of Grant"), by Guidant Corporation, an Indiana corporation, with its principal offices in Indianapolis, Indiana (the "Company"), to
Upon the Date of Grant, the fair market value of a share of Common Stock of the Company was _______.
RECITALS
Under the Guidant Corporation 1998 Stock Plan ("1998 Plan"), the Company's Management Development and Compensation Committee of the Board of Directors (the "Committee") has determined the form of this Restricted Stock Grant and selected the Grantee, an Eligible Person, to receive this Restricted Stock Grant and the shares of Common Stock that are subject hereto. The applicable terms of the 1998 Plan are incorporated in this Restricted Stock Grant by reference, including the definition of terms contained in the 1998 Plan.
RESTRICTED STOCK GRANT
In accordance with the terms of the 1998 Plan, the Committee has made this Restricted Stock Grant and concurrently has issued or transferred to the Grantee shares of Common Stock upon the following terms and conditions:
SECTION 1. Number of Shares. The number of shares of Common Stock issued or transferred under this Restricted Stock Grant is _______________.
SECTION 2. Rights of the Grantee as Shareholder. The Grantee, as the owner of the shares of Common Stock issued or transferred pursuant to this Restricted Stock Grant, is entitled to all the rights of a shareholder of the Company, including the right to vote, the right to receive dividends payable either in stock or in cash, and the right to receive shares in any recapitalization of the Company, subject, however, to the restrictions stated in this Restricted Stock Grant. If the Grantee receives any additional shares by reason of being the holder of the shares of Common Stock issued or transferred under this Restricted Stock Grant or of the additional shares previously distributed to the Grantee, all of the additional shares shall be subject to the provisions of this Restricted Stock Grant. Initially, the shares of Common Stock will be held in an account maintained with the processor under the 1998 Plan (the "Account"). At the discretion of the Company, the Company may provide the Grantee with a certificate for the shares, which would bear a legend as described in Section 7.
SECTION 3. Restriction Period. The period of restriction ("Restriction
Period") for the shares of Common Stock issued under this Restricted Stock Grant
shall commence on the Date of Grant and expire on ____; [provided that the
Restriction Period may expire earlier with respect to all or part of the shares
if Performance Vesting Criteria as follows are satisfied: _______________. ] In
addition, the Restriction Period shall expire earlier as to all shares of Common
Stock issued under this Restricted Stock Grant upon the earliest of (i) the date
of death of the Grantee, (ii) the date of qualifying disability of the Grantee,
(iii) the date on which the Grantee becomes a Retired Employee (as defined
below), or (iv) upon the occurrence of a Change of Control of the Company, as
set forth in Section 9 of the 1998 Plan.
A Retired Employee shall be a person whose employment with the Company has terminated upon or after the earlier of (i) the day upon which the person's age plus years of service with the Company, including any predecessor company, equals 80, (ii) the day the person has attained at least 55 years of age and has at least 10 years of service with the Company, including any predecessor company, (iii) the day the person attained 65 years of age or (iv) as the Committee otherwise shall determine.
SECTION 4. Conditions During Restriction Period. During the entire Restriction Period the following conditions must continue to be satisfied:
a. the employment of the Grantee with the Company must not terminate for any reason.
b. the Grantee must not, voluntarily or involuntarily, sell, assign, transfer, pledge, or otherwise dispose of the shares of Common Stock issued or transferred pursuant to this Restricted Stock Grant; and
c. the Grantee must not exercise any appraisal rights with respect to the shares of Common Stock issued or transferred pursuant to this Restricted Stock Grant that are otherwise available under any provisions of the Indiana Business Corporation Law.
For purposes of this Restricted Stock Grant, the Company will determine when employment terminates. A Grantee's employment will not be deemed to have terminated if the Grantee goes on military leave, medical leave or other bona fide leave of absence, if the leave was approved by the Company in writing and if continued crediting of employment is required by applicable law, the Company's policies or the terms of Grantee's leave; provided that vesting dates may be adjusted in accordance with the Company's policies or the terms of Grantee's leave.
SECTION 5. Consequences of Failure to Satisfy Conditions. The following
shall be the consequences of Grantee's failure to satisfy the conditions in
Section 4 during the Restriction Period:
a. If the condition in Section 4.a is not satisfied, either by act of the Grantee or otherwise, (i) the Grantee will forfeit the shares of Common Stock
issued or transferred pursuant to this Restricted Stock Grant, (ii) the Grantee will assign, transfer, and deliver the certificates or any other evidence of ownership of such shares to the Company, (iii) all interest of the Grantee in such shares shall terminate and (iv) the Grantee shall cease to be a shareholder with respect to such shares.
b. Any attempted sale, assignment, transfer, pledge or other disposition of the shares of Common Stock issued or transferred pursuant to this Restricted Stock Grant in violation of the condition in Section 4.b, whether voluntary or involuntary, shall be ineffective and the Company (i) shall not be required to transfer the shares, (ii) may impound any certificates for the shares or otherwise restrict Grantee's account and (iii) hold the certificates until the expiration of the Restriction Period.
c. Any attempted exercise of appraisal rights in violation of the condition in Section 4.c shall be ineffective and the Company may disregard any purported notice of exercise of appraisal rights by the Grantee during the Restriction Period with respect to the shares of Common Stock issued or transferred pursuant to this Restricted Stock Grant.
SECTION 6. Lapse of Restrictions. At the end of the Restriction Period, if the condition specified in Section 4.a has been satisfied during the Restriction Period, all restrictions shall terminate on the related shares, and the Grantee shall be entitled to transfer the shares from the Account or receive certificates without the legend prescribed in Section 7. However, in the event of an attempted violation of the condition specified in Section 4.b, the Company shall be entitled to delay transfers or withhold delivery of any of the certificates if, and for so long as, in the judgment of the Company's counsel, the Company would incur a risk of liability to any party to whom such shares were purported to be sold, transferred, pledged or otherwise disposed.
SECTION 7. Legend on Certificates. Any certificate evidencing ownership of shares of Common Stock issued or transferred pursuant to this Restricted Stock Grant that is delivered during the Restriction Period shall bear the following legend on the back side of the certificate:
These shares have been issued or transferred subject to a Restricted Stock Grant and are subject to substantial restrictions, including but not limited to, a prohibition against transfer, either voluntary or involuntary, a waiver of any appraisal rights, and a provision requiring transfer of these shares to Guidant Corporation (the "Company") without any payment in the event of termination of the employment of the registered owner, all as more particularly set forth in a Restricted Stock Grant, a copy of which is on file with the Company.
At the discretion of the Company, the Company may hold the shares of Common Stock issued or transferred pursuant to this Restricted Stock Grant in an Account as described in Section 2, otherwise hold them in escrow during the Restriction Period, or issue a certificate to the Grantee bearing the legend set forth above.
SECTION 8. Specific Performance of the Grantee's Covenants. By accepting this Restricted Stock Grant and the issuance and delivery of the shares of Common Stock pursuant to this Restricted Stock Grant, the Grantee acknowledges that the Company does not have an adequate remedy in damages for the breach by the Grantee of the conditions and covenants set forth in this Restricted Stock Grant and agrees that the Company is entitled to and may obtain an order or a decree of specific performance against the Grantee issued by any court having jurisdiction.
SECTION 9. Employment with the Company. Nothing in this Restricted Stock Grant or in the 1998 Plan shall confer upon the Grantee the right to continued employment with the Company.
SECTION 10. Section 83(b) Election. If the Grantee makes an election pursuant to Section 83(b) of the Internal Revenue Code, the Grantee shall promptly (but in no event after thirty (30) days from grant) file a copy of such election with the Company, and cash payment for taxes shall be made at the time of such election.
SECTION 11. Withholding Tax. Before the Company removes restrictions on transfer from the Account or delivers a certificate for shares of Common Stock issued or transferred pursuant to this Restricted Stock Grant that bears no legend or otherwise delivering shares free from restriction, the Grantee shall be required to pay to the Company the amount of federal, state or local taxes, if any, required by law to be withheld ("Withholding Obligation"). Subject to any subsequent Committee determination, the Company will withhold the number of shares required to satisfy any Withholding Obligation, and provide to Grantee a net balance of shares ("Net Shares") unless the Company receives notice not less than five (5) days before any Withholding Obligation arises that Grantee intends to deliver funds necessary to satisfy the Withholding Obligation in such manner as the Company may establish or permit. Notwithstanding any such notice, if Grantee has not delivered funds within fifteen (15) days of after the Withholding Obligation arises, the Company may elect to deliver Net Shares.
SECTION 12. Notices and Payments. Any notice to be given by the Grantee under this Restricted Stock Grant shall be in writing and shall be deemed to have been given only upon receipt by the Treasurer of the Company at 111 Monument Circle, 29th Floor, Indianapolis, IN 46204, or at such address as may be communicated in writing to the Grantee from time to time. Any notice or communication by the Company to the Grantee under this Restricted Stock Grant shall be in writing and shall be deemed to have been given if mailed or delivered to the Grantee at the address listed in the records of the Company or at such address as specified in writing to the Company by the Grantee.
SECTION 13. Waiver. The waiver by the Company of any provision of this Restricted Stock Grant shall not operate as, or be construed to be, a waiver of the same or any other provision of this Restricted Stock Grant at any subsequent time for any other purpose.
SECTION 14. Termination or Modification of Restricted Stock Grant. This Restricted Stock Grant shall be irrevocable except that the Company shall have the right under Section 11(e) of the 1998 Plan to revoke this Restricted Stock Grant at any time during the
Restriction Period if it is contrary to law or modify this Restricted Stock Grant to bring it into compliance with any valid and mandatory law or government regulation. Upon request in writing by the Company, the Grantee will tender any certificates for amendment of the legend or for change in the number of shares of Common Stock issued or transferred as the Company deems necessary in light of the amendment of this Restricted Stock Grant. In the event of revocation of this Restricted Stock Grant pursuant to the foregoing, the Company may give notice to the Grantee that the shares of Common Stock are to be assigned, transferred and delivered to the Company as though the Grantee's employment with the Company terminated on the date of the notice.
SECTION 15. Section Headings. The section headings in this Restricted Stock Grant are for convenience of reference only and shall not be deemed a part of, or germane to, the interpretation or construction of this Restricted Stock Grant.
SECTION 16. Determinations by Committee. Determinations by the Committee shall be final and conclusive with respect to the interpretation of the 1998 Plan and this Restricted Stock Grant.
SECTION 17. Governing Law. The validity and construction of this Restricted Stock Grant shall be governed by the laws of the State of Indiana.
IN WITNESS WHEREOF, the Company has caused this Restricted Stock Grant to be executed and granted in Indianapolis, Indiana.
GUIDANT CORPORATION
THE GUIDANT EMPLOYEE SAVINGS
AND STOCK OWNERSHIP PLAN
January 1, 2003 Restatement
Page ESTABLISHMENT AND PURPOSE......................................................1 ARTICLE I. DEFINITIONS.......................................................2 1.01. Definitions.......................................................2 ARTICLE II. ELIGIBILITY......................................................13 2.01. General..........................................................13 2.02. Special Status Employees.........................................13 2.03. Year of Eligibility Service......................................13 2.04. Hour of Service..................................................13 2.05. Special Rules for Crediting Hours of Service.....................14 2.06. Reemployment.....................................................15 ARTICLE III. NON-ESOP CONTRIBUTIONS...........................................15 3.01. Salary Reduction Contributions...................................15 3.02. Election of Salary Reduction Contributions.......................15 3.03. Limitations on Salary Reduction Contributions....................16 3.04. Return of Excess Deferrals and Excess Salary Reduction Contributions....................................................18 3.05. Nonforfeitability of Contributions...............................20 3.06. Employer Contributions...........................................20 3.07. Contributions Not Recoverable by Employer........................24 3.08. Return of Employer Contributions.................................24 3.09. Rollover Contributions...........................................24 3.10. Hardship Distributions Under Other Plans.........................25 ARTICLE IV. LIMITATIONS ON ANNUAL ADDITIONS..................................25 4.01. Basic Limitation.................................................25 4.02. Definitions......................................................26 4.03. Preclusion of Excess Annual Additions............................27 4.04. Disposal of Excess Annual Additions..............................27 4.05. Other Defined Contribution Plans.................................27 ARTICLE V. INVESTMENT PROVISIONS............................................27 5.01. Investment Options--Salary Reduction Contributions and Rollover Contributions....................................................27 5.02. Change of Investment Directions..................................28 5.03. Failure to Make Investment Direction.............................28 5.04. Direction To Invest in Two or More Funds.........................28 5.05. Transfers Between Funds..........................................29 5.06. Company Stock Fund...............................................29 5.07. Trustee's Investment Discretion..................................29 5.08. Transferred Participant Loans....................................30 ARTICLE VI. PARTICIPANTS' ACCOUNTS...........................................30 |
6.01. Separate Accounts................................................30 6.02. Accounting for Units Under Investment Funds......................31 6.03. Value of Units...................................................32 6.04. Units Credited To Participant Accounts...........................32 ARTICLE VII. HARDSHIP WITHDRAWALS FROM SALARY REDUCTION CONTRIBUTIONS ACCOUNTS.........................................................32 7.01. Withdrawals......................................................32 ARTICLE VIII. WITHDRAWALS FROM NON-SALARY REDUCTION CONTRIBUTION ACCOUNTS........................................................34 8.01. Voluntary Withdrawals............................................34 8.02. Categories of Contributions......................................34 8.03. Restrictions Applicable to Participants with Less Than Five Years of Service.................................................35 8.04. General Provisions Applicable to Withdrawals.....................36 ARTICLE IX. RESTRICTIONS ON WITHDRAWALS......................................36 9.01. Restrictions Upon Number of Withdrawals..........................36 9.02. Notice Requirements for Withdrawals..............................36 ARTICLE X. PAYMENTS UPON TERMINATION OF EMPLOYMENT..........................37 10.01. Terms of Payment.................................................37 10.02. Beneficiary and Payment Upon Death...............................44 10.03. Inability To Locate Payee........................................46 10.04. Qualified Domestic Relations Orders..............................46 ARTICLE XI. METHODS OF PAYING WITHDRAWALS AND PAYMENTS........................46 11.01. Payment from Company Stock Fund..................................46 11.02. Optional Direct Rollover.........................................47 ARTICLE XII. ADMINISTRATION...................................................47 12.01. Administrative Committee.........................................47 12.02. Appointment, Resignation, and Organization of Committees.........47 12.03. Powers and Duties of the Employee Benefits Committee.............49 ARTICLE XIII. TITLE TO ASSETS AND MANAGEMENT OF FUNDS.........................51 13.01. Fund Advisory Committee..........................................51 13.02. Trustee..........................................................51 ARTICLE XIV. MISCELLANEOUS PROVISIONS.........................................52 14.01. Nonalienation....................................................52 14.02. Spendthrift Provision............................................53 14.03. Nonguarantee.....................................................53 14.04. Indemnification of Certain Fiduciaries...........................53 14.05. Payments from the end............................................54 14.06. Employment Rights................................................55 14.07. Voting Rights....................................................55 14.08. Tender Offers....................................................55 -ii- |
14.09. Governing Law....................................................57 14.10. Merger or Consolidation..........................................57 14.11. Transfer from Affiliate..........................................57 14.12. Reorganization...................................................58 14.13. Loans to Participants............................................58 14.14. Transfer From Sulzer Medica USA Retirement Plan..................59 14.15. Transfer From EVT Plan...........................................60 14.16. Transfer From InControl Plan.....................................61 14.17. Transfer From CTS Plan...........................................61 14.18. Transfer From DVI Plan...........................................61 ARTICLE XV. AMENDMENT OR TERMINATION.........................................61 15.01. Internal Revenue Approval, ERISA Compliance......................61 15.02. Modification and Termination.....................................61 15.03. Termination of Participation by Subsidiaries and Affiliate.......62 15.04. Distribution on Termination......................................63 ARTICLE XVI. AGENT FOR SERVICE OF PROCESS.....................................63 ARTICLE XVII. TOP HEAVY PLAN..................................................63 17.01. General Rule.....................................................63 17.02. Top-Heavy Plan...................................................63 17.03. Definitions......................................................64 17.04. Requirements Applicable if Plan is Top-Heavy.....................66 ARTICLE XVIII. PAYSOP ACCOUNT.................................................67 18.01. Transfer of Assets...............................................67 18.02. Investment In the Company Stock Fund.............................67 18.03. Withdrawal of PAYSOP Accounts....................................67 18.04. Distribution of PAYSOP Accounts..................................67 18.05. Qualified Domestic Relations Orders..............................68 ARTICLE XIX. ESOP PROVISIONS..................................................68 19.01. Introduction.....................................................68 19.02. Definitions......................................................69 19.03. Eligibility......................................................69 19.04. Employer Contributions...........................................69 19.05. Payment to Trustee...............................................74 19.06. Limits on Annual Additions.......................................75 19.07. Limits on Employer Contributions.................................76 19.08. Vesting and Forfeitures..........................................77 19.09. ESOP Accounts....................................................77 19.10. Payment of Dividends.............................................77 19.11. ESOP Shares Fund.................................................78 19.12. Exempt Loan Provisions...........................................79 19.13. Distribution of ESOP Accounts....................................84 19.14. Withdrawal and Diversification Rights............................84 -iii- |
19.15. Voting and Tendering of Company Securities.......................85 19.16. Election Regarding Dividends.....................................85 ARTICLE XX. AMENDMENT OF THE PLAN FOR EGTRRA..................................86 20.01. Adoption and Effective Date of Amendment.........................86 20.02. Supersession of Inconsistent Provisions..........................86 20.03. Limitation on Contributions......................................86 20.04. Increase In Compensation Limit...................................87 20.05. Modification of Top-Heavy Rules..................................87 20.06. Direct Rollovers of Plan Distributions...........................89 20.07. Rollovers Disregarded in Involuntary Cash-Outs...................89 20.08. Repeal of Multiple Use Test......................................90 20.09. Elective Deferrals: Contribution Limitation.....................90 20.10. Catch-Up Contributions...........................................90 20.11. Suspension Period Following Hardship Distribution................90 ARTICLE XXI. MINIMUM DISTRIBUTION REQUIREMENTS................................90 21.01. General Rules....................................................90 21.02. Time and Manner of Distribution..................................91 21.03. Required Minimum Distributions During Participant's Lifetime.....92 21.04. Required Minimum Distributions After Participant's Death.........92 21.05. Election of Five Year Rule.......................................94 21.06. Definitions......................................................94 |
THE GUIDANT EMPLOYEE SAVINGS AND STOCK OWNERSHIP PLAN
(2003 Restatement)
Guidant Corporation (the "Company") hereby amends and restates The Guidant Employee Savings and Stock Ownership Plan ("Plan"), which was originally effective as of January 1, 1995. Except as otherwise specified in the Plan, the effective date of this amendment and restatement is January 1, 2003. The purpose of the Plan is to help the Company's eligible employees, and the eligible employees of its subsidiary and affiliated companies that adopt the Plan, to provide additional security for their retirement by (1) affording those employees the means of making regular savings and (2) providing Employer Contributions invested in stock of Guidant Corporation as an incentive to enhance their individual performance and the performance of Guidant Corporation.
The Plan contains an employee stock ownership plan (the "ESOP"), which is designed to invest exclusively in qualifying employer securities. The non-ESOP portion of the Plan (the "Profit-Sharing Plan") is intended to be a profit-sharing plan that is qualified under Code section 401(a), with a cash or deferred arrangement qualified under Code section 401(k). The ESOP is intended to be a stock bonus plan and an employee stock ownership plan qualified under Code sections 401(a) and 4975(e)(7) and described in ERISA section 407(d)(6). The Profit-Sharing Plan and the ESOP together are designed to constitute a single plan under Treasury Regulation ss. 1.414(1)-l(b)(1). The Plan is also designed to satisfy the requirements of ERISA. The Trust Fund maintained under the Plan is intended to be tax-exempt under Code section 501(a).
Guidant Corporation was previously a wholly-owned subsidiary of Eli Lilly and Company. All of the stock of Guidant Corporation was distributed to the shareholders of Eli Lilly and Company in a tax-free reorganization within the meaning of Code section 368(a)(1)(D). Following adoption of this Plan, employees of Guidant Corporation and its affiliates who were participating in The Lilly Employee Savings Plan had their ESOP and PAYSOP accounts in The Lilly Employee Savings Plan transferred to this Plan. In addition, the Advanced Cardiovascular Systems, Inc. Employee Savings Plan, the Cardiac Pacemakers, Inc. Employee Savings Plan, and the Origin Medsystems, Inc. Employee Savings Plan were merged into this Plan, and all employees who were participating in those plans now participate in this Plan. The Employees' 401(k) Plan of Devices for Vascular Intervention, Inc. will be merged into this Plan as soon as practicable after March 31, 2003. To the extent the accounts of employees who were participating in The Lilly Employee Savings Plan or an affiliate plan were transferred to or merged into this Plan, any beneficiary designation or any other applicable agreement, elections, or consents that participants, spouses, or beneficiaries validly executed under those plans shall be honored by this Plan, to the extent not inconsistent with this Plan and unless otherwise required by law.
The Plan, as amended from time to time, shall be known as "The Guidant Employee Savings and Stock Ownership Plan." The rights to benefits of any employee whose employment terminated prior to the effective date of this restatement or any subsequent
amendment shall be determined solely by the provisions of the Plan in effect at the time of termination of employment, unless the Plan expressly provides otherwise.
(a) The following words and phrases shall have the following meanings unless a different meaning is plainly required by the context:
(1) Base Earnings. The term "Base Earnings" means base pay on, or converted to, a monthly basis, provided that in no event shall base earnings include amounts paid as commissions or sales bonuses. Base earnings shall include base pay that would have been paid to the Participant during the Plan Year in the absence of a salary reduction agreement but are excluded from gross income pursuant to Code section 125, 132(f) or 402(g). For a Participant's initial year of participation in the Plan, Base Earnings will be recognized for the entire Plan Year.
Notwithstanding any other provision of the Plan to the contrary, except for purposes of Section 3.01, the Base Earnings of each Participant taken into account under the Plan in any Plan Year shall not exceed $150,000, as adjusted for increases in the limitation pursuant to Code section 401 (a)(17)(B).
(2) Base Earnings Plus Commissions. The term "Base Earnings Plus Commissions" means, with respect to a Participant for a period, the sum of the Participant's Base Earnings for the period plus any amounts paid to the Participant as sales commissions during the period. For this purpose, "sales commissions" means sales commissions (whether revenue based, unity based, or otherwise) and sales bonuses (whether quarterly, monthly, annual, percentage to revenue, unit, or otherwise) to which a Participant is entitled due to the sale of an Employer's products by the Participant. Base Earnings Plus Commissions shall include any Base Earnings or sales commissions that would have been paid to a Participant during a Plan Year in the absence of a salary reduction agreement but are excluded from gross income pursuant to Code section 125, 132(f) or 402(g). For a Participant's initial year of participation in the Plan, Base Earnings Plus Commissions will be recognized for the entire Plan Year.
Notwithstanding any other provision of the Plan to the
contrary, except for purposes of Section 3.01, the Base Earnings
Plus Commissions of each Participant taken into account under the
Plan in any Plan Year shall not exceed $150,000, as adjusted for
increases in the limitation pursuant to Code section
401(a)(17)(B).
(3) Board of Directors. The term "Board of Directors" means the Board of Directors of the Company.
(4) Code. The term "Code" means the Internal Revenue Code of 1986, as amended from time to time, and interpretive rules and regulations.
(5) Company. The term "Company" means Guidant Corporation.
(6) Disabled Employee. The term "Disabled Employee" means an Employee who is unable to perform the material duties of his regular occupation with the Employer in the same salary grade that is commensurate with the Employee's education, training, and experience; provided that the inability results from an injury or illness that requires the Employee to be under the care of a licensed physician; and provided further that the inability is not attributable to intentionally self-inflicted injuries (whether sane or insane), or to active participation in a riot. The term "Disability" means the condition that causes the Employee to become a Disabled Employee.
(7) Employee. The term "Employee" means a person
(A) Who
(i) is a citizen of the United States, but not a resident of the Commonwealth of Puerto Rico, employed by an Employer, or
(ii) is a citizen or resident of the United States, designated by the Company as an international service employee, employed by a Qualified Subsidiary and as to whom no contributions under a funded plan of deferred compensation are being provided by any person other than the Company with respect to the remuneration paid to such person by the Qualified Subsidiary; and
(B) who receives regular compensation from an Employer or Qualified Subsidiary that the Employer or Qualified Subsidiary initially reports on a federal wage and tax statement (Form W-2); and
(C) who is not a member of a recognized collective-bargaining unit, unless there is a collective-bargaining agreement making the Plan applicable to members of that unit.
(D) The term "Employee" also means a person, who, in addition to meeting the requirement of Section 1.01(a)(7)(C),
(i) is not a citizen of the United States;
(ii) is not a resident of the Commonwealth of Puerto Rico;
(iii) is employed by an Employer or an affiliate (as defined in Section 1.01(a)(26)(A)(ii)); and
(iv) has been selected for participation in the Plan by the Salary Committee of the Company or its designee.
(E) The term "Employee" also means a Leased Employee who is an employee of Eli Lilly and Company providing services to the Company, but does not include any other Leased Employees.
(F) The term "Employee" also means a person who, in addition to meeting the requirement of Section 1.01(a)(7)(C),
(i) is a resident of the Commonwealth of Puerto Rico;
(ii) is employed by an Employer and classified as a global service employee; and
(iii) receives regular compensation from the Employer through a payroll in the United States.
(G) The term "Employee" also means a person who, in addition to meeting the requirement of Section 1.01(a)(7)(C),
(i) is not a citizen or permanent resident of the United States;
(ii) is eligible to participate in one or more employee benefit plans maintained by an Employer or Qualified Subsidiary (other than the Plan); and
(iii) receives regular compensation from an Employer or Qualified Subsidiary through a payroll in the United States for services performed in the United States, that the Employer or Qualified Subsidiary initially reports on a federal wage and tax statement (Form W-2).
A person who meets the requirements of Section 1.01(a)
(7)(A)(ii), (B), and (C), or a person who meets the requirements
of Section
1.01(a)(7)(D) and is not employed by an Employer, shall be deemed to be an Employee of the Company for purposes of the Plan.
(8) Employee Benefits Committee. The term "Employee
Benefits Committee" means the committee established pursuant to
Section 12.01 to administer the Plan.
(9) Employer. The term "Employer" means the Company and any subsidiary and affiliated company specifically designated by the Board of Directors as such for the purposes of this Plan, provided that the subsidiary or affiliated company adopts this Plan by resolution of its own board of directors. A subsidiary or affiliated company shall cease to be an Employer as of the date on which the subsidiary or affiliated company ceases to be a member of the controlled group (within the meaning of Code section 414(b) or 414(c)) of which the Company is a member.
(10) Employer Contribution. The term "Employer Contribution" means the Minimum Matching Contributions, Additional Matching Contributions, and Basic Contributions that an Employer makes to the Profit-Sharing Plan pursuant to Section 3.06 or to the ESOP pursuant to Section 19.04, any forfeitures that are allocated to Participants' Accounts pursuant to Section 3.06 or 19.04, and any employer contributions made under a Prior Savings Plan that are transferred to or merged into this Plan.
(11) ERISA. The term "ERISA" means the Employee Retirement Income Security Act of 1974, as amended from time to time, and interpretive rules and regulations.
(12) Excess Salary Reduction Contribution. The term "Excess Salary Reduction Contribution" means, with respect to any Participant, that portion of the amount that he has elected to have contributed to the Profit-Sharing Plan as a Salary Reduction Contribution pursuant to Section 3.02 but that exceeds the actual deferral percentage limitations described in Section 3.03(a).
(13) Fund Advisory Committee. The term "Fund Advisory Committee" means the committee established pursuant to Section 13.01.
(14) Leased Employee. The term "Leased Employee" means any person who is not an employee of the Company (including, for purposes of this paragraph, an affiliate of the Company) and who provides services to the Company, provided that (i) the services are provided pursuant to an agreement between the Company and any other person ("leasing organization"); (ii) the person has performed the services for the Company on a substantially full-time basis for a period of at least 1 year; and (iii) the services are performed under the primary direction and
control of the Company; provided that, an individual shall not be
considered a Leased Employee of the Company if (i) the employee
is covered by a money purchase plan maintained by the leasing
organization providing: (1) a nonintegrated employer contribution
rate of at least 10 percent of compensation, as defined in Code
section 415(c)(3), but including amounts contributed pursuant to
a salary reduction agreement which are excludable from the
employee's gross income under Code section 125, 132(f),
402(a)(8), 402(h) or 403(b), (2) immediate participation, and (3)
full and immediate vesting; and (ii) leased employees do not
constitute more than 20 percent of the Company's non-highly
compensated workforce.
(15) Normal Retirement Age. The term "Normal Retirement Age" means age 65.
(16) Participant. The term "Participant" means an Employee who has satisfied the requirements of Article IL
(17) Participant's Account. The term "Participant's Account" means the sum of the amounts credited to the Participant at the time of reference in each of the categories listed in Section 6.01.
(A) The portion of a Participant's Account that is attributable to contributions made under the Profit- Sharing Plan, including a Participant's Profit-Sharing Account (or similar account) in a Prior Savings Plan that is transferred to or merged into this Plan, and earnings thereon, shall be referred to as the Participant's "Profit-Sharing Account."
(B) The portion of a Participant's Account that reflects a Participant's interest in the ESOP, including a Participant's ESOP Account (or similar account) in a Prior Savings Plan that is transferred to or merged into this Plan, shall be referred to as the Participant's "ESOP Account."
(C) The portion of a Participant's Account that represents amounts from a Participant's PAYSOP Account (or similar account) in a Prior Savings Plan transferred to or merged into this Plan, and earnings thereon, shall be referred to as the Participant's "PAYSOP Account."
(18) Plan. The term "Plan" means the Guidant Employee Savings and Stock Ownership Plan as modified or amended from time to time as herein provided. The Plan shall comprise both a profit-sharing plan described in Code section 401(a) with a cash or deferred arrangement described in Code section 401(k) (the "Profit-Sharing Plan") and a stock bonus plan and employee stock ownership plan described in Code sections
401(a) and 4975(e)(7) and section 407(d)(6) of ERISA (the "ESOP"). The ESOP shall be known as the "Guidant Corporation Common Stock Fund."
(19) Plan Fiduciary. The term "Plan Fiduciary" means the following:
(A) The Board of Directors, but only to the extent that the Board of Directors appoints Plan Fiduciaries or performs other functions with respect to the Plan that are identified in ERISA as fiduciary functions. The Board of Directors shall not be a "Plan Fiduciary" to the extent that it makes decisions regarding the design of the Plan or performs other settlor functions with respect to the Plan.
(B) Any Investment Manager appointed pursuant to
Section 13.02(d).
(C) The Employee Benefits Committee and the Fund Advisory Committee.
(D) Any Trustee.
A person or entity shall be a Plan Fiduciary only with respect to the duties allocated to him or it under the terms of the Plan and only to the extent that those duties are identified by ERISA as fiduciary functions.
(20) Plan Year. The term "Plan Year" means the calendar year.
(21) Prior Savings Plan. The term "Prior Savings Plan" shall mean the Lilly Employee Savings Plan, the Advanced Cardiovascular Systems, Inc. Employee Savings Plan, the Cardiac Pacemakers, Inc. Employees Savings Plan, the Origin Medsystems, Inc. Employees Savings Plan, or the Employees' 401(k) Plan of Devices for Vascular Intervention, Inc., as amended from time to time.
(22) Qualified Subsidiary. The term "Qualified Subsidiary" means a corporation other than an Employer that is either
(A) A foreign corporation not less than ten percent (10%) of the voting stock of which is owned, directly or through one or more subsidiaries, by the Company, but only if the Company has entered into an agreement under Code section 3121(l) or the corresponding provisions of any subsequent revenue law that applies to the foreign corporation and that agreement remains in effect, or,
(B) A domestic corporation not less than 80 percent of the voting stock of which is owned by the Company, 95 percent or
more of the gross income of which, for the three-year period immediately preceding the close of the taxable year (or for such part of such period during which the corporation was in existence), was derived from sources without the United States, and 90 percent or more of the gross income of which for such period (or such part) was derived from the active conduct of a trade or business.
(23) Retirement. The term "Retirement" or "Retire" means a Participant's termination of employment with the Employer after:
(A) The Participant has attained Normal Retirement Age;
(B) The Participant has attained age 55 and completed ten years of Service; or
(C) With respect to a Participant who is eligible for transition benefits under The Guidant Retirement Plan, the sum of the Participant's full years of age and years of Service equals or exceeds 80.
(24) Rollover Contribution. The term "Rollover Contribution"
means a contribution made to the Profit-Sharing Plan pursuant to
Section 3.09.
(25) Salary Reduction Contribution. The term "Salary Reduction Contribution" means a contribution made by an Employer (or, in the case of a Leased Employee treated as an Employee under Section 1.01(a)(7)(E), the contribution made by Eli Lilly and Company) on behalf of an Employee pursuant to Section 3.01 and any salary reduction contributions made under a Prior Savings Plan on behalf of a Participant that are transferred to this Plan.
(26) Service. The term "Service" means employment that is credited under the Plan in accordance with the following rules:
(A) Employers for Whom Service Is Credited. Service means periods of employment with:
(i) an Employer;
(ii) any member of a controlled group of
corporations (within the meaning of Code section
414(b), (c), (m), or (o) of which an Employer is a
member (hereinafter referred to as an "affiliate");
(iii) a Qualified Subsidiary;
(iv) any corporation that is a predecessor
corporation of an Employer, or a corporation merged,
consolidated, or liquidated into an Employer or a
predecessor of an Employer, or a corporation,
substantially all of the assets of which have been
acquired by an Employer, if the Employer maintains a
plan of such a predecessor corporation. If the Employer
does not maintain a plan maintained by such a
predecessor, periods of employment with the
predecessor shall be credited as Service only to the
extent required under regulations prescribed by the
Secretary of the Treasury pursuant to Code section
414(a)(2); and
(v) for Participants who began participation in the Plan before January 1, 1996, periods of employment that are counted as Service under a Prior Savings Plan.
(vi) for Participants who began participation in the Plan on January 1, 1998 and who, as of December 31, 1997, were employees of Endovascular Technologies, Inc., periods of employment that counted as service under the 401(k) Savings Plan For Employees of Endovascular Technologies, Inc.
(vii) for Participants who began participation in
the Plan on January 1, 1999, and who, as of December
31, 1998, were employees of InControl, Inc., periods of
employment that counted as service under the InControl
401(k) Plan.
(viii) for Participants who began participation in the Plan on May 1, 1999, and who, as of April 30, 1999, were employees of Intermedics, Inc., periods of employment that counted as service under the Sulzer Medica USA Retirement Plan.
(ix) for Participants who began participation in the Plan on January 1, 2000, and who, as of December 31, 1999, were employees of CardioThoracic Systems, periods of employment that counted as service under the CardioThoracic Systems 401(K) Savings Plan.
Notwithstanding the foregoing, an Employee may receive credit for periods of employment with an affiliate or predecessor corporation in addition to that which is required under regulations prescribed by the Secretary of the Treasury pursuant to Code section 414(a)(2), or for periods of employment with prior employers, provided that the Employee
Benefits Committee specifically so determines and records its decision in writing.
(B) Periods Credited. An Employee shall receive credit for Service under the Plan from the date he is first credited with an hour of Service to the date his employment is severed. In no event shall an Employee receive credit more than once for the same period of Service. Except as otherwise provided in Section 1.01(a) (26)(F) with regard to leaves of absence, an Employee's employment shall be severed on the earlier of the date on which he Retires, is discharged, resigns, or dies, or the first anniversary of his first date of absence for any reason other than retirement, discharge, resignation, or death. A Disabled Employee's employment shall be severed on the first anniversary of the date on which he becomes disabled.
An Employee shall receive credit for Service, and shall not be deemed to have severed from employment, during, by way of illustration but not by way of limitation, the following:
(i) any period of unpaid leave for military service in the armed forces of the United States required to be credited by law; provided, however, that the Employee returns to employment within the period his reemployment rights are protected by law;
(ii) any period of unpaid family or medical leave required to be credited by law; provided, however, that the Employee returns to employment at the expiration of the leave;
(iii) any unpaid absence from work during which no duties are performed due to the pregnancy of the Employee, the birth of a child of the Employee, the placement of a child with the Employee in connection with the adoption of the child by the Employee or the caring for a child for a period immediately following birth or placement, but only to the extent required by law;
(iv) any other period as specified by the Employee Benefits Committee in writing or as required by law.
(C) Reemployment Within 12 Months. Notwithstanding the foregoing, in the event that an Employee's Service is severed but he is reemployed within the 12 consecutive
month period commencing on the date of severance, the period of severance shall constitute Service.
(D) Measurement of Service. Service shall be measured in years and days. A period of 365 days of Service shall constitute one Year of Service. All periods of service shall be aggregated for purposes of this Section.
(E) One Year Period of Severance. A one year period of severance shall occur if employment is severed and the Employee is not reemployed within the 12 consecutive month period commencing on the date of severance.
(F) Leaves of Absence. An Employee shall receive
credit for Service for all purposes under the Plan during a
leave of absence in accordance with the provisions of
Section 1.01(a)(26)(B) and the following rules:
(i) Unpaid Leaves. An Employee shall receive credit for Service under the Plan during the period of an unpaid leave, other than a Special Educational Leave as provided in Section 1.01(a)(26)(F)(iii), only in accordance with Section 1.01(a)(26)(B). The employment of an Employee who fails to return to employment shall be deemed severed, and credit for Service shall cease, as of the first anniversary of the Employee's first date of absence for the leave, unless employment is earlier severed by reason of the Employee's Retirement, discharge, resignation, or death. Where such an Employee's period of leave is authorized to extend beyond the period for which Service is credited under Section 1.01(a)(26)(B), the Employee shall not be deemed to have terminated employment for purposes of payments upon termination of employment under Article X until the date upon which the authorized leave period expires and the Employee fails to return to employment.
(ii) Paid Leaves. An Employee shall receive credit for Service under the Plan during the period of any paid leave of absence. The employment of an Employee who fails to return to employment as of the date specified for the termination of the paid leave shall be severed, and credit for Service shall cease, as of the first anniversary of the date specified for the termination of the leave, unless employment is earlier severed by reason of the Employee's retirement, discharge, resignation, or death. Such an Employee shall be deemed to have terminated employment
for purposes of payments upon termination of employment under Article X as of the date credit for Service ceases.
(iii) Special Educational Leaves. An Employee who
does not return to employment as of the date specified
for the termination of the Special Educational Leave
shall be governed by the provisions for unpaid leave in
Section 1.01(a)(26)(F)(i). An Employee who returns to
employment as of the date specified for the termination
of the Special Educational Leave shall receive credit
for Service under the Plan for the entire period of the
Special Educational Leave.
(G) Crediting of Service for Leased Employees. An individual who is a Leased Employee shall receive credit for Service under the Plan during any period in which the individual is a Leased Employee.
(27) Shares. The term "Shares" means shares of Guidant Corporation common stock.
(28) Split. The term "Split" means September 25, 1995, the date as of which Guidant Corporation ceased to be a member of the controlled group of corporations that includes Eli Lilly and Company.
(29) Trust. The term "Trust" means a trust created by and under any Trust Agreement.
(30) Trust Agreement. The term "Trust Agreement" means an agreement provided for in Article XIII, as that agreement may be modified from time to time.
(31) Trustee. The term "Trustee" means the trustee or the co-trustees under a Trust Agreement and any successor trustee or co-trustees hereafter designated under the terms of any Trust Agreement.
(32) Unit of Participation or Unit. The term "Unit of Participation" or "Unit" means the unit of measure of a Participant's proportionate interest in one of the unsegregated funds described in Article V.
(33) Value Determination Date. The term "Value Determination Date" means the date as of which the value of each Unit in each Fund shall be determined.
(b) Gender. Words used in the masculine gender shall be construed to include the feminine gender, where appropriate, and vice versa.
An Employee shall be eligible to participate in the Plan for all purposes upon commencement of employment with an Employer.
Notwithstanding the provisions of Section 2.01, an Employee who is classified as a special status Employee shall not be eligible to participate in the Plan and to have Salary Reduction Contributions contributed to the Profit-Sharing Plan on his behalf until the first day of the month following his completion of one year of eligibility service. An Employee shall be considered a special status Employee if his employment status is temporary or seasonal, he is a part-time Employee regularly scheduled to work fewer than 20 hours per week, or his employment status is otherwise inconsistent with regular employment status.
A special status Employee shall be credited with a year of eligibility service at the end of an eligibility computation period if he completes 1,000 hours of service in that eligibility computation period. An eligibility computation period shall be the 12 consecutive month period beginning on the first date on which a special status Employee is employed and completes one hour of service and each 12 consecutive month period thereafter; provided, however, that if the Employee's employment is terminated and during such 12 consecutive month period he does not complete more than 500 hours of service, but he is subsequently reemployed, subsequent eligibility computation periods shall be measured by reference to his date of reemployment.
A special status Employee shall receive credit for 1 hour of service for each hour:
(a) for which the Employee is directly or indirectly compensated
by, or entitled to compensation from, any employer described in
Section 1.01(a)(26)(A);
(b) for which back pay, irrespective of mitigation of damages, has been awarded or agreed to by such an employer;
(c) for which he is paid or entitled to payment by such an employer, but during which no duties are performed due to vacation, holiday, illness, incapacity (including Disability), layoff, jury duty or leave of absence; provided, however, that no credit shall be given for periods for which payment is made solely to comply with worker's compensation, unemployment compensation, or disability insurance laws or for payments that solely reimburse an Employee for medical or medically-related expenses incurred by the Employee; and
(d) during which the Employee is absent from work and during which no duties are performed due to the pregnancy of the Employee, the birth of a child of the Employee, the placement of a child with the Employee in connection with the adoption of the child by the Employee, or the caring for a child for the period immediately following birth or placement.
Credit for hours of service under Section 2.04 will be provided in accordance with the following special rules:
(a) The number of hours with which an Employee is credited for reasons described in Section 2.04(c) (or the number of hours to which an award of, or agreement to pay, back pay for a period described under that Section applies) shall be determined in accordance with Department of Labor regulations ss. 2530.200b-2; provided, however, that in no event shall more than 501 hours of service be credited for any single continuous period during which the Employee performs no duties but for which he is entitled to credit under Section 2.04(c).
The number of hours with which an Employee is credited for
reasons described in Section 2.04(d) shall be the number of hours that
normally would have been credited to the Employee but for the absence
or, if the Employee Benefits Committee is unable to determine the
number of these hours, 8 hours per day of such absence; provided,
however, that in no event shall more than 501 hours of service be
credited for any single continuous period during which the Employee
performs no duties but for which he is entitled to credit under
Section 2.04(d).
(b) Hours of service described in Section 2.04(a) shall be credited to the eligibility computation period in which the duties are performed. The eligibility computation period to which hours of service described in Section 2.04(b) or (c) are credited shall be determined in accordance with Department of Labor regulations ss. 2530.200b-2.
Hours of service described in Section 2.04(d) shall be credited
to the eligibility computation period in which an absence described in
Section 2.04(d) begins if, as of the date the absence begins, the
Employee has completed less than 501 hours of service; in any other
case, those hours shall be credited to the next eligibility
computation period.
(c) In addition to credit for hours described in Section 2.04(a), (b), (c), and (d), an Employee shall receive credit for hours of service for any period of military service in the Armed Forces of the United States, and for any period of family or medical leave, required to be credited by law.
(d) during which the Employee is absent from work and during which no duties are performed due to the pregnancy of the Employee, the birth of a child of the Employee, the placement of a child with the Employee in connection with
the adoption of the child by the Employee, or the caring for a child for the period immediately following birth or placement.
A former Participant who is reemployed by an Employer shall be eligible to participate in the Plan again upon the date of his reemployment.
(a) Each Participant hired before October 1, 2000, may elect that his Employer shall contribute to the Profit-Sharing Plan on his behalf a Salary Reduction Contribution in an amount equal to a stated whole percentage of his Base Earnings Plus Commissions.
(b) Each Participant hired or rehired on or after October 1, 2000, shall have 3% of his Base Earnings Plus Commissions contributed on his behalf to the Profit-Sharing Plan as Salary Reduction Contributions until and unless he elects, in accordance with the procedures within the time period prescribed by the Employee Benefits Committee, to have a different percentage, or 0%, contributed on his behalf to the Profit-Sharing Plan as a Salary Reduction Contribution. The automatic Salary Reduction Contributions will begin with the first payroll of the first month that begins at least 60 days after the Participant becomes a Participant.
(c) If the Participant is eligible to make a deferral election under The Guidant Excess Benefit Plan-Savings for a Plan Year, the Participant's Salary Reduction Contribution for the Plan Year shall not be more than 16 percent of the Participant's Base Earnings Plus Commissions for the Plan Year. If a Participant is not eligible to participate in The Guidant Excess Benefit Plan--Savings for a Plan Year, the Participant's Salary Reduction Contribution for the Plan Year shall not be more than 75 percent of Base Earnings Plus Commissions for the Plan Year.
(d) Each Participant's Salary Reduction Contributions shall be paid by the Employer to the Trustee no less frequently than monthly, and the Participant's Base Earnings Plus Commissions for that month shall be reduced by an identical amount.
(e) A Participant shall be required to have Salary Reduction Contributions made on his behalf in a Plan Year in order to receive an allocation of Matching Contributions or Additional Matching Contributions.
(a) Each Participant electing to have his Employer contribute a Salary Reduction Contribution on his behalf with respect to a Plan Year shall designate
(at such time and in such manner as prescribed by the Employee Benefits Committee) the percentage of his Base Earnings Plus Commissions (within the limits stated in Section 3.01) to be contributed and authorize the Employer to reduce his Base Earnings Plus Commissions by that amount, to take effect as soon as administratively practicable. A Participant who elects not to have any Salary Reduction Contributions made to the Profit-Sharing Plan on his behalf or who wishes to change the amount of Salary Reduction Contributions made to the Profit-Sharing Plan on his behalf may change his election at any time in accordance with procedures prescribed by the Employee Benefits Committee, to take effect as soon as administratively practicable.
(b) Notwithstanding any other provisions of this Plan, a Participant who is credited with Service because of a period of service in the uniformed services of the United States may elect, before or after the period of service, to contribute to the Profit Sharing PIan the Salary Reduction Contributions that would have been made on the Participant's behalf pursuant to Section 3.01 had he remained actively working for an Employer throughout that period of military service ("make-up contributions"). The amount of make-up contributions shall be determined based on the Participant's Base Earnings Plus Commissions immediately prior to the period of military service and the terms of the Plan in effect at that time. Any make-up contributions shall be limited as provided in Section 3.03 with respect to the Plan Year to which the contributions relate rather than the Plan Year in which the make-up contributions are made. Any make-up contributions pursuant to this Section shall be made during the period beginning on the date of reemployment, the duration of which is the lesser of three times the period of absence or 5 years. Investment earnings and losses on make-up contributions shall be credited commencing with the date the contribution is made. Make-up contributions shall be treated as "annual additions" for purposes of Article IV with respect to the Plan Year to which the contributions relate rather than the Plan Year in which they are paid to the trust.
(a) For Plan Years beginning on or after January 1, 1997, notwithstanding anything in the Plan to the contrary, in no event may the Salary Reduction Contributions made on behalf of all eligible highly compensated Employees with respect to any Plan Year result in an actual deferral percentage for that group of Employees that exceeds the greater of (1) or (2) below, where:
(1) is an amount equal to 125 percent of the actual deferral percentage for the Plan Year being tested for all Employees eligible to participate in the Plan other than eligible highly compensated Employees; and
(2) is an amount equal to the lesser of (1) the sum of the actual deferral percentage for the Plan Year being tested for all Employees eligible to participate in the Plan other than eligible highly compensated
Employees and 2 percent, or (2) 200 percent of the actual deferral percentage for the Year being tested for all Employees eligible to participate in the Plan other than eligible highly compensated Employees.
By the foregoing provision, the Employee Benefits Committee has elected to use the actual deferral percentage for Employees other than highly compensated Employees for the Plan Year being tested rather than the preceding Plan Year, recognizing that the election may not be changed for Plan Years after 1997 except as provided by the Secretary of the Treasury. In determining the actual deferral percentage for a group for a Plan Year, all "eligible Employees" shall be taken into account. For this purpose, "eligible Employee" for a Plan Year is any Employee who is directly or indirectly eligible to make a Salary Reduction Contribution for all or a portion of the Plan Year and includes an Employee who would be eligible to make a Salary Reduction Contribution but did not make any because he failed to make an election pursuant to Section 3.01, his contributions were suspended on account of a withdrawal pursuant to Section 3.10 or 7.01, or because the Salary Reduction Contribution would cause the limitation of Article IV to be exceeded.
(b) For purposes of this Article III, the following terms shall have the following meanings:
(1) "Highly compensated Employee" shall mean, with respect to any Plan Year:
(A) An Employee who performs service for the Company or an affiliate during the Plan Year and is described in one or both of the following groups:
(i) An Employee who is a 5 percent owner, as defined in Code section 416(i)(l)(B), at any time during the Plan Year or the preceding Plan Year; or
(ii) An Employee who received compensation in
excess of $80,000 (as adjusted pursuant to Code section
415(d)) during the preceding Plan Year.
(B) For purposes of this definition of highly compensated Employee, the term "compensation" means compensation within the meaning of Code section 415(c)(3), including elective or salary reduction contributions to a cafeteria plan, cash or deferred arrangement, simplified employee pension, or tax-sheltered annuity.
(2) "Actual deferral percentage" with respect to any specified group of Employees for a Plan Year shall mean the average of the actual deferral ratios (calculated separately for each Employee in the group) of
(A) the amount of Salary Reduction Contributions paid to the Profit-Sharing Plan on behalf of each such Employee for the Plan Year, to
(B) the Employee's compensation, determined using a definition of compensation that is nondiscriminatory within the meaning of Code section 414(s), for the Plan Year or such other period as is permitted under Treasury Regulations ss. 1.401(k)-1(g)(2)(i) (provided that the section 414(s) definition of compensation used and the period over which compensation is determined is applied uniformly to all Employees for the Plan Year).
If any highly compensated Employee is a Participant under two (2) or more qualified cash or deferred arrangements (as defined in Code section 401(k)) of the Employer or an affiliate, for purposes of determining the actual deferral percentage for any such Employee, all such qualified cash or deferred arrangements shall be treated as a single qualified cash or deferred arrangement.
(c) In the event that it is determined prior to the first day of any Plan Year or during the course of any Plan Year that the amount of Salary Reduction Contributions elected by the highly compensated Employees to be contributed to the Profit-Sharing Plan would cause the actual deferral percentage limitations described in Section 3.03(a) to be exceeded, then the Salary Reduction Contribution elected by each highly compensated Employee shall be reduced to the extent necessary to meet such limitations in such manner as the Employee Benefits Committee, in its sole discretion, determines.
(d) Notwithstanding anything in the Plan to the contrary, a Participant's Salary Reduction Contribution to the Profit-Sharing Plan for any calendar year may not exceed the limitation imposed by Code section 402(g)(1) (as adjusted pursuant to Code section 402(g)(5)), reduced to the extent required by Section 7.01(b)(2)(D).
(e) Notwithstanding the foregoing, the actual deferral percentage limitations described in Section 3.03(a) may be satisfied by combining the Salary Reduction Contributions under the Profit-Sharing Plan with the salary reduction contributions under any other plan maintained by a member of a controlled group of corporations (as defined in Section 1.01(a)(26)(A)(ii)) of which an Employer is a member, to the extent required or permitted under Code section 401(k).
(a) If a Participant's elective deferrals (as defined in Code section 402(g)(3)) for the Participant's taxable year under this Profit-Sharing Plan or under any other plan in which the Participant has participated during the taxable
year exceed the limit imposed by Code section 402(g), the following rules shall apply to such excess deferrals:
(1) Not later than the first February 1 following the close of the taxable year, the Participant may allocate to the Profit-Sharing Plan all or any portion of the Participant's excess deferrals for the taxable year (provided that the amount of the excess deferrals allocated to the Profit-Sharing Plan shall not exceed the amount of the Participant's Salary Reduction Contributions to the Profit-Sharing Plan for the Plan Year ending in the taxable year that have not been withdrawn or distributed), and may notify the Employee Benefits Committee, in writing, of the amount allocated to the Profit-Sharing Plan.
(2) As soon as practicable, but in no event later than the first April 15 following the close of the taxable year, the Profit-Sharing Plan shall distribute to the Participant any excess deferrals allocated to the Profit-Sharing Plan and any income attributable to that amount. The distribution described in this Section 3.04(a)(2) shall be made notwithstanding any other provision of the Plan.
(b) After any excess deferrals (and income attributable thereto)
have been allocated to the Profit-Sharing Plan and distributed in
accordance with Section 3.04(a), if the actual deferral percentage for
the Plan Year of those Participants who are highly compensated
Employees exceeds the applicable limit imposed by Section 3.03(a), the
amount of the Excess Salary Reduction Contributions (determined in
accordance with Code section 401(k)(8)(B)), and any income
attributable to those contributions, shall be distributed before the
end of the following Plan Year to Participants who are highly
compensated Employees, on the basis of the respective portions of the
Excess Salary Reduction Contributions allocated to each Participant as
described in this Section 3.04(b). The distribution described in this
Section 3.04(b) shall be made notwithstanding any other provision of
the Plan. The amount of the Excess Salary Reduction Contributions to
be distributed under this Section 3.04(b) for a Plan Year with respect
to a Participant shall be reduced by any excess deferrals previously
distributed from the Plan to the Participant for the Plan Year.
The amount of Excess Salary Reduction Contributions shall be determined, allocated, and distributed as follows:
(1) First, the actual deferral ratio of the highly compensated Employee with the highest actual deferral ratio shall be reduced to the extent necessary to satisfy the actual deferral percentage test or cause the ratio to equal the actual deferral ratio of the highly compensated Employee with the next highest ratio. Second, this process shall be repeated until the actual deferral percentage ratio test is satisfied.
(2) The total dollar amount of Excess Salary Reduction Contributions determined under Section 3.04(b)(1) shall be allocated among highly compensated Employees by reducing the Salary Reduction Contributions of the highly compensated Employee with the highest dollar amount of Salary Reduction Contributions until (A) the total amount of the Excess Salary Reduction Contributions have been allocated or (B) his remaining Salary Reduction Contributions are equal in dollar amount to the Salary Reduction Contributions of the highly compensated Employee with the next highest dollar amount. This process shall be repeated until all Excess Salary Reduction Contributions are allocated. The Excess Salary Reduction Contributions allocated to a highly compensated Employee, together with all income attributable to them, shall be distributed to him within one year after the end of the Plan Year for which the contributions were made.
(c) Amounts distributed under Sections 3.04(a) and (b) shall be deemed to have been made from that portion of the Participant's Salary Reduction Contributions not eligible for a Minimum Matching Contribution or for an Additional Matching Contribution, to the extent that the Participant has unmatched Salary Reduction Contributions for the Plan Year. Notwithstanding the provisions of Section 3.06(a), in the event that a distribution of matched Salary Reduction Contributions is required, the Minimum Matching Contribution or Additional Matching Contribution amount related to the distributed Salary Reduction Contribution amount shall be forfeited.
A Participant shall be fully vested at all times in his Salary Reduction Contributions and any accumulated earnings thereon.
(1) Minimum Matching Contributions. Except as otherwise
provided in this Section 3.06, an Employer shall contribute to
the Profit-Sharing Plan on behalf of its Employees for each month
an amount equal to 50 percent of its Employees' Salary Reduction
Contributions for that month; provided, however, that in no event
shall Minimum Matching Contributions be made with respect to (1)
Salary Reduction Contributions that exceed 6 percent of an
Employee's Base Earnings Plus Commissions for the month, (2)
Salary Reduction Contributions that exceed the limit set forth in
Section 3.03(d); (3) Excess Salary Reduction Contributions; or
(4) Salary Reduction Contributions attributable to Catch-Up
Contributions under Section 20.10. If an Employee's Salary
Reduction Contributions stop before the end of a Plan Year
because they reached the dollar limitation applicable to the
Employee under federal tax law, then his
Employer shall make a true-up Minimum Matching Contribution on behalf of the Employee for the month in which his Salary Reduction Contributions stop and for each month after that month through the last month of the Plan Year. The true-up Minimum Matching Contribution made for a month shall be equal to the difference, if any, between (A) 50 percent of the Employee's total Salary Reduction Contributions (other than those attributable to Catch-Up Contributions under Section 20.10) for the Plan Year to date that are not in excess of 6 percent of the Employee's Base Earnings Plus Commissions for the Plan Year to date, and (B) the Minimum Matching Contributions previously made for the Participant for the Plan Year (including any true-up Minimum Matching Contributions).
Notwithstanding any of the foregoing, in no event shall Minimum Matching Contributions be made to the extent that those contributions would cause the contribution percentage limit set forth in Section 3.06(d) to be exceeded. An Employer shall make its Minimum Matching Contributions on a monthly basis. The Minimum Matching Contributions made by an Employer on behalf of an Employee participating in the Plan shall be allocated to the Employee's Profit-Sharing Account.
(2) Additional Matching Contributions. In the discretion of
the Board of Directors, and except as otherwise provided in this
Section 3.06, each Employer shall make an Additional Matching
Contribution to the Profit-Sharing Plan for the Plan Year in an
amount, as is determined by the Board of Directors, in proportion
to the Salary Reduction Contributions made for the Plan Year on
behalf of, or by, their respective Employees who are
participating in the Plan as of the first day of the last month
of the Plan Year, who Retire during the Plan Year, or who die
during the Plan Year while actively employed and participating in
the Plan provided, however, that in no event shall Additional
Matching Contributions be made with respect to (1) Salary
Reduction Contributions that exceed 6 percent of a Participant's
Base Earnings Plus Commissions, (2) Salary Reduction
Contributions that exceed the limit set forth in Section 3.03(d),
above, or (3) Excess Salary Reduction Contributions; (4) Salary
Reduction Contributions attributable to Catch-Up Contributions
under Section 20.10; and provided further that in no event shall
Additional Matching Contributions be made to the extent that such
contributions would cause the contribution percentage limit set
forth in Section 3.06(d) to be exceeded. An Employer's Additional
Matching Contributions for any Plan Year shall become due for
payment to the Trustee of the Company Stock Fund on the last day
of the Plan Year and shall be paid to the Trustee by the Employer
within the period of time prescribed by law to permit a federal
income tax deduction with respect to the Plan Year for such
contributions. The Additional Matching Contributions made by an
Employer on behalf of an Employee participating in the Plan shall
be allocated to the Employee's Profit-Sharing Account.
(b) Basic Contributions. In the discretion of the Board of Directors, and except as otherwise provided in this Section 3.06, an Employer shall contribute to the Profit-Sharing Plan on behalf of each of its Employees participating in the Plan an amount equal to a percentage, determined annually by the Board of Directors prior to the end of each Plan Year, of each Employee's Base Earnings. An Employer shall make its Basic Contributions on a monthly basis. The Basic Contribution made by an Employer on behalf of an Employee participating in the Plan shall be allocated to the Employee's Profit-Sharing Account.
(c) Forfeitures. Forfeitures attributable to Matching
Contributions that arise under the Plan shall be allocated to
Participants' Profit-Sharing Accounts on the basis of their Salary
Reduction Contributions for any Plan Year in which the Employers have
elected to make Minimum Matching Contributions and Additional Matching
Contributions to the Profit-Sharing Plan rather than to the ESOP.
Forfeitures attributable to Basic Contributions shall be allocated to
Participants' Profit-Sharing Accounts on the basis of their Base
Earnings for any Plan Year in which the Employers have elected to make
Basic Contributions to the Profit-Sharing Plan rather than to the
ESOP. Forfeitures allocated in this manner shall be treated as
Minimurh Matching Contributions, Additional Matching Contributions, or
Basic Contributions, whichever is applicable, and shall be allocated
to Participants' Profit-Sharing Accounts in the manner described in
Section 3.06(a) or (b), above. The forfeiture allocations described in
this Section 3.06(c) shall reduce, dollar for dollar, the amount of
the Minimum Matching Contributions, Additional Matching Contributions,
or Basic Contributions that otherwise would be allocated to the
Participant pursuant to Section 3.06(a) or (b).
(1) Minimum Matching and Additional Matching Contributions to the Profit-Sharing Plan for any Plan Year shall satisfy the contribution percentage test in Code section 401(m)(2) and the regulations thereunder, including Treasury Regulations ss. 1.401(m)-l(b) or any successor provision. Minimum Matching Contributions and Additional Matching Contributions forfeited by a Participant under Section 3.04(c), above, with respect to a Plan Year shall not be taken into account in determining whether Employer Contributions for that Participant satisfy the contribution percentage test for that Plan Year. Notwithstanding anything to the contrary in this Article III, if the contribution percentage of those Participants who are highly compensated Employees (as defined in Section 3.03) exceeds the limit imposed by Code section 401(m), the following rules shall apply:
(A) The amount of the excess aggregate contributions
(determined in accordance with Code section 401(m)(6)(B))
for the Plan Year, and any income attributable to those
contributions, shall
be distributed (or, if forfeitable, shall be forfeited) before the end of the following Plan Year.
(B) Any distribution in accordance with Section 3.06(d)(1)(A), shall be made to Participants who are highly compensated Employees on the basis of the respective portions of the excess aggregate contributions allocated to each Participant. The total dollar amount of excess aggregate contributions shall be allocated to some or all highly compensated Employees by reducing first the contributions of the highly compensated Participant with the highest dollar amount of contributions until (i) the total amount of excess aggregate contributions has been allocated or (ii) his remaining contributions are equal in dollar amount to the contributions of the highly compensated Employee with the next highest dollar amount. This process shall be repeated until all excess aggregate contributions are allocated.
(2) The determination of the amount of excess aggregate contributions under Section 3.06(d)(1) for any Plan Year shall be made after first determining the excess deferrals under Section 3.04(a), and then determining the Excess Salary Reduction Contributions under Section 3.04(b).
(e) Contributions of Shares. The Employers may, at their election, make all or any part of any mum Matching Contribution, Additional Matching Contribution, or Basic Contribution to the Profit-Sharing Plan in Shares rather than in cash. The Shares so contributed shall have a fair market value equal to the amount of such Minimum Matching Contribution, Additional Matching Contribution, or Basic Contribution (or portion thereof). The fair market value of a Share shall be the mean between the highest and lowest quoted selling price per share for a 100 Share lot on the composite tape of New York Stock Exchange issues on the date of payment to the Trustee.
(f) Contributions to the ESOP. The Employers may, at their election, make a Minimum Matching Contribution, Additional Matching Contribution, or Basic Contribution to the ESOP pursuant to Section 19.04 in lieu of all or a portion of the Minimum Matching Contribution, Additional Matching Contribution, or Basic Contribution otherwise required under this Section 3.06. The amount of the Minimum Matching Contribution, Additional Matching Contribution, or Basic Contribution otherwise required to be made pursuant to this Section 3.06(a) or (b) with respect to a Participant shall be reduced, dollar for dollar, by the value of any Shares (or the amount of any cash) allocated to the Participant's ESOP Account by reason of a Minimum Matching Contribution, Additional Matching Contribution, or Basic Contribution to the ESOP for the Plan Year. The value of the Shares that are allocated to a Member's ESOP Account for any Plan Year shall be determined in accordance with Sections 19.04 and 19.13.
(g) Deductibility. All Minimum Matching Contributions, Additional Matching Contributions, and Basic Contributions to the Profit-Sharing Plan are conditioned on the deductibility of the contributions under Code section 404 for the taxable year with respect to which the contributions were made.
(h) Qualified Nonelective Contributions. Any Employer who was required to make, but did not make, a Catch-Up Contribution on behalf of an eligible Employee pursuant to Section 20.10 for the 2002 Plan Year, shall make a qualified nonelective contribution ("QNEC") to the Plan on behalf of the Employee by December 31, 2003. The amount of the QNEC shall be equal to the amount of the Catch-Up Contribution that was required to be made, but was not made, plus any positive earnings that would have accrued on the Catch-Up Contribution from the date it was required to be made through the date the QNEC is made to the Plan. The QNEC made on behalf of an Employee shall be allocated to the Employee's Participant's Account and shall be considered a Catch-Up Contribution for all Plan purposes, except that an Employee may not withdraw it solely on account of a hardship.
3.07. Contributions Not Recoverable by Employer. The Trustee shall hold the contributions received by it under Section 3.06 for the respective Participants subject to the provisions of the Plan. No such contribution shall be recoverable by the Employers, except as provided in Section 3.08.
In the event that an Employer Contribution made pursuant to Section 3.06
(a) is made under a mistake of fact, or
(b) is disallowed as a deduction under Code section 404 for the taxable year with respect to which it was made, the contribution shall, at the option of the Employer, be returned to the Employer within 1 year after the payment of the contribution or the disallowance of the deduction (to the extent disallowed), whichever is applicable. The amount returned shall not be increased to reflect any investment earnings, but shall be decreased to reflect any losses. If the amount returned to the Employer would cause the balance of any Participant's Account to be less than the balance would have been had the returned contribution never been made, the amount to be returned shall be limited to prevent the loss.
Subject to the approval of the Employee Benefits Committee and any administrative procedures that the Employee Benefits Committee may prescribe, Rollover Contributions to the Profit-Sharing Plan will be accepted from or on behalf of an Employee that constitute:
(a) all or part of an "Eligible Rollover Distribution" (as defined in Code section 402(c)) from a qualified plan; or
(b) a distribution from an individual retirement account or annuity described in Code section 408(d)(3)(A)(ii).
Rollover Contributions will not be accepted in a form other than cash. All Rollover Contributions made to the Profit-Sharing Plan on behalf of an Employee shall be allocated to the Rollover Contributions portion of the Employee's Profit-Sharing Account. For purposes of Section 8.02(a), that portion of a Participant's Account attributable to amounts transferred to this Plan from the CardioThoracic Systems 401(K) Savings Plan, that are attributable to that plan, are considered Rollover Contributions.
Notwithstanding anything in this Plan to the contrary, the following provisions shall apply with regard to any Participant who receives a hardship distribution under the Employees' 401(k) Plan of Devices For Vascular Intervention, Inc., the 401(k) Savings Plan For Employees of Endovascular Technologies, the InControl 401(k) Plan, or the CardioThoracic Systems 401(K) Savings Plan:
(a) A Participant's right to elect to have his Employer
contribute Salary Reduction Contributions on his behalf to the
Profit-Sharing Plan shall be suspended for a period of 12 months after
the Participant's receipt of a hardship distribution under the
Employees' 401(k) Plan of Devices For Vascular Intervention, Inc., the
401(k) Savings Plan For Employees of Endovascular Technologies, the
InControl 401(k) Plan, or the CardioThoracic Systems 401(K) Savings
Plan; and
(b) For the Participant's taxable year immediately following the taxable year of the Participant's receipt of a hardship distribution under the Employees' 401(k) Plan of Devices For Vascular Intervention, Inc., the 401(k) Savings Plan For Employees of Endovascular Technologies, the InControl 401(k) Plan, or the CardioThoracic Systems 401(K) Savings Plan, a Participant may not elect to have his Employer contribute Salary Reduction Contributions on his behalf to the Profit-Sharing Plan in excess of the applicable limit under Code section 402(g) for such taxable year less the amount of the Participant's Salary Reduction Contributions in the taxable year of the hardship distribution.
Subject to the adjustments set forth in this Article IV, the maximum aggregate annual addition to a Participant's Profit-Sharing Account in any limitation year shall in no event exceed the lesser of:
(a) $30,000 (as adjusted to reflect increases in that limitation pursuant to Code section 415(d)); or
(b) 25 percent of the amount of a Participant's compensation for the limitation year.
(a) For purposes of Article IV, the term "annual addition" shall mean the sum for any limitation year of the following amounts:
(1) Salary Reduction Contributions;
(2) Employer Contributions to the Profit-Sharing Plan;
(3) Forfeitures if allocated to the Participants' Profit-Sharing Accounts;
(4) Contributions allocated to an individual medical account (within the meaning of Code section 415(1)) that is part of a pension or annuity plan, provided that this Section 4.02(a)(4) shall not be taken into account in applying Sections 4.01(b) and 19.06(a)(2); and
(5) Contributions attributable to post-retirement medical benefits that are allocated to the separate account of a Key Employee (within the meaning of Code section 419A(d)(3)), under a welfare benefit fund (within the meaning of Code section 419(e)) maintained by an Employer; provided that this Section 4.02(a)(5) shall not be taken into account in applying Sections 4.01(b) and 19.06(a)(2).
Amounts allocated to a Participant's ESOP Account shall be
treated as annual additions, and shall be subject to the limits on
annual additions, to the extent provided in Section 19.06. A
Participant's Excess Salary Reduction Contributions (distributed under
Section 3.04(b)) and excess aggregate contributions (distributed or
forfeited in accordance with Section 3.06(d)) shall be treated as
annual additions; a Participant's excess deferral amounts (distributed
in accordance with Section 3.04(a)) shall not be treated as annual
additions. A Participant's Rollover Contributions made pursuant to
Section 3.09 shall not be treated as annual additions.
(b) For purposes of this Article IV, the term "compensation" shall mean the Participant's wages within the meaning of Code section 3401 (without regard to any rule under Code section 3401 that limits amounts included in wages based on the nature or location of the employment) and all other payments for which the Employer is required to furnish the Participant with a written statement under Code sections 6041(d) and 6051(a)(3). "Compensation" also includes amounts that would have been paid to the Employee during the Plan Year in the absence of a salary redirection agreement but are excluded from gross income pursuant to Code section 125, 132(f), 457, or 402(g).
(c) For purposes of this Article IV, the term "limitation year" or "year" means the calendar year.
The Employee Benefits Committee may establish those procedures that it deems necessary and appropriate to monitor compliance with Article IV during a limitation year. If, during the course of a limitation year, the Employee Benefits Committee determines, with respect to a Participant, that no additional contributions may be made and credited to the Participant's Account during the year without exceeding the limitations prescribed in Article IV for the year, then no further contributions shall be made or credited to the Participant's Account during the year.
In the event that the limitations with respect to annual additions prescribed in this Section are exceeded with respect to any Participant, the following rules shall apply. If the excess arises as a consequence of the crediting of forfeitures to the Participant's Account, or a reasonable error in estimating the Participant's compensation, the excess shall be held in a suspense account and reallocated among all the Participants' Profit-Sharing Accounts in the limitation year succeeding the year in which the excess arose. If such excess arises as a consequence of a reasonable error in determining the amount of Salary Reduction Contributions that may be made with respect to the Participant, that excess shall be distributed. Distributed excess Salary Reduction Contribution amounts shall be deemed to be unmatched to the extent that the Participant has unmatched Salary Reduction Contributions for the Plan Year; excess Salary Reduction Contributions eligible for a Minimum Matching Contribution or an Additional Matching Contribution shall be distributed only to the extent permitted under the nondiscrimination rules of Code section 401(a)(4).
All defined contribution plans (including voluntary employee contribution accounts in a defined benefit plan and key employee accounts under a welfare benefit plan described in Code section 419, as well as Employer contributions allocated to an IRA) of the Employer (including, for purposes of this Section, an affiliate of the Employer), whether or not terminated, will be treated as one defined contribution plan for purposes of the limitations under Code section 415(c).
A Participant may at any time or from time to time, by direction to, and in a manner prescribed by, the Employee Benefits Committee, direct that any or all of his Salary Reduction Contributions and Rollover Contributions made after his election becomes effective shall be invested, subject to Section 5.04, in one or more of the investment fund options ("Funds") that the Fund Advisory Committee may designate from time to time by written
addendum to this Plan. The respective assets of each Fund will be accounted for separately from those of each other Fund and will be invested in the manner prescribed in the Addendum. A Participant may make an investment election with respect to his Rollover Contributions that is separate and different from his investment election with respect to his Salary Redirection Contributions.
The Employee Benefits Committee shall implement a Participant's
investment directions in accordance with the terms of this Article V, except
that the Committee may decline to implement any investment direction to the
extent that the investment direction would, if implemented, result in a
transaction (a) that is expressly excluded from protection under ERISA section
404(c), (b) that is a prohibited transaction under ERISA section 406 or Code
section 4975, (c) that would generate income that would be taxable to the Plan,
or (d) that would otherwise violate applicable federal law.
The Fund Advisory Committee, in its discretion, may change or
terminate the existing investment Funds or establish additional investment Funds
at any time by amending the written addendum to the Plan. However, any
investment Fund that is not an investment company registered under the
Investment Company Act of 1940 shall be managed by an Investment Manager (within
the meaning of ERISA section 3(38)) appointed by the Fund Advisory Committee.
The selection of investment Fund choices and the administration of Plan
investments are intended to comply with the requirements of ERISA section
404(c). To the extent the requirements of ERISA section 404(c) are satisfied,
neither the Employee Benefits Committee, the Fund Advisory Committee, the
Trustee, nor any other Plan Fiduciary, shall be responsible for any losses
resulting from a Participant's individual selection of investment Fund choices.
Subject to such rules as the Employee Benefits Committee from time to time may establish, a Participant may change his direction for the investment of his Salary Reduction Contributions at any time. Any direction by a Participant for the investment of such funds shall be deemed to be a continuing direction until changed by the Participant.
If a Participant fails to give directions to the Employee Benefits Committee for investment of his Rollover Contributions, they shall be invested in the same manner as his Salary Reduction Contributions. If a Participant fails to give directions to the Employee Benefits Committee for investment of his Salary Reduction Contributions, they shall be invested in the Near Term Horizon Portfolio.
If a Participant directs the investment of his Salary Reduction Contributions in more than one of the Funds described in Section 5.01, the amount of the contributions invested monthly in any one Fund shall be not less than 1 percent of his total monthly Salary Reduction Contributions (rounded to the nearest penny).
Subject to such rules as the Employee Benefits Committee from time to time may establish, a Participant may direct that all or any part of his Units in any one or more of the Funds described in Section 5.01 be converted to Units in one or more of the other of such Funds.
(a) Employer Contributions to the Plan shall be invested in a Fund held in Trust and consisting of Shares (commonly known as "the Company Stock Fund"). Except as provided in Sections 5.06(b) and (c), below, a Participant shall not be entitled to have the Employer Contributions that are credited to his Participant's Account and any earnings attributable thereto invested in any Fund other than the Company Stock Fund. The Trustee shall purchase Shares for the Company Stock Fund in the open market or by private purchase, including purchase from the Company. Any such purchase from the Company shall be at a price per share not in excess of the mean between the highest and lowest quoted selling price per share for a 100 Share lot on the composite tape of New York Stock Exchange issues on the date of purchase by the Trustee.
(b) A Participant who has retired shall be entitled to transfer
all or a portion of his Participant's Account invested in the Company
Stock Fund to one or more of the Funds described in Section 5.01.
Similarly, a Beneficiary of a Deceased Participant shall be entitled
to transfer all or a portion of the Participant's Account invested in
the Company Stock Fund to one or more of the Funds described in
Section 5.01. An election to transfer amounts from the Company Stock
Fund to another Fund or Funds shall be made in accordance with Section
5.05. An amount transferred from the Company Stock Fund to another
Fund or Funds pursuant to this Section 5.06 shall subsequently be
subject to the same rules governing reinvestment as the rules that
apply under this Article V to the reinvestment of Salary Reduction
Contributions.
(c) A Participant who has attained age 50 and has completed at least 10 Years of Service may diversify his ESOP Account in accordance with Section 19.14(b) of this Plan.
(d) Valuations of Shares that are not readily tradable on an established market will be made by an independent appraiser who meets requirements similar to the requirements of the regulations prescribed under Code section 170(a)(1).
Except for the ESOP Shares Fund under the Company Stock Fund, any Trustee in its sole discretion may, to the extent that it is prudent to do so, maintain all or a part of the assets of any fund in cash or short term government or corporate obligations (other than obligations of an Employer or a Qualified Subsidiary). The Trustee shall not be liable for interest on the part of the assets of any fund that it is authorized to hold in cash pursuant to the authority granted herein.
The Trustee may maintain the assets of the ESOP Shares Fund in cash only to the extent provided in Article XIX.
Income from investments in each fund shall be reinvested in the same fund.
To the extent that outstanding Participant loans under a Prior Savings
Plan or the Endovascular Technologies, Inc. 401(k) Savings Plan, the InControl
401(k) Plan, the Sulzer Medica USA Retirement Plan, or the CardioThoracic
Systems 401(K) Savings Plan are transferred to or merged into this Plan, those
loans shall be treated as investments of the Profit-Sharing Accounts of the
Participant to whom they relate, subject to the terms and conditions of the plan
under which they were made. Participant loan repayments shall be invested in
accordance with the Participant's investment election currently in effect for
Salary Reduction Contributions.
The Employee Benefits Committee shall maintain a separate Participant's Account for each Participant, showing separately the following:
(a) Salary Reduction Contributions. The Participant's Salary
Reduction Contributions to the Plan, including amounts attributable to
salary reduction contributions under a Prior Savings Plan or the
Endovascular Technologies, Inc. 401(k) Savings Plan, the InControl
401(k) Plan, the Sulzer Medica USA Retirement Plan, or the
CardioThoracic Systems 401(K) Savings Plan transferred to or merged
into this Plan, and the earnings thereon;
(b) Employee Contributions. The Participant's after-tax employee contributions under a Prior Savings Plan or another qualified retirement plan that are transferred to or merged into this Plan, and any earnings thereon;
(c) Employer Contributions. The Employer Contributions to the Profit-Sharing Plan on behalf of the Participant, including amounts attributable to employer contributions under a Prior Savings Plan or another qualified retirement plan that are transferred to or merged into this Plan, and the earnings thereon;
(d) Rollover Contributions. The Participant's Rollover Contributions to the Plan, including amounts attributable to rollover contributions under a Prior Savings Plan or another qualified retirement plan that are transferred to or merged into this Plan, and the earnings thereon;
(e) ESOP Pre-Split Matching Account. The Participant's ESOP Account under a Prior Savings Plan that is transferred or merged into this Plan, and the earnings thereon;
(f) Company Matching Account (formerly the ESOP Post-Split Matching Account). The amounts allocated to the Participant by reason of Employer Minimum Matching Contributions and Additional Matching Contributions and Exempt Loan payments under the ESOP, and the earnings thereon;
(g) Retirement ESOP Account (formerly the ESOP Basic Contribution Account). The amounts allocated to the Participant by reason of Employer Basic Contributions and Exempt Loan payments under the ESOP, and the earnings thereon; and
(h) PAYSOP Account. The amounts transferred from the Participant's PAYSOP Account in a Prior Savings Plan that is transferred to or merged into this Plan, and the earnings thereon.
(i) Intermedics Matching Account. The amounts (including both contributions and attributable earnings) transferred from the Participant's Matching Contribution Account in the Sulzer Medica USA Retirement Plan and merged into this Plan.
(j) EVT Qualified Matching Account. The amounts (including both contributions and attributable earnings) transferred from the Participant's qualified matching contribution account in the Endovascular Technologies, Inc. 401(k) Savings Plan and merged into this Plan.
A Participant's Profit-Sharing Account shall comprise the amounts described in Section 6.01(a) through (d), above.
A Participant's ESOP Account shall comprise the amounts described in
Section 6.01(e) through (g), above.
A Participant's ESOP Pre-Split Matching Account, Intermedics Matching Account and EVT Qualified Matching Account comprise his Prior Company Account.
In addition to the separate accounting required by Section 6.01, the
Employee Benefits Committee shall maintain a separate account for each
Participant that shows his proportionate interest in the funds described in
Article V. A Participant's proportionate interest in each Fund shall be
represented by "Units of Participation," also called "Units." The Employee
Benefits Committee shall assign Units of Participation in the Company Stock Fund
to any Suspense Account (as defined in Section 19.02(e)) maintained pursuant to
Section 19.12, based on the Suspense Account's proportionate interest in the
Company Stock Fund at the time of the determination.
Subject to reasonable materiality standards adopted by the Employee Benefits Committee, the Employee Benefits Committee shall determine the value of a Unit in each Fund on a daily basis. That value will be determined by dividing the sum of uninvested cash and the fair market value of securities (redemption value in the case of United States Savings Bonds and principal plus accrued interest in the case of investment contracts) as determined by the Employee Benefits Committee, by the total number of Units of the Fund.
The number of Units credited to a Participant under any Fund in each month shall be calculated by dividing the sum of his Salary Reduction Contributions or the Employer Contributions allocated to him under the Fund by the value of the Unit on the last Value Determination Date prior to the date on which the Trustee receives payment of the contributions.
A Participant may withdraw a portion of monies accruing from his Salary Reduction Contributions and, if applicable, his salary redirection contributions under the Endovascular Technologies, Inc. 401(k) Savings Plan, the InControl 401(k) Plan, the Sulzer Medica USA Retirement Plan or the CardioThoracic Systems 401(K) Savings Plan transferred to this Plan, in accordance with the following rules:
(a) An application for withdrawal shall be made in accordance with procedures prescribed for that purpose by the Employee Benefits Committee.
(b) Hardship withdrawals shall be approved only in those cases where the requirements of Sections 7.01(b)(1) and (b)(2), below, are satisfied.
(1) Hardship withdrawals shall be approved only if needed on account of one of the following:
(A) medical expenses described in Code section 213(d)
incurred by, or amounts necessary to obtain such medical
care for, the Participant, the Participant's spouse, or any
dependent of the Participant (as defined in Code section
152);
(B) Purchase (excluding mortgage payments) of a principal residence for the Participant;
(C) Payment of tuition, related educational fees, and room and board expenses for the next 12 months of post-secondary education for the Participant or his spouse, children, or dependents (as defined in Code section 152);
(D) The need to prevent the eviction of the Participant from his principal residence or foreclosure on the mortgage of the Participant's principal residence; or
(E) Payment of funeral expenses incurred by the Participant, the Participant's spouse, or any dependent of the Participant (as defined in Code section 152), provided that the Employee Benefits Committee determines, on a case-by-case basis and in view of all relevant facts and circumstances, that these expenses create an immediate and heavy financial need.
The Employee Benefits Committee may require any and all documentation that it deems necessary, and any such documentation shall be provided by the Participant in a timely fashion. The decision of the Employee Benefits Committee shall be final in all cases.
(2) A hardship withdrawal that satisfies Section 7.01(b)(1) shall be approved only if all of the following requirements also are satisfied:
(A) The withdrawal is not in excess of the amount
necessary to discharge the expense (or expenses) listed in
Section 7.01(b)(1) above (plus the reasonably anticipated
amount of any tax attributable to the amount of the
withdrawal);
(B) The Participant has obtained all distributions, other than hardship distributions, and all nontaxable loans currently available under all plans maintained by the controlled group (as defined in Section 1.01(a)(26)(A)(ii)) of which the Employer is a member;
(C) The Participant's contributions, elective or otherwise, under this Plan and any other plan maintained by the controlled group (as defined in Section 1.01(a)(26)(A)(ii)) of which the Employer is a member, and the Participant's right to make further hardship withdrawals under this Section or withdrawals under Article VIII, shall be suspended for the 12-period following receipt of the withdrawal; and
(D) For the Participant's taxable year immediately following the taxable year of the withdrawal, the limitation set forth in Code section 402(g) shall be reduced for this Plan and all other plans maintained by the controlled group (as defined in Section 1.01(a)(26)(A)(ii)) of which the Employer is a member by the amount of the Participant's elective contributions made under such plans in the taxable year of the withdrawal.
(3) The amount of the withdrawal shall be deducted from the Participant's Account, and the remaining portion of the Account shall then become the total value of the Participant's Account.
(4) Withdrawals shall be made in cash only. Withdrawals shall be made on a pro rata basis from all the investment Funds described in Section 5.01 in which the Participant's Salary Reduction Contributions are then invested.
(5) In no event shall the amount of the withdrawal exceed 100 percent of (i) the Participant's Salary Reduction Contributions and (ii) any earnings on those contributions accrued prior to January 1, 1989 (less any amount described in this sentence that have been previously withdrawn from the Participant's Account).
(c) A Participant may withdraw monies accruing from his Salary Reduction Contributions Account only after he has withdrawn all amounts that he is eligible to withdraw pursuant to Article VIII.
A Participant may, by request in accordance with the procedures prescribed by the Employee Benefits Committee, make withdrawals of his interest under the Plan, other than hardship withdrawals governed by Article VII, upon the conditions specified in this Article VIII.
Subject to such rules as the Employee Benefits Committee may from time to time prescribe, a Participant may make a withdrawal in any amount, and such amount may include all or any portion of any of the following categories of contributions; provided, however, that withdrawals shall be deemed to be made in the following order:
(a) First, a Participant may withdraw the portion of his Profit-Sharing Account attributable to Employee Contributions and Rollover Contributions, and earnings thereon, as described in Sections 6.01(b) and 6.01(d);
(b) Second, a Participant may withdraw his vested interest in his PAYSOP Account, and the earnings thereon, as described in Section 6.01(h), to the extent that those amounts accrued prior to June 1, 1998;
(c) Third, a Participant may withdraw his vested interest (determined in accordance with Section 10.01) in the portion of his ESOP Pre-Split Matching Account that is attributable to Employer Contributions, and earnings thereon, as described in Section 6.01(e), to the extent that those amounts accrued prior to June 1, 1998;
(d) Fourth, a Participant may withdraw his vested interest (determined in accordance with Section 10.01) in the portion of his Company Matching Account that is attributable to Employer Contributions, and earnings thereon, as described in Section 6.01(f), to the extent that those amounts accrued prior to June 1, 1998;
(e) Fifth, a Participant may withdraw amounts from his Intermedics Matching Account, as described in Section 6.01(i), to the extent that those amounts accrued prior to May 1, 1999;
(f) Sixth, a Participant who has attained age 59 1/2 may withdraw his vested interest (determined in accordance with Section 10.01) in the portion of his PAYSOP Account, and the earnings thereon, as described in Section 6.01(h); his vested interest (determined in accordance with Section 10.01) in the portion of his Profit Sharing Account that is attributable to Employer Contributions, other than Basic Contributions made under this Plan, and earnings thereon, as described in Section 6.01(c); his vested interest (determined in accordance with Section 10.01) in the portion of his ESOP Pre-Split Matching Account that is attributable to Employer Contributions, and earnings thereon, as described in Section 6.01(e); and his vested interest (determined in accordance with Section 10.01) and the portion of his Company Matching Account that is attributable to Employer Contributions, and earnings thereon, as described in Section 6.01(f); to the extent that those amounts accrued after May 31, 1998;
(g) Seventh, a Participant who has attained age 59 1/2 may withdraw his vested interest in his Salary Reduction Contributions Account, as described in Section 6.01(a), without regard to hardship; and
(h) Eighth, a Participant who has attained age 59 1/2 may withdraw his vested interest (determined in accordance with Section 10.01) in the portion of his Profit-Sharing Account that is attributable to Basic Contributions made under this Plan, and his Retirement ESOP Account that is attributable to Basic Contributions made under this Plan, as described in Sections 3.06(b) and 3.06(f).
(a) In no event shall the amount of a withdrawal pursuant to Section 8.01 by any Participant who has completed less than 5 years of Service as of the date of withdrawal include any matching contributions that have not been held in the Trust for at least the 24 month period prior to the date of the withdrawal.
(b) In the event of a withdrawal by a Participant who has completed less than 5 years of Service of the portion of his Participant's Account that is attributable to Employer Contributions, pursuant to Section 8.02(b) or 8.02(c) and prior to 5 consecutive One Year Periods of Severance, the portion of those Employer Contributions that are not withdrawn shall be accounted for separately
until the Participant incurs 5 consecutive One Year Periods of Severance. The Participant's vested interest in those Employer Contributions at any time shall be the Participant's vested percentage times the sum of the remaining Employer Contributions and all prior distributions of Employer Contributions, minus all prior distributions of Employer Contributions.
(a) The date on which the Employee Benefits Committee receives a Participant's request for payment shall be the applicable Value Determination Date for the amount that is withdrawn under any paragraph of Section 8.02.
(b) The amount of a withdrawal shall be deducted from the Participant's Account and the remaining portion of that account shall then become the total value of the Participant's Account.
(c) Withdrawals shall be made in cash only, except for withdrawals from the Company Stock Fund under Section 11.01. The withdrawals shall be made on a pro rata basis from all of the investment Funds in which the amounts withdrawn are then invested.
(a) Subject to such rules as the Employee Benefits Committee may from time to time prescribe, a Participant may make no more than one (1) withdrawal pursuant to either Article VII or Article VIII in any Plan Year.
(b) If a Participant has a hardship as defined in Section 7.01(b), and the amount available for the Participant to withdraw under Article VIII is insufficient to satisfy the hardship, then for purposes of Section 9.01(a), the Participant shall be treated as taking one withdrawal if he simultaneously requests to withdraw (1) pursuant to Article VIII, the maximum amount available for him to withdraw under that Article; and (2) pursuant to Article VII, the remaining amount required to satisfy the hardship.
With respect to withdrawals under Article VII and Article VIII, no less than 30 days and no more than 90 days before the date as of which the withdrawal occurs (or within any other period permissible under applicable law), the Employee Benefits Committee shall furnish the Participant with a general written explanation of the form in which the withdrawal will be made, the effect on his Participant's Account of the Participant's taking such a withdrawal, and any other information the Employee Benefits Committee deems material to the Participant's request. No request for a withdrawal shall be valid unless it is made after receipt of the written explanation. The Participant may waive the requirement that the withdrawal occur at least 30 days after receipt of the written explanation. The Participant's written request for a withdrawal
shall be deemed to be the Participant's consent to the distribution of the withdrawn amounts and, if applicable, a waiver of the 30 day notice requirement. Distribution of the withdrawal shall be made as soon as practicable after the expiration of the 30-day period following the Participant's receipt of the written explanation or, if applicable, as soon as practicable after the Participant waives the 30-day period.
(a) General. Upon termination of employment, a Participant, or, in a proper case, his designated beneficiary or legal representative, shall be entitled to payment from his Participant's Account in accordance with the following terms and conditions:
(1) Resignation or Dismissal. Upon resignation or dismissal, a Participant shall be entitled to payment from his Participant's Account as follows:
(A) Amount of Payment. A Participant who resigns or is dismissed from employment and who has completed 5 years of Service as of such date shall be entitled to the entire value of his Participant's Account. A Participant shall always be 100 percent vested in his Rollover Contributions Account. A Participant who has completed less than 5 years of Service shall be entitled to the value of his Salary Reduction Contributions and Employee Contributions to the Plan, plus the value of his salary reduction contributions and qualified matching contributions made under the Endovascular Technologies, Inc. 401(k) Savings Plan transferred to this Plan, plus the value of any amounts transferred from the CardioThoracic Systems 401(K) Savings Plan to the Plan, plus his vested interest in the value of the Employer Contributions credited to his Participant's Account. Such vested interest shall be determined by a percentage equal to 20 percent for each full year of Service.
(B) Time and Method of Payment. Subject to Section
10.01(b)(1) and Section 10.01(d), payment shall be made in a
lump sum as soon as practicable following the Participant's
resignation or dismissal. Notwithstanding Section 8.03(b),
any amount in which the Participant is not vested shall be
forfeited immediately. Forfeitures arising under the
preceding sentence shall be used to reduce Employer
Contributions as provided in Section 3.06 or 19.04, or shall
be used to reduce administrative expenses as provided in
Section 12.02(n). If a Participant who is less than 100
percent vested is reemployed before the earlier of (i) the
date on which he incurs 5 consecutive One Year Periods of
Severance, or
(ii) 5 years after the date of his reemployment, the balance of his Participant's Account as of the date of distribution, unadjusted for any subsequent gains and losses, shall be restored to him. If the present value of any Participant's vested accrued benefit exceeds $5,000, and the Participant does not consent to the distribution, then forfeiture of the Participant's non-vested interest in the value of the Employer Contributions credited to his Participant's Account shall be postponed until the Participant incurs 5 consecutive One Year Periods of Severance.
(C) Valuation of the Participant's Account. The value of a Participant's Account shall be determined as of the date on which the Employee Benefits Committee (or its designee) receives the Participant's request for payment.
(D) Payment Not Treated as Withdrawal. Payment upon termination of employment shall not be treated as a withdrawal for purposes of Articles VII and VIII.
(2) Retirement and Disability. Except as otherwise provided in Section 10.01(b)(1)(B), if the value of a Participant's vested accrued benefit exceeds $5,000, then, upon Retirement or upon becoming a Disabled Employee, the Participant, or his legal representative may elect payment under options (A), (B), or (C) of Section 10.01(a)(3) below, with respect to any portion of his benefit under the Plan that has accrued under this Plan, a Prior Savings Plan, or another qualified retirement plan that has merged into this Plan. The Participant's election of one or more payment options shall be made pursuant to procedures prescribed by the Employee Benefits Committee. Upon becoming a Disabled Employee, Retirement, or death while employed by an Employer, a Participant shall be fully vested in the value of his entire Participant's Account regardless of the number of years of Service he has completed.
(3) Payment Options. Payment upon Retirement or Disability shall be made under one of the following options:
(A) Lump Sum. Payment of the entire Participant's Account with the value of the Participant's Account to be calculated as of the date on which the Employee Benefits Committee (or its designee) receives a Participant's request for payment. Payment under this option (A) may be made at any time not later than the late date of payment permitted by Section 10.01(b)(1).
(B) Installment Payments of All or Part of the Account.
(i) Substantially equal annual, semi-annual, quarterly, or monthly payments of the value of a specified proportion of Units held at the date of Retirement or Disability, the proportion to be not less than 10 percent per year of the Units held at the date of Retirement or Disability. The value of the specified proportion of the Participant's Account to be paid to the Participant shall be calculated as of the date of each payment.
(ii) Lump-sum payment of any part or all of the value of the Participant's Account, with any balance of the Participant's Account to be paid at later dates. For the purpose of making the initial lump-sum payment under this Section 10.01(a)(3)(B)(ii), the value of the Participant's Account shall be calculated as of the date on which the Employee Benefits Committee (or its designee) receives the Participant's request for payment. For the purpose of making any subsequent payments under this Section 10.01(a)(3)(B)(ii), the value of the Participant's Account shall be calculated as of the date of each payment.
(iii) A Participant who has elected payment under
Section 10.01(a)(3)(B)(i) or (ii), above, may request
any number of additional payments during a Plan Year in
amounts specified by the Participant. In addition, a
Participant who has elected payment under this Section
10.01(a)(3)(B) may elect at any time to accelerate the
payment of all remaining payments into a single
lump-sum payment. For purposes of making additional or
accelerated payments, the value of the Participant's
Account shall be calculated as of the date on which the
Employee Benefits Committee receives the Participant's
request for payment.
(C) Fixed Amount Installment Payments. Substantially equal annual, semi-annual, quarterly, or monthly payments of an amount specified by the Participant, with payments continuing until the Participant's Account is exhausted. A Participant who has elected payment under this Section 10.01(a)(3)(C) may request any number of additional payments during a Plan Year in amounts specified by the Participant. In addition, a Participant who has elected payment under this Section 10.01(a)(3)(C) may elect at any time to accelerate the payment of all remaining payments into a single lump-sum payment. For purposes of making additional or accelerated payments, the value of the Participant's Account shall be calculated as of the date on which the Employee Benefits Committee receives the Participant's request for payment.
(A) Notice. No less than 30 days and no more than 90 days before the date benefits are to commence, the Employee Benefits Committee shall furnish to each Participant who is eligible to receive a distribution under Section 10.01(a)(1) information as applicable regarding: the Participant's right to defer receipt of the distribution, the material features and relative values of the optional forms of benefits under the Plan, and the Participant's right to make (and the effect of) an election to receive benefits in a particular form.
(B) Waiver of Notice. If the distribution is one to which Code sections 401(a)(11) and 417 do not apply, such distribution may commence less than 30 days after the notice required under Treasury Regulation ss. 1.411(a)-11(c) is given, provided that all of the following requirements are satisfied:
(i) The Employee Benefits Committee or its designee clearly informs the Participant that the Participant has a right to a period of at least 30 days after receiving the notice to consider the decision of whether or not to elect a distribution (and, if applicable, a particular distribution option);
(ii) the Participant, after receiving the notice, affirmatively elects the distribution.
(5) Living Trust. A Participant who Retires or who becomes a Disabled Employee as described in Section 10.01(a)(2), may elect that distributions to be made to the Participant shall instead be made directly to a revocable grantor trust (a "living trust"), provided that such election is revocable and is in accordance with such other rules as may be prescribed by the Employee Benefits Committee, and provided that the trustee of the living trust files a written acknowledgment with the Employee Benefits Committee that the living trust has no enforceable right in, or to, any benefit payment that has not yet been made.
(A) General. Upon termination of a Participant's Service, payment shall be made, or in the case of a payment option requiring periodic payment, payment shall commence, as soon thereafter as practicable; provided, however, that if the present value of any Participant's vested accrued benefit exceeds $5,000, no immediate distribution shall be made without the consent of the
Participant. Except as provided below, in no event shall payment be made or payments commence later than the "required beginning date."
(i) For purposes of this Section, "required beginning date" means, with respect to a Participant who is not a 5 percent owner as described in Code section 416 and who did not reach 70 1/2 before January 1, 1997, April 1 of the calendar year following the later of (a) the calendar year in which the Participant attains age 70 1/2 or (b) the calendar year in which the Participant retires. With respect to a Participant who is a 5 percent owner as described in Code section 416 or any Participant who reaches age 70 1/2 before January 1, 1997, "required beginning date" means April 1 of the calendar year following the calendar year in which the Participant reaches age 70 1/2.
(ii) Notwithstanding the provisions of this Section, "required beginning date" means, with respect to a Participant's accrued benefit under the Endovascular Technologies, Inc. 401(k) Savings Plan transferred to this Plan ("EVT Plan Benefits") or under the Employees' 401(k) Plan of Devices for Vascular Intervention, Inc. transferred to this Plan ("DVI Plan Benefits") with respect to a Participant who is not a 5 percent owner as described in Code section 416 and who did not reach age 70 1/2 before January 1, 2000, April 1 of the calendar year following the later of (a) the calendar year in which the Participant attains age 70 1/2 or (b) the calendar year in which the Participant retires. With respect to a Participant who reaches age 70 1/2 on or after January 1, 1997, but before January 1, 2000, the Participant's "required beginning date" means April 1 of the calendar year following the calendar year in which the Participant reaches age 70 1/2 unless the Participant elects with his spouse's consent to defer commencement of his EVT Plan benefits or his DVI Plan Benefits, whichever is applicable, until a date no later than April 1 of the calendar year following the calendar year in which he retires. With respect to a Participant who is a 5 percent owner as described in Code section 416 or any Participant who reached age 70 1/2 before January 1, 1997, "required beginning date" means April 1 of the calendar year following the calendar year in which the Participant reaches age 70 1/2.
(iii) Further, also notwithstanding the provisions of this Section, "required beginning date" means, with
respect to a Participant's accrued benefit under the CardioThoracic Systems 401(K) Savings Plan transferred to this Plan ("CTS Plan Benefits"), with respect to a Participant who is not a 5 percent owner as described in Code section 416 and who did no reach age 70 1/2 before January 1, 2002, April I of the calendar year following the later of (a) the calendar year in which the Participant attains age 70 1/2 or (b) the calendar year in which the Participant retires. With respect to a Participant who is a 5 percent owner as described in Code section 416 or any Participant who reaches age 70 1/2 before January 1, 2002, "required beginning date" means April 1 of the calendar year in which the Participant reaches age 70 1/2.
(B) Retirement and Disability. If a Participant's Service terminates as a result of his Retirement or permanent Disability, the Participant may defer payment or the commencement of payments until any day thereafter; provided, that if the Participant wishes to defer payment or commencement of payment beyond his required beginning date as specified in Section 10.01(b)(1)(A), above, the Participant shall withdraw, pursuant to Section 10.01(b)(3), at least an amount sufficient to satisfy the required distribution rules of Code section 401(a)(9) with respect to each year for which such a distribution is required. For purposes of the preceding sentence, a Participant who does not make an affirmative election to commence distribution will be deemed to have elected to defer distribution. Notwithstanding all of the foregoing, if the present value of the Participant's vested accrued benefit does not exceed $5,000, the Participant's vested accrued benefit will be distributed in a lump sum as soon as practicable after termination of Service.
(2) Restriction Relating to Form of Payment. In no event shall any form of payment hereunder provide (i) for payment of benefits over a period longer than the life of the Participant, the lives of the Participant and his beneficiary, the life expectancy of the Participant, or the joint life expectancies of the Participant and his beneficiary, or (ii) for payment of benefits pursuant to any schedule under the Plan unless the schedule satisfies the incidental benefit requirement at Code section 401(a)(9)(G). For purposes of Section 10.01(b)(1)(B)(2)(i), the Participant may elect whether or not his life expectancy and/or the life expectancy of his spouse (but not of any other beneficiary) will be recalculated annually. Notwithstanding any other provisions of the Plan, distributions under the Plan should be made in accordance with Code section 401(a)(9) and the regulations thereunder, including the minimum distribution incidental benefit requirement of proposed Treasury Regulation ss. 1.401(a)(9)-2. With respect to distributions under the Plan made for calendar years
beginning on or after January 1, 2002, the Plan will apply the minimum distribution requirements of Code section 401(a)(9) in accordance with the regulations under Code section 401(a)(9) that were proposed on January 17, 2001, notwithstanding any provision of the Plan to the contrary. This provision shall continue in effect until the end of the last calendar year beginning before the effective date of final regulations under Code section 401(a)(9) or such other date as may be specified in guidance published by the Internal Revenue Service.
(3) Withdrawals Prior to Commencement of Distribution. If a
Participant has Retired or become a Disabled Employee and has
elected to defer commencement of the distribution of his
Participant's Account, the Participant shall be entitled to make
withdrawals from time to time from his Participant's Account
before the distribution of his Participant's Account commences.
For purposes of the preceding sentence, a Participant who has not
affirmatively elected to commence distribution will be deemed to
have elected to defer distribution. If the beneficiary of a
Participant who died while actively employed, or of a Participant
who died after Retiring or becoming a Disabled Employee, has
elected to defer commencement of the distribution of the vested
portion of the Participant's Account pursuant to Section
10.02(a), the beneficiary shall also be entitled to make periodic
withdrawals from the vested portion of the Participant's Account
before the distribution of the vested portion of the
Participant's Account commences. Any withdrawal under this
Section 10.01(b)(3) shall be subject to the rules prescribed in
Articles VIII and IX of the Plan; provided, however, that a
Participant's withdrawal under this Section 10.01(b)(3) may
include Salary Reduction Contributions and earnings thereon, and
provided further that neither Section 8.03(b) nor 9.01 shall
apply to a withdrawal under this Section 10.01(b)(3). Any
withdrawal under this Section 10.01(b)(3) on or after January 1,
2004 may be made during the 60-day period beginning on the date
the Participant Retired, became a Disabled Employee or died,
whichever is applicable, only if the amount remaining in the
Participant's or beneficiary's Plan accounts after the withdrawal
is at least $5,000.
(c) Transfer to Affiliate. Notwithstanding the foregoing provisions of this Section 10.01, if a Participant's employment with an Employer is terminated, but he is transferred from employment with an Employer to employment with any affiliate designated by the Employee Benefits Committee, the Participant may elect, in accordance with uniform rules prescribed by the Committee, that his Participant's Account under the Plan shall be transferred by the Trustee to the trust under the savings plan maintained by the affiliate, provided that the affiliate's plan is a plan intended to meet the requirements for qualification under Code section 401(a) and that the trust is a trust intended to be exempt from tax under Code section 501(a).
(d) Distribution of Benefits to Certain Particinants in Case of Sale or other Disposition of Assets or Stock. A Participant who,
(1) as a result of a sale or other disposition of assets or stock, terminates employment with an Employer or Qualified Subsidiary and immediately becomes employed by, and performs the same or substantially the same duties for, a successor employer (hereinafter, the "Successor Employer") that is not a member of the controlled group of corporations (within the meaning of Code section 414(b), (c), (m), or (o)) that includes the Employer (hereinafter, the "controlled group"), and
(2) is not reemployed by a member of the controlled group upon his termination of employment with the Successor Employer, shall be eligible to receive a benefit pursuant to this Section 10.01, subject to the following rules:
(A) If the Employee has not attained Normal Retirement Age at the time he becomes employed by the Successor Employer, he shall receive any benefit for which he is eligible pursuant to Section 10.01(a)(1) in a lump sum as soon as practicable following his termination of employment with the Successor Employer.
(B) If the Employee has attained Normal Retirement Age at the time he becomes employed by the Successor Employer, he shall receive a benefit pursuant to this Section 10.01; provided that, solely for purposes of determining the time of payment, his termination of employment with an Employer or Qualified Subsidiary shall not be deemed to occur until the date of his termination of employment with the Successor Employer.
(a) Beneficiary. Upon the death of a Participant while actively employed or upon his death after his Retirement, his becoming a Disabled Employee, his resignation, or his discharge, but prior to the receipt of any benefits under the Plan, the vested portion of the Participant's Account, determined as of the date of his death, shall be distributed to his beneficiary. Notwithstanding the preceding sentence, if the beneficiary of a deceased Participant is the Participant's spouse, as specified below, such spousal beneficiary, upon filing a written election with the Employee Benefits Committee, may have payment made or payments commence at any date not later than December 31 of the calendar year in which the Participant would have attained age 70 1/2 (or December 31 of the calendar year following the calendar year in which the Participant died, if that is later). All other beneficiaries, upon filing a written election with the Employee Benefits Committee, (1) may have payment made on a date not later than December 31 of the calendar year containing the fifth anniversary of the date of the Participant's death or (2) if the beneficiary is a designated beneficiary as that
term is described in Code section 401(a)(9)(E), may have payment made or payments commence at any date not later than December 31 of the calendar year following the calendar year in which the Participant died. The value of the Participant's Account shall be determined in such cases as of the date payment is made or payments commence. The sole beneficiary of a Participant who is married on the date of his death shall be the spouse to whom he is then married unless the Participant and his spouse have given their written notarized consent, in accordance with rules prescribed by the Employee Benefits Committee, to the designation of another beneficiary or beneficiaries. The beneficiary or beneficiaries of any other Participant shall be the person or persons designated by the Participant in a written notice filed with the Employee Benefits Committee, in accordance with rules prescribed by the Committee, designating a beneficiary or beneficiaries. A beneficiary may designate his own beneficiary by filing with the Employee Benefits Committee a written notice designating, in accordance with rules prescribed by the Committee, a beneficiary. If a beneficiary who survives the Participant dies before having received all benefits due under the Plan, and the beneficiary has not designated his own beneficiary, then any remaining benefits shall be paid to the estate of the deceased beneficiary. A Participant, but not a beneficiary, may designate a trust as his beneficiary by filing with the Employee Benefits Committee a written notice designating, in accordance with rules prescribed by the Committee, such trust beneficiary; provided, however, that a married Participant may designate a trust as his beneficiary only if the Participant and his spouse have given their written, notarized consent to the designation as specified above.
(b) Change of Beneficiary; Receipt. A Participant may from time to time change or cancel any beneficiary designation; provided, however, that any change or cancellation that diminishes the rights of the person who is the Participant's spouse as of the date that the change or cancellation is purported to be effective shall not be effective without the written consent of the Participant's spouse. No designation or change or cancellation of a designation of beneficiaries shall be effective unless received by the Employee Benefits Committee, in a form satisfactory to it, and in no event shall it be effective before the day of such receipt.
(c) Effect of Designation. The designation of a beneficiary under the Plan, including the deemed designation of a Participant's spouse as his sole beneficiary pursuant to Section 10.02(a), shall be controlling over any testamentary or other disposition. In case of doubt as to the right of any person claiming to be a beneficiary, distribution shall be made to the Participant's surviving spouse; provided, however, that if it is established to the satisfaction of the Employee Benefits Committee that there is no surviving spouse, payment shall be made to the Participant's estate. Any distribution pursuant to the preceding sentence shall discharge the Employee Benefits Committee, the Trustees, the Company, and the Employers from any further liability with respect to distribution of the Participant's Account.
(d) Form of Payment. If the Participant dies before distribution
of his benefits begins, distribution to a beneficiary pursuant to
Section 10.02(a) shall be made in the form elected by the beneficiary
from among the options described in Section 10.01(a)(3). Effective
December 1, 2003, notwithstanding the preceding sentence, if the value
of a Participants vested Account on the Participant's death does not
exceed $5,000, distribution to the beneficiary pursuant to Section
10.02(a) shall be made in a single lump sum payment as soon as
administratively practicable after the death of the Participant. If
the Participant dies after distribution of his benefits has begun,
distribution to a beneficiary pursuant to Section 10.02(a) hereof
shall be made in the form in which the Participant is receiving
distribution at the time of his death or, at the election of the
beneficiary, in a lump sum.
If reasonable efforts have been made during a 12 month period to
locate a Participant or beneficiary to whom a distribution is due, and if the
Participant or beneficiary cannot be located in spite of these efforts, the
Employee Benefits Committee, after the expiration of the 12 month period, may
direct that the balance remaining in the Participant's Account be forfeited and
allocated to all of the other Participants' Accounts in the manner described in
Section 3.06(c). If the Participant or beneficiary whose Participant's Account
is forfeited in accordance with the preceding sentence subsequently makes a
valid claim for the Participant's Account, the Participant's Employer shall
restore the Participant's Account. The amount restored shall be the value of the
Participant's Account as of the date of forfeiture, exclusive of any earnings
after that date.
Notwithstanding any other provisions of the Plan, in the event that a qualified domestic relations order, as defined in Code section 414(p), is received by the Employee Benefits Committee, benefits shall be payable in accordance with that order and with Code section 414(p). Payment may be made at any time specified in the order, irrespective of whether the Participant has reached the "earliest retirement age" as defined in Code section 414(p).
Upon written request made at any time prior to payment, a Participant or former Participant, or, in a proper case, a designated beneficiary or legal representative, may receive payment in cash, or in Shares, or in a combination of any of these, provided that he shall not be entitled to receive in Shares any amount greater in value than the value represented by the Units that are being withdrawn by the Participant from the Company Stock Fund. The value of the Participant's Units in the Company Stock Fund shall be calculated as of the date on which the Employee Benefits Committee receives the Participant's request for payment from the Fund. The Employee Benefits Committee shall direct the Trustee to fulfill any such request, but the Committee may not direct the issuance of partial Shares upon any request.
This Section 11.01 shall apply to withdrawals under Article VIII and
Section 19.14 and to distributions under Article X and Section 19.13.
A Participant, a beneficiary who is a surviving spouse of a Participant, or an alternate payee who is a spouse or a former spouse of a Participant, may elect to have any portion of a payment or withdrawal that is an "Eligible Rollover Distribution" as defined in Code section 402(c)(4) paid to an "Eligible Retirement Plan" as defined in Code section 402(c)(8)(B) in a direct rollover; provided that with respect to a beneficiary who is a surviving spouse, an "Eligible Retirement Plan" shall be as defined in regulations issued by the Internal Revenue Service under Code section 402. An election under this Section shall be made in the form and at the time prescribed by the Employee Benefits Committee, shall specify the eligible retirement plan to which the withdrawal amount is to be paid, and shall be subject to such rules as the Employee Benefits Committee may establish.
This Section 11.02 shall apply to withdrawals under Article VII, Article VIII, and Section 19.14 of the Plan, and to distributions under Article X and Section 19.13 of the Plan.
The Plan shall be administered by an Employee Benefits Committee that shall consist of not less than 5 nor more than 15 members appointed by the Board of Directors or its designee. The Employee Benefits Committee shall be the "Plan Administrator" for purposes of ERISA.
(a) Employee Benefits and Fund Advisory Committees. The provisions of this Section 12.02 apply to the Employee Benefits Committee established pursuant to Section 12.01 and the Fund Advisory Committee established pursuant to Section 13.01.
(b) Appointed by Board of Directors. The exact number of members of each of the committees, the members thereof, and their respective terms of office shall be designated from time to time by the Board of Directors or its designee.
(c) Acceptance and Resignation. Upon becoming a member of one of the respective committees, the member shall file an acceptance of his appointment in writing with the Board of Directors or its designee and with the Secretary of the committee. Any member of either of such committees may resign by submitting a written resignation to the Board of Directors or its designee and the Secretary of the applicable committee, effective upon the date specified in the instrument of resignation.
(d) Officers. The Board of Directors or its designee shall appoint for each committee one of its members as Chairman and one of its members as Secretary and may also appoint such other officers as it deems necessary.
(e) Notice to Trustee. The Secretary or an Assistant Secretary of the Company shall, from time to time, notify the Trustee of the appointment of members of the respective committees and of any other person or persons authorized and designated to act on behalf of the respective committees, together with specimens of the signature of each of such persons, and for all purposes hereunder the Trustee shall be conclusively entitled to rely upon the identity and authority of the Secretary or Assistant Secretary and the members constituting the respective committees and of such other person or persons as disclosed by such certificate.
(f) No Compensation. No member of either committee shall receive any compensation for his services as a member.
(g) Manner of Acting. A majority of the members of each committee shall constitute a quorum for the transaction of business, and all resolutions or other actions of the committee at any meeting shall be by vote of a majority of those present at the meeting, provided, however, that any action required or permitted to be taken at any meeting of the committee may be taken without a meeting, if prior to the action a written consent thereto is signed by a majority of the members of the committee and the written consent is filed with the minutes of the committee.
(h) Meetings. Each committee shall hold meetings at such time, places, and upon such notice as its members may from time to time determine. Each committee shall maintain accurate records of actions taken at its meetings.
(i) Delegations of Authority by Committee. Either committee may, in its discretion, delegate authority to any other person or persons to act on behalf of the committee, including, without limitation, the right to make any determination or to sign checks, warrants, and other instruments incidental to the operation of the Plan or to the making of any payment specified therein.
(j) Employment of Counsel. Each committee is authorized to employ counsel and such actuarial or clerical services as it may require in carrying out the provisions of the Plan.
(k) Allocation of Responsibilities Between Committees. The committees, by mutual agreement, in writing, may allocate to either of the committees any duty or responsibility that is not expressly assigned to either of the committees by the provisions of the Plan. Any allocation so made shall be fully effective to assign the duty or responsibility to the designated committee as though the allocation had been made expressly by provisions of the Plan.
(l) Records and Reports. Each committee shall maintain adequate records for accounting valuation purposes and shall deliver to the Company or to all Employers making contributions under the Plan an annual report showing the status of the Fund established pursuant to the Plan.
(m) Standard of Conduct. The members of each committee shall discharge their duties with the care, skill, prudence, and diligence under the circumstances then prevailing that a prudent man acting in a like capacity and familiar with such matters would use in the conduct of an enterprise of a like character and with like aims.
(n) Costs and Expenses. The costs and expenses of administering the Plan, including, but not limited to, legal fees, accountant's fees, reasonable compensation for any Investment Manager and the Trustee, and the expenses of the Fund Advisory Committee and the Employee Benefits Committee in the performance of their duties relating to the operation of the Plan, shall be paid for by the Plan, except to the extent their are paid by the Company. The Fund Advisory Committee may establish guidelines for the allocation of any such administrative costs and expenses to the Fund. Forfeitures that are not allocated to Participants' Accounts or used to repay an Exempt Loan in accordance with other provisions of the Plan shall be used to pay administrative expenses for which the Plan is liable.
(a) Rules and Rights. Subject to the provisions of the Plan and to such restrictions as the Board of Directors or its designee may adopt, the Employee Benefits Committee may establish rules for the transaction of its business and the administration of the Plan. Subject to such provisions and restrictions, the Employee Benefits Committee shall have the authority to determine, in its complete discretion, all questions relating to the interpretation of the terms and provisions of the Plan and all other questions arising under the Plan or in connection with the administration of the Plan, including without limitation the right to remedy possible ambiguities, inconsistencies, or omissions by general rule or particular decision. All rules, interpretations, determinations, and decisions of the Committee or of the Board of Directors or its designee in respect to any matter or question under the Plan shall be final, conclusive, and binding upon all persons having or claiming to have any interest in or under the Plan including, but not by way of limitation, all Employees, retired Employees, deferred benefit employees, contingent beneficiaries, spouses, dependent children, alternate payees, and any other person. The Committee shall determine Base Earnings, Base Earnings Plus Commissions, years of Service, and years of participation and make any finding of fact necessary for the determination of any right or any benefit payable under the Plan.
(b) Checking Account. To facilitate payments to Participants who are making withdrawals, the Employee Benefits Committee may establish and maintain one or more checking accounts in the name of the Plan.
(c) Claims Procedures. Each Participant or his beneficiary must claim any benefit to which he believes he is entitled under this Plan in accordance with procedures established by the Employee Benefits Committee.
The Employee Benefits Committee will decide a claim within 90 days of the date on which the claim is filed, unless special circumstances require a longer period for adjudication and the claimant is notified in writing, prior to the expiration of the 90-day period, of the reasons for an extension of time; provided, however, that no extensions will be permitted beyond 90 days after the expiration of the initial 90-day period. If the Employee Benefits Committee fails to notify the claimant of its decision to grant or deny a claim within the time specified by this paragraph, the claim will be deemed to have been denied and the review procedure described below will become available to the claimant.
If a claim is denied, the claimant must receive a written notice stating:
(1) The specific reason for the denial
(2) A specific reference to the Plan provision on which the denial is based;
(3) A description of additional information necessary for the claimant to perfect his claim, and an explanation of why such material is necessary; and
(4) An explanation of the Plan's claim review procedures. The claimant will have 60 days to request in writing a review of the denial of his claim by the Employee Benefits Committee, which shall provide a full and fair review. The claimant may review pertinent documents, and he may submit issues and comments in writing. The decision by the Employee Benefit Committee with respect to the review will be given within 60 days after receipt of the request, unless special circumstances require an extension. In no event will the decision be delayed beyond 120 days after receipt of the request for review. The decision will be written in a manner calculated to be understood by the claimant, and it will include specific reasons on which the decision is based and refer to the specific Plan provisions on which the denial is based.
The Employee Benefits Committee shall promulgate such additional rules and procedures for processing claims as it deems advisable or as may be required by regulations issued pursuant to ERISA.
A Fund Advisory Committee consisting of not less than 3 nor more than 12 members shall be appointed by the Board of Directors or its designee. In addition to the other responsibilities assigned to it in the Plan, the Fund Advisory Committee shall advise the respective Trustee of the investment objectives of the Trust and of any changes or modifications therein. The foregoing shall not relieve the Trustee from the sole responsibility for the Investment of the Trust Fund under its control. The Fund Advisory Committee shall be responsible for providing investment-related information to Participants and beneficiaries. The Fund Advisory Committee shall be subject to the procedures and rules set forth in Section 12.02.
(a) Appointment of Trustees. The Fund Advisory Committee shall appoint one or more individuals, banks, or trust companies as Trustees to hold, pursuant to one or more Trusts, all contributions made pursuant to the Plan and all other assets of the Plan. Each Trustee shall serve at the pleasure of the Fund Advisory Committee and shall have such rights, powers, and duties as are contained in the Trust Agreement by which it or he is appointed, and as the same may be amended.
Execution of the Trust Agreement by the Trustee shall be evidence of the Trustee's acceptance of its fiduciary capacity with respect to the Fund created by the applicable Trust Agreement to the allocation of fiduciary responsibilities, obligations, and duties contained in the Plan and the applicable Trust Agreement.
(b) Management of Assets. All assets of the Plan shall be held in trust by the Trustee for use in providing the benefits of the Plan. Each Trustee shall have the sole responsibility, subject to Section 13.02(d), for the investment of the funds held pursuant to the applicable Trust. In the event that a contribution by an Employer is made under circumstances described in Section 3.08, the Employer shall be entitled to have the contribution returned on the conditions stated in the Section. In addition, the proceeds of an Exempt Loan (or Financed Shares purchased with such proceeds), and earnings thereon, may be used to repay an Exempt Loan under the circumstances described in Article X1X. Except as provided in the preceding two sentences, no part of the corpus or income of any Trust shall be used for or diverted to purposes other than the exclusive benefit of Participants, retired Participants, and spouses and other beneficiaries of the Participants under the Plan.
(c) Investment Standards. All contributions made under this Plan shall be delivered to the Trustee and shall be held, invested, and reinvested as hereinafter set forth and in accordance with the provisions of the Trust Agreement. Investments shall consist only of those in which a prudent man familiar with the objectives of the Plan and using care, skill, prudence, and
diligence would invest in the conduct of an enterprise of a like character and with like aims, diversifying the investments so as to minimize the risk of market losses; provided, however, that investment in the Company Stock Fund as provided by the Plan may be made without any limitation on the percentage of the total fair market value of the trust fund or any Participant's Account that is so invested.
(d) Investment Responsibility. Each Trustee shall have sole responsibility for investment of the applicable Trust unless the Fund Advisory Committee appoints an Investment Manager and allocates control and management of all or any portion of the assets held in the Trust to the Investment Manager. The Investment Manager shall be an investment adviser registered under the Investment Advisers Act of 1940, a bank as defined in that Act, or an insurance company that is qualified to manage the assets of employee benefit plans under the laws of more than one state. An Investment Manager shall acknowledge in writing its appointment as a fiduciary of the Plan and shall serve until a proper resignation is receivell by the Fund Advisory Committee, or until it is removed or replaced by the Fund Advisory Committee.
(e) Responsibility of Investment Manager. An Investment Manager shall have sole investment responsibility for that portion of the assets of the Plan that it has been appointed to manage, and no other Plan Fiduciary or any Trustee shall have any responsibility for the investment of any of the assets, the management of which has been delegated to an Investment Manager, or liability for any loss to, or diminution in value of, the assets of the Plan resulting from any action directed, taken, or omitted by an Investment Manager. The Board of Directors, the committees, and the Trustee shall be under no duty to question the direction or lack of direction of any Investment Manager, but shall act, and shall be fully protected in acting, in accordance with each such direction. The investment responsibility of an Investment Manager shall not include responsibility for lending securities held in one or more of the Funds.
(f) Securities Lending. The right to lend securities, if any, in each of the Funds is expressly reserved to the Trustee that is the custodian of the Fund or portion thereof. The Trustee may, with the consent of the Fund Advisory Committee, lend securities held in one or more of the Funds.
No Employee, retired Employee, or other person shall have any right or power, by draft, assignment, or otherwise, to mortgage, pledge, or otherwise encumber in advance any interest in or portion of the assets held pursuant to any Trust or to give any order in advance upon any Trustee therefore and every attempted draft, assignment, or other disposition thereof shall be absolutely void except to the extent permitted under Code section 401(a)(13) and the regulations thereunder.
Except as otherwise provided in this Section, the funds held pursuant to any Trust shall not be liable in any way, whether by process of law or otherwise, for the debts or other obligations of any Employee, retired Employee, or other person. Unless expressly permitted by this Section benefits payable under this Plan shall not be subject, in any manner, to anticipation, alienation, sale, transfer, or assignment by the Employee, and any attempt to do so shall be void. Notwithstanding the foregoing, the Plan Fiduciaries are expressly authorized to comply with a qualified domestic relations order pursuant to Section 10.04; to permit the use of Participant's Account as security for a loan pursuant to Section 14.13; and to off-set a Participant's Accounts against an amount that the Participant is ordered or required to pay to the Plan pursuant to Code section 401(a)(13)(C).
Plan Fiduciaries; Employers; and employees, officers, and directors of the Employers and the Plan Fiduciaries, shall not be held or deemed in any manner to guarantee the Plan against loss or depreciation.
(a) Persons Entitled to Indemnification. Any person who is a member of the Employee Benefits Committee, the Fund Advisory Committee, the Board of Directors, and any employee of the Company or of any subsidiary or affiliated company who acts in a fiduciary capacity or any other capacity pursuant to the terms of the Plan, shall be indemnified by the Company against any and all liability and reasonable expense that may be incurred by either of them in connection with, or resulting from, any claim, action, suit, or proceeding (whether actual or threatened; civil, criminal, administrative, or investigative; or in connection with any appeal relating thereto) in which any of such persons may become involved as a party or otherwise by reason of acting in a fiduciary capacity or by reason of any action taken or not taken in such capacity whether or not such person continued to be a fiduciary at the time such liability or expense is incurred; provided such person acted in good faith, in what he reasonably believed to have been in the best interest of the Plan or the Employers, as the case may be, and, in addition, in any criminal action or proceeding, had no reasonable cause to believe that his conduct was unlawful.
(b) Definition. As used in this Section 14.04, the terms "liability" and "expense" shall include, but shall not be limited to, attorneys' fees and disbursements, and amounts of judgments, fines, or penalties against, and amounts paid in settlement by, such persons.
(c) Effect of Termination of Proceeding. The termination of any claim, action, suit, or proceeding, civil or criminal, by judgment, settlement (whether with or without court approval), or conviction, or upon a plea of guilty
or of nolo contendere, or its equivalent, shall not create a presumption that the person did not meet the standards of conduct set forth in Section 14.04(a).
(d) Persons Successful on the Merits. Any person described in
Section 14.04(a), who has been wholly successful, on the merits or
otherwise, with respect to any claim, action, suit, or proceeding of
the character described therein shall be entitled to indemnification
as of right.
(e) Persons Not Successful on the Merits. Except as provided in
Section 14.04(d), any indemnification hereunder shall be made at the
discretion of the Company, but only if (i) the Board of Directors,
acting by a quorum consisting of directors who are not parties to, or
who have been wholly successful with respect to, such claim, action,
suit, or proceeding, shall find that the director, officer, or
employee has met the standards of conduct set forth in Section
14.04(a) or (ii) independent legal counsel (who may be regular counsel
of the Company) shall deliver to it their written opinion that the
person has met those standards.
(f) Indemnification on Less Than All Claims or Issues. If several claims, issues, or matters of action are involved, any such person may be entitled to indemnification as to some matters even though he is not so entitled as to others.
(g) Advance of Costs. The Company may advance expenses to, or where appropriate may, at its expense, undertake the defense of, any such person upon receipt of an undertaking by or on behalf of the person to repay the expenses if it should ultimately be determined that he is not entitled to indemnification under this Section 14.04.
(h) Application of Indemnification Provisions. The provisions of this Section 14.04 shall be applicable to claims, actions, suits, or proceedings made or commenced after December 31, 1975, whether arising from acts or omissions to act occurring before or after such date.
(i) Indemnification Not Exclusive. The rights of indemnification provided hereunder shall be in addition to any rights to which any person concerned may otherwise be entitled by contract or as a matter of law, and shall inure to the benefit of the heirs, executors, and administrators of any such person.
All payments of benefits as provided in this Plan shall be made solely out of, and to the extent of, the assets held in Trust, and no Employer shall be liable, directly or indirectly, for the payment of any benefits provided in this Plan, nor shall any Employer be liable for any deficiency existing at any time in any Trust.
The establishment or continuance of the Plan shall not be construed as conferring any legal rights upon any Employee or any person for a continuation of employment, nor shall it interfere with the right of an Employer to discharge any Employee or deal with him without regard to the existence of the Plan.
(a) The Company Stock Fund. Before each annual or special meeting of the stockholders of the Company, the Employee Benefits Committee shall cause to be sent to each Participant, and to the beneficiary of each deceased Participant, a form requesting confidential instructions to the Trustee of the Company Stock Fund on how to vote the number of Shares represented by the Units in the Company Stock Fund credited to each such Participant or beneficiary. Upon receipt of such instructions the Trustee shall vote the Shares as instructed. Instructions received from individual Participants and beneficiaries by the Trustee shall be held in the strictest confidence and shall not be divulged or released to any person, including officers or employees of the Company. The Fund Advisory Committee shall review the sufficiency of procedures established to safeguard the confidentiality of Participants and beneficiaries and shall monitor compliance with those procedures. For the purpose of voting Shares allocated to their Participants' Accounts, Participants and beneficiaries shall be "named fiduciaries" within the meaning of ERISA section 403(a)(1).
(b) Unvoted and Unallocated Shares. The Trustee shall have the
right to vote, in person or by proxy, at its discretion, any Shares
for which voting instructions shall not have been received. This
Section 14.07(b) shall apply to Shares held unallocated in a Suspense
Account under the ESOP as well as to Shares that are allocated to
Participants' Accounts.
(c) Other Funds. Voting rights, if any, with respect to securities in each of the funds other than the Company Stock Fund are delegated to the Trustee or the Investment Manager that has the investment responsibility with respect to each such Fund or portion thereof, unless the Fund Advisory Committee has expressly reserved such voting rights to the Trustee that is the custodian of the Fund or portion thereof for which the Investment Manager has the investment responsibility.
(a) General Rule. In the event of a tender offer by any party other than the Company for Shares, or in the event of any similar attempt to effect a change in control of the Company (as hereinafter defined) by sale or exchange of Shares, the Trustee of the Company Stock Fund shall cause to be sent to each Participant, and to the beneficiary of each deceased Participant, a form requesting confidential instructions to it as to whether the Shares represented by the Units in
the Company Stock Fund credited to each such Participant or beneficiary should be tendered pursuant to the offer or sold or exchanged pursuant to any similar attempt to effect a change in control. A Participant shall have the right to instruct the Trustee with respect to all Units credited to him, whether or not he is 100 percent vested. At or prior to the time the Trustee causes a request for instructions to be sent to each Participant and the beneficiary of each deceased Participant, it shall distribute or cause to be distributed to each such Participant and beneficiary copies of any materials required to be distributed by the Securities and Exchange Commission or by any other appropriate regulatory body in connection with the tender offer or similar attempt to effect a change in control. Upon receipt of instructions from a Participant or beneficiary, the Trustee shall tender or retain the Shares as instructed. Instructions received from individual Participants and beneficiaries by the Trustee shall be held in the strictest confidence and shall not be divulged or released to any person, including officers or employees of the Company. The Board of Directors shall appoint an independent fiduciary to review the sufficiency of procedures established to safeguard the confidentiality of Participants and beneficiaries and to monitor compliance with those procedures. For the purpose of tendering Shares allocated to their Participants' Accounts, Participants and beneficiaries shall be "named fiduciaries" within the meaning of ERISA section 403.
(b) Undirected and Unallocated Shares. The Trustee shall tender or take other action pursuant to Section 14.08(a) only pursuant to a Participant's or beneficiary's written instructions and shall not be entitled to assume that failure to receive written instructions from a Participant or beneficiary indicates a particular instruction from the Participant or beneficiary. Accordingly, in the case of any Shares with respect to which the Trustee has not received instructions, after its due diligence to do so, the Trustee shall act in such manner as it, in its sole discretion, determines. This Section 14.08(b) shall apply to Shares held unallocated in a Suspense Account under the ESOP as well as to Shares that are allocated to Participants' Accounts.
(c) Change in Control. For purposes of this Section 14.08, a change in control of the Company shall mean the accumulation by any individual, firm, corporation, or other entity (other than the Company or any subsidiary thereof or by any employee benefit plan maintained by the Company or such a subsidiary), singly or in combination with any associates or affiliates, of the beneficial ownership of more than 20 percent of the outstanding shares of capital stock of the Company authorized to be issued from time to time under the Company's certificate of incorporation.
(d) Tender Offer Proceeds Fund. Any proceeds from the sale of Shares pursuant to Section 14.08(a) shall be held in a Tender Offer Proceeds Fund. Pending instructions from the Fund Advisory Committee, that Fund shall be invested in such manner as the Trustee of the Company Stock Fund, in its sole discretion, determines.
The Plan shall be administered and construed under ERISA and the internal laws of the State of Indiana (to the extent not preempted by federal law) and ERISA.
In case of any merger or consolidation of this Plan or the assets of the Plan with, or transfer of the assets or liabilities of the Plan to, any other Plan, the terms of the merger, consolidation, or transfer shall be such that each Participant would (if the Plan then terminated) receive a benefit immediately after the merger, consolidation or transfer that is equal to or greater than the benefit he would have been entitled to receive immediately before the merger, consolidation, or transfer (if the Plan had then terminated).
In the case of a Participant who was transferred to employment with an Employer from employment with
(a) Any affiliate designated by the Employee Benefits Committee;
(b) Eli Lilly and Company, Advanced Cardiovascular Systems, Inc., Cardiac Pacemakers, Inc., Origin Medsystems, Inc., or Devices for Vascular Intervention, Inc. (the "Prior Employers"); or
(c) Any other company designated by the Employee Benefits Committee, the Trust shall accept a transfer of such Participant's account under the savings plan maintained by such affiliate, Prior Employer, or by such other company (as the case may be); provided that such savings plan is a plan intended to meet the requirements for qualification under Code section 401(a) and that the trust maintained pursuant thereto is a trust intended to be exempt from tax under Code section 501(a). In the case of a Participant whose account under a Prior Savings Plan is transferred to the Trust, the following rules shall apply:
(1) Any optional form of benefit (within the meaning of Code section 411(d)(6)) that is available under a Prior Savings Plan with respect to the transferred amount immediately before the transfer shall be available under the Plan with respect to such amount following the transfer.
(2) To the extent required by applicable law, the amount transferred, and the earnings accrued thereon following the transfer, shall be separately accounted for under the Plan and allocated to the Participant's Account pursuant to Section 6.01.
(3) To the extent required by Code sections 401(a)(11) and 417, any requirements imposed by Code sections 401(a)(11) and 417 with respect to the transferred amount immediately before the transfer shall
continue to apply to such amount (and the earnings thereon) following the transfer.
The voting provisions of Sections 14.07 and 14.08 shall have no application with respect to any offer to exchange stock of Guidant Corporation for shares of Eli Lilly and Company held hereunder. Pursuant to Section 19.11(a), the Trustee shall accept any such offer and shall have no discretion to hold any shares of Eli Lilly and Company after the exchange is completed.
A Participant may obtain a loan from the Plan as provided in this Section.
(a) To obtain a loan, a Participant must apply to the Employee Benefits Committee or its designee for the loan. The Employee Benefits Committee or its designee will have the sole responsibility for determining whether or not to grant a Plan loan. The Employee Benefits Committee will establish written guidelines with respect to application procedures, minimum amounts of loans, frequency of loans, and other conditions, limitations, and procedures.
(b) The amount of a loan to a Participant may not be less than $1,000 and may not exceed the least of the following:
(1) $50,000, reduced by the excess, if any, of
(A) the highest outstanding balance of loans from the Plan to the Participant during the one-year period ending on the day before the date on which the loan is made, over
(B) the outstanding balance of loans from the Plan to the Participant on the date on which the loan is made; or
(2) one-half of the value of that portion of the Participant's vested Accounts not invested in the Company Stock Fund.
For purposes of the limitations imposed by this Section, loans from any other plan of the Employer or a Related Employer will be treated as a loan from the Plan.
(c) Each loan will provide for a definite term and repayment schedule. The maximum period of repayment will not exceed 5 years.
(d) The outstanding balance of a loan must be repaid by level payments through payroll deduction, by a single payment of the entire balance, or according to other procedures established by the Employee Benefits Committee in
written guidelines. Except as otherwise permitted by the Secretary of the Treasury, the written guidelines will require that a loan must be repaid no less frequently than in substantially equal quarterly payments over the term of the loan. Notwithstanding the preceding provisions of this Section and in accordance with Code section 414(u), an individual's loan repayments may be suspended for any period during which the individual is performing service in the uniformed services.
(e) A Plan loan will be in default upon the failure by the Participant to repay the loan in accordance with the provisions of Sections 14.13(c) and (d). If default occurs, the Employee Benefits Committee will foreclose on, sell, or otherwise dispose of the security for the loan at the time and in the manner determined by the Employee Benefits Committee.
(f) A loan will be evidenced by a promissory note and will bear interest at a reasonable rate determined by the Employee Benefits Committee. The rate will be commensurate with the prevailing interest rate charged on similar commercial loans under similar circumstances.
(g) A loan will be secured by a security interest in up to 50 percent of the value of the Participant's vested Participant's Account.
(h) The Employee Benefits Committee will make its determinations under this Section such that (1) loans are available to all Participants on a reasonably equivalent basis; and (2) the loan program does not discriminate in favor of Participants who are highly compensated Employees (as defined in Section 3.03).
(i) For purposes of crediting earnings to Participant's Accounts, a loan will be deemed a distribution from a Participant's Account and from particular Funds within a Participant's Account, as established by the Employee Benefits Committee in its written guidelines. That Participant's Account will share in applicable Fund earnings at a proportionately reduced rate and will be credited with accrued interest and principal repayments on the loan.
(j) If a Participant is married, his vested Account exceeds $5,000, and any portion of his vested Account includes amounts that must be paid in the form of a joint and survivor annuity absent his spouse's consent, the Participant's spouse must consent to the use of the Participant's vested Account as security for the loan. The consent must be obtained no earlier than the beginning of the 90-day period that ends on the date on which the loan is so secured, be in writing, be irrevocable, acknowledge the effect of the loan, and be witnessed by a Plan representative or notary public.
14.14. Transfer From Sulzer Medica USA Retirement Plan. As soon as practicable after May 1, 1999, the Trust shall accept a transfer from the trust for the Sulzer Medica USA Retirement Plan ("Sulzer Plan") of amounts representing the account balances in
the Sulzer Plan of those individuals who, as of the date of the transfer, are Employees. In the case of an Employee whose account balance under the Sulzer Plan is transferred to the Trust pursuant to the preceding sentence, the following rules shall apply:
(a) Any optional form of benefit (within the meaning of Code section 411(d)(6)) that is available under the Sulzer Plan with respect to the transferred amount immediately before the transfer shall be available under the plan with respect to that amount following the transfer.
(b) To the extent required by applicable law, the amount transferred with respect to a Participant, and the earning accrued thereon following the transfer, shall be separately accounted for under the Plan and allocated to the Participant's Account under this Plan.
(c) To the extent required by Code sections 401(a)(11) and 417, any requirements imposed by those Code sections with respect to the transferred amounts shall continue to apply to those amounts (and the earnings thereon) following the transfer.
14.15. Transfer From EVT Plan. As of June 1, 2000, the Trust shall accept a transfer from the trust for the Endovascular Technologies, Inc. 401(k) Savings Plan ("EVT Plan") of amounts representing the account balances in the EVT Plan of those individuals who, as of the date of the transfer, are Employees. In the case of an Employee whose account balance under the EVT Plan is transferred to the Trust pursuant to the preceding sentence, the following rules apply:
(a) Any optional form of benefit (within the meaning of Code section 411(d)(6)) that is available under the EVT Plan with respect to the transferred amount immediately before the transfer shall be available under the Plan with respect to that amount following the transfer.
(b) To the extent required by applicable law, the amount transferred with respect to a Participant, and the earnings accrued thereon following the transfer, shall be separately accounted for under the Plan and allocated to the Participant's Account under this Plan.
(c) To the extent required by Code sections 401(a)(11) and 417, any requirements imposed by those Code sections with respect to the transferred amounts shall continue to apply to those amounts (and the earnings thereon) following the transfer.
14.16. Transfer From InControl Plan. As of August 1, 2002, the Trust shall accept a transfer from the trust for the InControl, Inc. 401(k) Plan (the "InControl Plan") of amounts representing all of the assets of the InControl Plan. Amounts credited to the accounts of an individual under the InControl Plan shall be credited to a corresponding Participant's Account for that individual under the Plan. To the extent required by applicable law, an amount transferred with respect to an individual, and the earnings accrued thereon following the transfer will be separately accounted for under the Plan.
14.17. Transfer From CTS Plan. As soon as practicable after September 30, 2002, the Trust shall accept a transfer from the trust for CardioThoracic Systems 401(K) Savings Plan ("CTS Plan") of amounts representing all of the assets of the CTS Plan. Amounts credited to the accounts of an individual under the DVI Plan shall be credited to a corresponding Participant Account for that individual under the Plan. To the extent required by applicable law, an amount transferred with respect to an individual, and the earnings accrued thereon following the transfer, will be separately accounted for under the Plan. Amounts transferred from the CTS Plan to this Plan as described in this Section are fully vested at all times.
14.18. Transfer From DVI Plan. As soon as practicable after March 31, 2003, the Trust shall accept a transfer from the trust for the Employees 401(k) Plan of Devices for Vascular Intervention, Inc. (the "DVI Plan") of amounts representing all of the assets of the DVI Plan. Amounts credited to the accounts of an individual under the DVI Plan shall be credited to a corresponding Participant's Account for that individual under the Plan. To the extent required by applicable law, an amount transferred, with respect to an individual, and the earnings accrued thereon following the transfer, will be separately accounted for under the Plan.
The Plan is designed to qualify under Code section 401(a) and other applicable provisions of the Code and to comply with ERISA. The Company through action of its Board of Directors may make any modifications or amendments to the Plan that are necessary or appropriate to qualify or maintain the Plan as a plan meeting the requirements of Section 401(a) or any other applicable provisions of the Code, ERISA, or other laws, regulations, or rulings.
(a) By Board of Directors. It is the Company's expectation that the Plan will continue indefinitely, but the Company, by resolution of the Board of Directors, reserves the right to amend or modify the Plan in any respect or to terminate it in whole or in part. Any such termination or modification shall be effective at such date as the Company, by resolution of the Board of Directors, may determine. A modification that affects the rights or duties of any Trustee may be made only with the consent of that Trustee. Upon such an amendment, the affected Trustee shall be furnished with a certified copy thereof. The Plan may be amended retroactively, in the discretion of the Board of Directors. Notwithstanding the above, the accrued benefit of a Participant shall not be
decreased by an amendment to the Plan, other than an amendment described in Code section 412(c)(8) or in ERISA section 4281.
(b) Delegation of Amending Authority. The Board of Directors delegates to the Employee Benefits Committee the power to amend the Plan, pursuant to a written instrument filed with the important papers of the Company, for the limited purposes specified in Sections 1.01(a)(26)(A), 1.01(a)(26)(B)(iv), and 3.01. When acting in accordance with the delegation of authority provided in this Section 15.02(b), the Employee Benefits Committee shall be acting in a settlor capacity, and not as a fiduciary of the Plan.
(c) Effect of Termination or Modification on Employers. Any action taken by the Board of Directors or its designee under Section 15.02(a) above in terminating or modifying the Plan, or any decision made by the Company to discontinue further contributions that results in a termination of the Plan, shall be effective similarly to terminate or modify the Plan as to all subsidiary and affiliated companies that, at the effective date of such action, are included within the definition of "Employer" as set out in Article I.
(1) Right To Terminate. There is hereby separately reserved to each subsidiary or affiliated company of the Company that has been designated by the Company and that has adopted this Plan by resolution of its own board of directors (and which company by reason of such action is included within the definition of "Employer" under Article I), the right to terminate its participation in this Plan by action of its board of directors.
(2) Effect on Participants in Event of Termination. Upon the effective date of any termination by any Employer, all Employees of that Employer who are not, or do not thereupon become, Employees of another Employer shall cease thereafter to be Employees or Participants under the Plan, but all such employees who have been Participants in the Plan and who cease to be Employees or Participants under the Plan as above provided shall be treated as though they had a minimum of 5 years of Service under the Plan and shall be entitled to such rights of payment of Participants' Accounts as are available under Article X to Participants having at least 5 years of Service.
(3) Effect on Participants Where Plan Continued After Termination. Notwithstanding the foregoing, if a subsidiary or affiliated company shall terminate its participation as an Employer in the Plan but shall continue the Plan, with appropriate amendments, or adopt a substantially similar plan, the withdrawal from the Plan by that Employer shall not be regarded as a termination of the Plan so far as such Employer and its Employees are concerned. In that event the rights of those Employees and their beneficiaries shall be governed in accordance with
the provisions of the Plan, as appropriately amended, and continued, or of the substantially similar plan so adopted by that company as if no withdrawal from the Plan had taken place, provided, however, that if an employee of the subsidiary or affiliated company is not eligible to continue participation in the Plan as so continued by that company but continues to meet the definition of "Employee" contained in Sections 1.01(a)(7)(A)(ii), (B), (C), and (D), his participation hereunder shall not be interrupted by the withdrawal of that company, and his rights and the rights of his beneficiaries shall continue to be governed in accordance with the provisions of this Plan.
(b) When Employer Is a "Qualified Subsidiary" upon Effective Date of Termination. Termination of, or withdrawal from, this Plan by an Employer shall not constitute a termination of this Plan if on the effective date of the termination or withdrawal the Employer is a Qualified Subsidiary as defined in Article I and all of the Employees of that Employer who are then participating in this Plan meet the definition of "Employee" contained in Sections 1.01(a)(7)(A)(ii), (B), (C), and (D). In that event, the rights of the Employees of the Employer and the rights of their beneficiaries shall continue to be governed in accordance with the provisions of this Plan, and the participation of those Employees in this Plan shall not be interrupted.
In the event of the complete or partial termination of the Plan or the complete discontinuance of contributions thereto, the assets then held in the Trust on behalf of affected Participants, after provision for payment of expenses of liquidation, shall be fully vested and distributable in accordance with the provisions of Section 10.01; provided, however, that, in the event the Employer has established or maintains another defined contribution plan (other than an employee ownership plan as defined in Code section 4975(e)(7)), the Salary Reduction Contributions (and the earnings thereon) in a Participant's Account shall not be distributed unless the Participant has met the withdrawal requirements in Section 7.01 or 8.01.
The agent for the service of legal process is the Secretary of the Company.
The Plan shall meet the requirements of this Article XVII in the event that the Plan is or becomes a Top-Heavy Plan.
(a) Subject to the aggregation rules set forth in Section 17.02(b), the Plan shall be considered a Top-Heavy Plan pursuant to Code section 416(g) in
any Plan Year if, as of the Determination Date, the present value of the cumulative accounts of all Key Employees exceeds 60 percent of the value of the cumulative accounts of all of the Employees as of that Determination Date, excluding former Key Employees and excluding any Employee who has not performed services for the Employer during the 5 consecutive Plan Year period ending on the Determination Date, but taking into account in computing the ratio any distributions made during the 5 consecutive Plan Year period ending on the Determination Date. For purposes of the above ratio, the account of a Key Employee shall be counted only once each Plan Year, notwithstanding the fact that an individual may be considered a Key Employee for more than one reason in any Plan Year.
(b) Aggregation and Coordination with Other Plans. For purposes of determining whether the Plan is a Top-Heavy Plan and for purposes of meeting the requirements of this Article XVII, the Plan shall be aggregated and coordinated with other qualified plans in a Required Aggregation Group and may be aggregated or coordinated with other qualified plans in a Permissive Aggregation Group. If a Required Aggregation Group that includes the Plan is Top-Heavy, this Plan shall be considered a Top-Heavy Plan. If a Permissive Aggregation Group that includes the Plan is not Top-Heavy, this Plan shall not be a Top-Heavy Plan.
For the purpose of determining whether the Plan is Top-Heavy, the following definitions shall apply:
(a) Determination Date and Valuation Dates. The term "Determination Date" shall mean, in the case of any Plan Year, the last day of the preceding Plan Year. The value of an individual's account shall be determined as of the Valuation Date and shall include any contribution actually made after the Valuation Date but on or before the Determination Date. The term "Valuation Date" means the most recent Value Determination Date defined in Section 1.01(a)(33) occurring within a twelve (12) month period ending on the Determination Date.
(b) Key Employee. An individual shall be considered a Key Employee if he is an Employee or former Employee who at any time during the current Plan Year or any of the 4 preceding Plan Years:
(1) was an officer of the Employer who has annual compensation from the Employer in the applicable Plan Year in an amount greater than 50 percent of the amount in effect under Code section 415(b)(1)(A) for the Plan Year; provided, however, that the number of individuals treated as Key Employees by reason of being officers shall not exceed the lesser of 50 or 10 percent of all Employees, and provided further that, for purposes of determining the number of officers,
individuals disregarded under Code section 414(q)(8) may be disregarded here, and provided further, that if the number of individuals treated as officers is limited to 50, the individuals treated as Key Employees shall be those who, while officers, received the greatest annual Compensation in the applicable Plan Year and any of the 4 preceding Plan Years (without regard to the limitation set forth in Code section 401(a)(17)); or
(2) was one of the 10 Employees owning or considered as owning the largest interests in the Employer who has annual Compensation from the Employer in the applicable Plan Year in excess of the dollar limitation under Code section 415(c)(1)(A) as increased under Code section 415(d); or
(3) was a more than 5 percent owner of the Employer; or
(4) was a more than 1 percent owner of the Employer whose annual Compensation from the Employer in the applicable Plan Year exceeded $150,000.
For purposes of determining who is a Key Employee, ownership shall mean ownership of the outstanding stock of the Employer or of the total combined voting power of all stock of the Employer, taking into account the constructive ownership rules of Code section 318, as modified by Code section 416(i)(1).
For purposes of Section 17.03(b)(1) but not for purposes of 17.03(b)
(2), (3) and (4)--except for purposes of determining Compensation under Section
17.03(b)(4)--the term "Employer" shall include any entity aggregated with an
Employer pursuant to Code section 414(b), (c) or (m).
For purposes of Section 17.03(b)(2), an Employee (or former Employee) who has some ownership interest is considered to be one of the top 10 owners unless at least 10 other Employees (or former Employees) own a greater interest than that Employee (or former Employee); provided that if an Employee has the same ownership interest as another Employee, the Employee having greater annual Compensation from the Employer is considered to have the larger ownership interest.
(c) Non-Key Employee. The term "Non-Key Employee" shall mean any Employee who is a Participant and who is not a Key Employee.
(d) Beneficiary. Whenever the term "Key Employee," "former Key Employee," or "Non-Key Employee" is used in this Article XVII, it includes the beneficiary or beneficiaries of that individual. If an individual is a Key Employee by reason of the foregoing sentence as well as a Key Employee in his own right, both the value of his inherited benefit and the value of his own account will be considered his Participant's Account for purposes of determining whether the Plan is a Top-Heavy Plan.
(e) Compensation and Compensation Limitation. For purposes of this Article XVII except as otherwise specifically provided, the term "Compensation" has the same meaning as in Section 4.02(b).
(f) Required Aggregation Group. The term "Required Aggregation Group" shall mean all other qualified defined benefit and defined contribution plans maintained by the Employer in which a Key Employee participates, and each other plan of the Employer that enables any plan in which a Key Employee participates to meet the requirements of Code section 401(a)(4) or 410(b).
(g) Permissive Aggregation Group. The term "Permissive Aggregation Group" shall mean all other qualified defined benefit and defined contribution plans maintained by the Employer that meet the requirements of Code sections 401(a)(4) and 410(b) when considered with a Required Aggregation Group.
In the event the Plan is determined to be Top-Heavy for any Plan Year, the following requirements shall apply:
(1) In the case of a Non-Key Employee who is covered under
this Plan but does not participate in any qualified defined
benefit plan maintained by the Employer, the Minimum Allocation
of contributions plus forfeitures allocated to the Participant's
Account of each such Non-Key Employee who has not separated from
service at the end of a Plan Year in which the Plan is Top-Heavy
shall equal the lesser of 3 percent of Compensation for the Plan
Year or the largest percentage of Compensation (including Salary
Reduction Contributions) provided on behalf of any Key Employee
for the Plan Year. The minimum Allocation provided hereunder may
not be suspended or forfeited under Code section 411(a)(3)(B) or
411(a)(3)(D). The Minimum Allocation shall be made for a Non-Key
Employee for each Plan Year in which the Plan is Top-Heavy, even
if he has not completed a year of Service in the Plan Year or if
he has declined to elect to have Salary Reduction Contributions
made on his behalf.
(2) A Non-Key Employee who is covered under this Plan and under a qualified defined benefit plan maintained by the Employer shall be entitled to the Minimum Allocation under this Plan.
(3) No amount of a Non-Key Employee's Salary Reduction Contributions, Minimum Matching Contributions, or Additional Matching Contributions shall be treated as part of the Non-Key Employee's Minimum Allocation.
(b) Ton-Heavy Vesting Schedule. The nonforfeitable percentage of a Participant's interest shall be determined in accordance with the vesting schedule provided under Section 10.01(a)(1)(A).
(a) Any PAYSOP Accounts maintained under the Prior Savings Plans on behalf of Participants who participated in those Prior Savings Plans shall be transferred to this Plan. The assets transferred from a PAYSOP Account with respect to a Participant shall be allocated to the Participant's PAYSOP Account in this Plan pursuant to Section 6.01. Accounting for amounts in a Participant's PAYSOP Account, including the earnings thereon, shall be separate from amounts attributable to Salary Reduction Contributions, Employer Contributions, and Employee Contributions to the Plan.
(b) A Participant shall be fully vested at all times in his PAYSOP Account and any accumulated earnings thereon.
(c) The transfer of a Participant's PAYSOP Account to the Plan shall not be treated as an annual addition for purposes of Article IV of the Plan.
Each Participant's PAYSOP Account shall be invested in the Company Stock Fund. A Participant shall not be entitled to have his PAYSOP Account and any earnings attributable thereto invested in any Fund other than the Company Stock Fund, except as provided in Sections 5.06(b) and (c).
Except as provided in Section 8.02, a Participant may not withdraw any portion of his PAYSOP Account, or the earnings attributable thereto, prior to his retirement, death, Disability, or other termination of employment with the Company and its affiliates.
(a) Upon a Participant's Retirement, death, Disability, or other termination of employment with the Company and its affiliates, the Participant (or, if applicable, the Participant's beneficiary) shall be entitled to receive a distribution of his PAYSOP Account at the same time and in the same manner as he receives a distribution of the other portions of his Participant's Account under Article X; provided, however, that for purposes of Article X, a Participant's entire PAYSOP Account shall be deemed to be part of the Participant's "post-1986 account." A Participant shall not be entitled to elect a time or method of distribution, or to designate a beneficiary, with respect to his PAYSOP Account
that is different from the time and method of distribution and beneficiary that are applicable to the other portions of his post-1986 account.
(b) For purposes of determining, pursuant to Article X, whether a Participant's vested accrued benefit exceeds $5,000, the Participant's PAYSOP Account shall not be considered separately, but shall be included with the other portions of his Participant's Account.
(c) A Participant or beneficiary may elect, pursuant to Article XI, to receive the distribution of the Participant's PAYSOP Account in Shares rather than in cash; provided, however, that the Trustee shall distribute fractional Shares in cash rather than in common stock.
(d) A retired Participant who has elected to defer commencement of the distribution of his Participant's Account may make periodic withdrawals from his PAYSOP Account pursuant to Section 10.01(b)(3).
If any portion of a Participant's PAYSOP Account is subject to a
qualified domestic relations order, that amount shall be paid in accordance with
Section 10.04. Notwithstanding the provisions of Section 18.03 and Code section
409(d), payments may be made from a Participant's PAYSOP Account to an alternate
payee under a qualified domestic relations order even if the Participant has not
terminated his employment with the Company and its affiliates, and even if part
or all of the Shares in the Participant's PAYSOP Account has not become eligible
for distribution to the Participant under Code section 409(d). Except to the
extent otherwise provided in the qualified domestic relations order, any
distribution to an alternate payee under this Section 18.05 shall be derived
from Shares in the order in which such Shares were allocated to the
Participant's PAYSOP Account, beginning with the Shares that were most recently
allocated to the Participant's PAYSOP Account.
This Article XIX shall be known as the "ESOP". The ESOP permits the Trustee to borrow amounts to finance the purchase of Shares, and provides for the investment of Employer Contributions, and the earnings thereon, in Shares, so that Participants will have an opportunity to become shareholders of the Company. The effective date of the ESOP shall be January 1, 1995.
The Company intends that the Profit-Sharing Plan and the ESOP together shall constitute a single plan under Treasury Regulation ss. 1.414(1)-l(b)(l). Accordingly, the provisions set forth in the other sections of the Plan shall apply to the ESOP in the same manner as those provisions apply to the Profit-Sharing Plan, except to the extent that those provisions are by their terms inapplicable to the ESOP, or to the extent that they are inconsistent with the specific provisions set forth below in this Article XIX.
The following words and phrases, as used in this Section XIX, shall have the following meanings unless a different meaning is plainly required by the context:
(a) "ESOP Account" shall mean the portion of a Participant's Account that reflects a Participant's or beneficiary's interest in the ESOP.
(b) "ESOP Shares Fund" shall mean the portion of the Company Stock Fund that is maintained for the investment of the ESOP assets. The ESOP Shares Fund shall include both ESOP assets that are allocated to Participants' and beneficiaries' ESOP Accounts and ESOP assets that are held unallocated in a Suspense Account.
(c) "Exempt Loan" shall mean a loan, loan guarantee, or other extension of credit to the ESOP from an individual or entity that is a "party in interest" within the meaning of ERISA section 3(14) or a "disqualified person" within the meaning of Code section 4975(e)(2), provided that the proceeds of the extension of credit are used by the Trustee to finance the purchase of Shares or to repay an Exempt Loan in accordance with Section 19.12.
(d) "Financed Shares" shall mean Shares purchased with the proceeds of an Exempt Loan and held in a Suspense Account. The term shall not include Shares that have been released from a Suspense Account and allocated to the ESOP Accounts of Participants or beneficiaries in accordance with Section 19.12.
(e) "Suspense Account" shall mean an account to which Shares purchased with the proceeds of an Exempt Loan (and earnings attributable to those Shares) shall be allocated until the Shares and earnings are released from suspense and allocated to the ESOP Accounts of Participants or beneficiaries in accordance with Section 19.12.
An Employee shall become a Participant in the ESOP on the effective date of the ESOP, provided that such Employee is a Participant in the Plan on that date. Any other Employee shall become a Participant in the ESOP as of the date on which the Employee becomes a Participant in the Plan.
(1) Minimum Matching Contributions. Except as otherwise provided in this Section 19.04, an Employer shall contribute to the ESOP on behalf of its Employees for each month an amount sufficient to provide each Employee with an allocation of Shares equal to 50 percent of the Employee's Salary Reduction Contributions for that month; provided,
however, that in no event shall Minimum Matching Contributions be
made with respect to (1) Salary Reduction Contributions that
exceed 6 percent of a Participant's Base Earnings Plus
Commissions for the month; (2) Salary Reduction Contributions
that exceed the limit set forth in Section 3.03(d); (3) Excess
Salary Reduction Contributions; or (4) Salary Reduction
Contributions attributable to Catch-Up Contributions under
Section 20.10. If an Employee's Salary Reduction Contributions
stop before the end of a Plan Year because they reach the dollar
limitation applicable to the Employee under federal tax law, then
his Employer shall make a true-up Minimum Matching Contribution
on behalf of the Employee for the month in which his Salary
Reductions stop and for each month after that month through the
last month of the Plan Year. The true-up Minimum Matching
Contribution shall be sufficient to provide the Employee with an
allocation of Shares equal to the difference, if any, between (A)
50 percent of the Employee's total Salary Reduction Contributions
(other than those attributable to Catch-Up Contributions under
Section 20.10) for the Plan Year to date that are not in excess
of 6 percent of the Employee's Base Earnings Plus Commissions for
the Plan Year to date, and (b) the Minimum Matching Contributions
previously made for the Employee for the Plan Year (including any
true-up Minimum Matching Contributions).
Notwithstanding any of the foregoing, in no event shall Minimum Matching Contributions be made to the extent that those contributions would cause the contribution percentage limit set forth in Section 19.07 to be exceeded. An Employer shall make its Minimum Matching Contributions on a monthly basis. The Minimum Matching Contributions made by an Employer on behalf of an Employee participating in the Plan shall be allocated to the Employee's ESOP Account.
(2) Additional Matching Contributions. In the discretion of the Board of Directors or its designee, and except as otherwise provided in this Section 19.04, each Employer shall make an Additional Matching Contribution to the ESOP for a Plan Year in such amount as is determined by the Board of Directors or its designee, but not in excess of an amount sufficient to provide its Employees with an allocation of Shares equal to 50 percent of the Employee's Salary Reduction Contributions, including Salary Reduction Contributions made under an Employer Savings Plan, made for the Plan Year. An Additional Matching Contribution shall be made only on behalf of Employees who are participating in the Plan as of the first day of the last month of the Plan Year, who Retired during the Plan Year, or who died during the Plan Year while actively employed and participating in the Plan; provided, however, that in no event shall Additional Matching Contributions be made with respect to (1) Salary Reduction Contributions that exceed 6 percent of a Participant's Base Earnings Plus Commissions; (2) Salary Reduction Contributions that exceed the limit set forth in Section 3.03(d); (3) Excess Salary Reduction
Contributions; or (4) Salary Reduction Contributions attributable to Catch-Up Contributions under Section 20.10; and provided further that in no event shall Additional Matching Contributions be made to the extent that such contributions would cause the contribution percentage limit set forth in Section 19.07 to be exceeded. An Employer's Additional Matching Contributions for any Plan Year shall become due for payment to the Trustee of the Company Stock Fund on the last day of the Plan Year and shall be paid to the Trustee by the Employer within the period of time prescribed by law to permit a federal income tax deduction with respect to the Plan Year for those contributions. The Additional Matching Contributions made by an Employer on behalf of an Employee participating in the Plan shall be allocated to the Employee's ESOP Account.
(b) Basic Contributions. In the discretion of the Board of
Directors or its designee, and except as otherwise provided in this
Section 19.04, an Employer shall contribute to the ESOP on behalf of
each of its Employees participating in the Plan an amount sufficient
to provide each Employee with an allocation of Shares equal to a
percentage, determined annually by the Board of Directors or its
designee prior to the beginning of each Plan Year, of each Employee's
Base Earnings. An Employer shall make its Basic Contributions on a
monthly basis. The Basic Contribution made by an Employer on behalf of
an Employee participating in the Plan shall be allocated to the
Employee's ESOP Account.
(c) Forfeitures. Except as otherwise provided in Section 19.04(d)(3), below, forfeitures attributable to Matching Contributions that arise under the Plan shall be allocated to Participants' ESOP Accounts on the basis of their Salary Reduction Contributions for any Plan Year in which the Employers have elected to make Minimum Matching Contributions and Additional Matching Contributions to the ESOP rather than to the Profit-Sharing Plan. Forfeitures attributable to Basic Contributions shall be allocated to Participants' ESOP Accounts on the basis of their Base Earnings for any Plan Year in which the Employers have elected to make Basic Contributions to the ESOP rather than to the Profit-Sharing Plan. Forfeitures allocated in this manner shall be treated as Minimum Matching Contributions, Additional Matching Contributions, or Basic Contributions, whichever is applicable, and shall be allocated to Participants' ESOP Accounts in the manner described in Section 19.04(a) or (b), above. The forfeiture allocations described in this Section 19.04(c)(3) shall reduce, dollar for dollar, the amount of the Minimum Matching Contributions, Additional Matching Contributions, or Basic Contributions, that otherwise would be allocated to the Participant pursuant to Section 19.04(a) or (b).
(1) Contribution Requirements. For each Plan Year (or portion thereof) during which there are Financed Shares in a Suspense Account, the Employer Contributions to the ESOP shall not be less than an amount
that is sufficient, when aggregated with dividend payments described in Section 19.10(a), to pay any currently maturing obligations under any Exempt Loan. The Employer Contributions under this Section 19.04(d) shall be paid in cash to the extent necessary to provide the ESOP with cash sufficient to pay any currently maturing obligations under any Exempt Loan, and shall be paid in two or more installments during the Plan Year to the extent necessary to permit the Trustee to meet the payment schedule for any Exempt Loan. The Employer Contributions described in this Section 19.04(d) shall be made without regard to whether the Employer Contributions exceed the current or accumulated earnings and profits of the Employers.
(2) Allocations. The value of the Shares released from a
Suspense Account and allocated to a Participant's ESOP Account by
reason of an Exempt Loan payment made pursuant to this Section
19.04(d) for any Plan Year (including the portion of the Exempt
Loan payment that is attributable to dividends as described in
Section 19.10(a)) shall determine whether the Minimum Matching
Contributions, Additional Matching Contributions, and Basic
Contributions for the Plan Year are sufficient to provide
eligible Participants with allocations whose value is at least as
great as the amounts determined under Sections 19.04(a) and (b).
(3) Forfeitures. Forfeitures shall not be used to repay an
Exempt Loan. For each Plan Year (or portion thereof) during which
there are Financed Shares in a Suspense Account, forfeitures
shall be applied in the manner described in Section 19.12 to
replace dividends that are used to repay an Exempt Loan or to
provide additional allocations to Participants. To the extent
that forfeitures are not required to be used for either of the
foregoing purposes under the provisions of Section 19.12, they
shall be used to pay administrative expenses in accordance with
Section 12.02(n).
(e) Contributions of Shares. Except as provided in Section 19.04(d)(1), the Employers may, at their election, make all or any part of any Minimum Matching Contribution, Additional Matching Contribution, or Basic Contributions to the ESOP in Shares rather than in cash. The Shares so contributed shall have a fair market value equal to the amount of the Minimum Matching Contribution, Additional Matching Contribution, or Basic Contribution (or portion thereof). The fair market value of a Share shall be the mean between the highest and lowest quoted selling price per share for a 100 Share lot on the composite tape of New York Stock Exchange issues on the date of payment to the Trustee.
(f) Contributions to the Profit-Sharing Plan. The Employers may, at their election, make a Minimum Matching Contribution, Additional Matching Contribution, or Basic Contribution to the Profit-Sharing Plan pursuant to Section 3.06 in lieu of all or a portion of the Minimum Matching Contribution, Additional
Matching Contribution, or Basic Contribution otherwise required under
this Section 19.04; provided that the Employers may not make a Minimum
Matching Contribution, Additional Matching Contribution, or Basic
Contribution to the Profit-Sharing Plan in lieu of any Minimum
Matching Contribution, or Additional Matching Contribution, or Basic
Contribution that is required to repay an Exempt Loan as described in
Section 19.04(d). The amount of the Minimum Matching Contribution,
Additional Matching Contribution, or Basic Contribution otherwise
required to be made pursuant to Section 19.04(a) or (b) with respect
to a Participant shall be reduced, dollar for dollar, by the amount of
any Minimum Matching Contribution, Additional Matching Contribution,
or Basic Contribution that is allocated to the Participant's
Profit-Sharing Account for the Plan Year.
(g) Deductibility. All Minimum Matching Contributions, Additional Matching Contributions, and Basic Contributions to the ESOP are conditioned on the deductibility of the contributions under Code section 404 for the taxable year with respect to which the contributions were made.
(1) Transfers at Election of Committee. The Fund Advisory Committee may, at its election, direct the Trustee to transfer from the Profit-Sharing Plan to the ESOP any portion of the Company Stock Fund that is attributable to Employer Contributions, and earnings thereon, credited to Participants` Profit-Sharing Accounts prior to the date of the transfer, or any portion of the Company Stock Fund that is credited to Participants' PAYSOP Accounts prior to the date of the transfer. Any Shares transferred in accordance with this Section 19.04(h) shall be held in the ESOP Shares Fund and shall be credited to the ESOP Accounts of those Participants and beneficiaries from whose Profit-Sharing Accounts or PAYSOP Accounts the Shares were transferred. Any shares transferred from a Participant's or beneficiary's PAYSOP Account to his ESOP Account shall continue to be accounted for separately after the transfer, and shall remain subject to the special rules set forth in Article XVIII.
(2) Effect of Transfers. Any Shares transferred in accordance with this Section 19.04(h) shall not be considered "annual additions" under Section 19.06, and shall not be taken into account in determining the contribution percentage of any Participant under Section 19.07.
(i) Contributions Not Recoverable by Employer. The Trustee shall hold the contributions received by it under this Section 19.04 for the respective Participants subject to the provisions of the Plan. No such contribution shall be recoverable by the Employers, except as provided in Section 19.04(j).
(j) Return of Employer Contributions. In the event that an Employer Contribution made pursuant to this Section 19.04
(1) is made under a mistake of fact, or
(2) is disallowed as a deduction under Code section 404 for the taxable year with respect to which it was made, the contribution shall, at the option of the Employer, be returned to the Employer within 1 year after the payment of the contribution or the disallowance of the deduction (to the extent disallowed), whichever is applicable; provided, however, that an Employer may not recover from the Plan any contribution that has been used to repay an Exempt Loan. The amount returned shall not be increased to reflect any investment earnings, but shall be decreased to reflect any losses. If the amount returned to an Employer would cause the balance of any Participant's Account to be less than the balance would have been had the returned contribution never been made, the amount to be returned shall be limited to prevent the loss.
(1) Minimum Matching Contributions. Except as provided in
Section 19.05(c), an Employer's Minimum Matching Contributions
shall become due for payment to the Trustee of the Company Stock
Fund at the end of each month during the Plan Year.
(2) Additional Matching Contributions. Except as provided in Section 19.05(c), an Employer's Additional Matching Contributions for any Plan Year shall become due for payment to the Trustee of the Company Stock Fund on the last day of the Plan Year and shall be paid to the Trustee by the Employer within the period of time prescribed by law to permit a Federal income tax deduction with respect to that Plan Year for those contributions.
(b) Basic Contributions. Except as provided in Section 19.05(c), an Employer's Basic Contributions shall become due for payment to the Trustee of the Company Stock Fund at the end of each month during the Plan Year.
(c) Exempt Loan Payments. Any Minimum Matching Contribution, Additional Matching Contribution, or Basic Contribution made pursuant to Section 19.04(d) shall be paid to the Trustee of the Company Stock Fund in time to permit the Trustee to satisfy any currently maturing obligation under any Exempt Loan. The Employers may, at their election, make all or any portion of such Minimum Matching Contribution, Additional Matching Contribution, or Basic Contribution (or direct the Trustee to use all or any portion of the dividends described in Section 19.10(a)) in time to permit the Trustee to pre-pay all or a portion of any obligation under an Exempt Loan, to the extent that such prepayment may be made without penalty to the ESOP.
(a) Limits on Additions to ESOP Accounts. The annual addition to a Participant's ESOP Account in any limitation year, when combined with the annual addition to a Participant's account under the Profit-Sharing Plan and under all other defined contribution plans described in Section 4.05, may not exceed the lesser of:
(1) $30,000 (as adjusted for increases in the limitation pursuant to Code section 415(d)); or
(2) 25 percent of a Participant's compensation (as defined in Section 4.02(b)) for the limitation year.
(1) The term "annual addition" as used in Section 19.06(a) means Employer Contributions allocated to the Participant's ESOP Account during a limitation year. Except as provided in Section 19.06(c), the term "annual addition" also includes any Employer Contributions of principal and interest used to repay an Exempt Loan for the limitation year. For purposes of the immediately preceding sentence, the amount of the annual addition shall be determined by reference to the amount of the Employer Contribution used to repay an Exempt Loan rather than by reference to the value of the Shares released from a Suspense Account and allocated to a Participant's ESOP Account for the limitation year.
(2) The term "annual addition" shall not include any dividend paid with respect to Shares that are held in a Suspense Account or allocated to a Participant's ESOP Account. The term "annual addition" also shall not include the value of any Shares that are allocated to a Participant's ESOP Account in accordance with Section 19.12, below, in order to replace any dividends that are used to make payments on an Exempt Loan.
(c) Special Rules for Exempt Loan Payments. If no more than one-third of the Employer Contributions for a limitation year that are deductible under Code section 404(a)(9) are allocated to Participants who are highly compensated Employees (within the meaning of Code section 414(q)), the limitation imposed by this Section 19.06 shall not apply to:
(1) Forfeitures of Shares that were acquired with the
proceeds of an Exempt Loan as described in Code section
404(a)(9)(A), or
(2) Employer Contributions that are deductible under Code section 404(a)(9)(B) and that are charged against a Participant's Account.
(d) Applicability of General Rules. Except to the extent
otherwise provided above, the provisions of Article IV shall apply for
purposes of determining the limits on annual additions under this
Section 19.06.
(a) Contribution Limits. Minimum Matching and Additional Matching Contributions to the ESOP for any Plan Year shall satisfy the contribution percentage test in Code section 401(m)(2), including the rules of Treasury Regulations ss. 1.401(m)-1(b) or any successor provision. Minimum Matching Contributions and Additional Matching Contributions forfeited by a Participant under Section 3.04(c), with respect to a Plan Year shall not be taken into account in determining whether Employer Contributions to the ESOP for that Participant satisfy the contribution percentage test for that Plan Year. Notwithstanding anything to the contrary in this Article XIX, if the contribution percentage of those Participants who are highly compensated Employees (as defined in Section 3.03) exceeds the limit imposed by Code section 401(m), the following rules shall apply:
(1) The amount of the excess aggregate contributions (determined in accordance with Code section 4.01(m)(6)(B) for the Plan Year, and any income attributable to those contributions, shall be distributed (or, if forfeitable, shall be forfeited) before the end of the following Plan Year.
(2) Any distribution in accordance with Section 19.07(a)
(1), above, shall be made to Participants who are highly
compensated Employees on the basis of the respective portions of
the excess aggregate contributions allocated to each such
Participant. Effective for Plan Years beginning on or after
January 1, 1997, the total dollar amount of excess aggregate
contributions shall be allocated to some or all highly
compensated Employees by reducing first the contributions of the
highly compensated Participant with the highest dollar amount of
contributions until (A) the total amount of excess aggregate
contributions has been allocated, or (B) his remaining
contributions are equal in dollar amount to the contributions of
the highly compensated Employee with the next highest dollar
amount. This process shall be repeated until all excess aggregate
contributions have been allocated.
(3) Distributions required under this Section 19.07(a) shall be made notwithstanding any other provision of the Plan.
(b) Treatment of Exempt Loan Payments. To the extent that an
Employer Contribution is used to repay an Exempt Loan as described in
Section 19.04(d), a Participant's contribution ratio for a Plan Year
shall be determined by reference to the amount of the Employer
Contribution that is made with respect to the Participant rather than
by reference to the value of the Shares that are released
from a Suspense Account and allocated to the Participant's ESOP Account by reason of the Employer Contribution.
(c) Separate Testing. The determination of the amount of excess aggregate contributions under Section 19.07(a), for any Plan Year shall be made without regard to any Employer Contributions allocated to a Participant's Profit-Sharing Account for the Plan Year.
(a) Vested Percentage. A Participant's vested interest in the Employer Contributions and earnings thereon allocated to his ESOP Account shall be determined in accordance with Section 10.01.
(b) Forfeitures. A Participant who is not 100 percent vested in
all amounts allocated to his ESOP Account shall forfeit the nonvested
portion of his ESOP Account in accordance with the rules prescribed by
Section 10.01(a). Shares that were allocated to the Participant's ESOP
Account from a Suspense Account as provided in Section 19.12 shall be
forfeited only after all other assets allocated to the Participant's
ESOP Account have been forfeited. If the Participant subsequently
returns to employment with the Company or an affiliate before he
incurs five consecutive One Year Periods of Severance, his ESOP
Account shall be restored if he satisfies the requirements of Section
10.01(a).
A separate account shall be established for each Participant, known individually as the ESOP Account and collectively as the ESOP Accounts. A Participant's ESOP Account shall be comprised of his ESOP Pre-Split Matching Account, his Company Match Account (formerly the ESOP Post-Split Matching Account), and his Retirement ESOP Account (formerly the ESOP Basic Contributions Account), maintained in accordance with the rules set forth in Article VI.
(a) Exempt Loan Payments. The Fund Advisory Committee may direct the Trustee to use any cash dividend, except cash dividends with respect to shares held in Participants' ESOP Pre-Split Matching Accounts, to make payments on an Exempt Loan, provided that the cash dividend is paid with respect to Shares that are held by the ESOP on the record date for the dividend. This Section 19.10(a) shall apply both to dividends paid with respect to Shares that are allocated to a Participant's or beneficiary's ESOP Account and to dividends paid with respect to Shares that are held in a Suspense Account. In addition, to the extent allowed by law, and as directed by the Fund Advisory Committee, this Section 19.10(a) shall apply to dividends paid with respect to Shares in Participants' ESOP Pre-Split Matching Contribution Accounts.
(b) Replacement of Dividends on Allocated Shares. To the extent that any dividend is paid with respect to Shares that are allocated to an ESOP Account, and the dividend is used to make a payment on an Exempt Loan in accordance with Section 19.10(a), Shares with a fair market value not less than the amount of the dividend shall be allocated to the ESOP Account for the Plan Year for which the dividend would have been allocated to the ESOP Account.
(c) Other Dividends. To the extent that any cash dividend is paid with respect to Shares that are allocated to a Participant's or beneficiary's ESOP Account on the record date for the dividend, and the dividend is not used to make a payment on an Exempt Loan in accordance with Section 19.10(a), the dividend shall be taken into account in determining the value of a Unit of Participation in the Company Stock Fund as described in Article VI except as otherwise provided in Section 19.16.
(a) Investment in Shares. Employer Contributions allocated to a Participant's or beneficiary's ESOP Account shall be credited entirely to the ESOP Shares Fund. The ESOP is designed to invest exclusively in qualifying employer securities, as defined in Code section 4975(e)(8). Accordingly, the ESOP Shares Fund shall consist solely of Shares except as provided in Section 19.11(c). The Trustee shall purchase such Shares required as a result of dividends and other distributions received with respect to Shares (other than dividends used to repay an Exempt Loan in accordance with Section 19.10) or distributed in accordance with Section 19.16 in the open market or by private purchase, including purchase from the Company.
(b) Purchase From the Company. Any purchase of Shares from the Company shall be at a price per share not in excess of the mean between the highest and lowest quoted selling price per share for a 100 Share lot on the composite tape of New York Stock Exchange issues on the date of purchase by the Trustee. Dividends and other distributions received with respect to Shares (other than dividends used to repay an Exempt Loan in accordance with Section 19.10) or distributed in accordance with Section 19.16 and Employer Contributions made in cash shall be invested in Shares as soon as practicable, except as otherwise provided in this Article XIX.
(c) Short-Term Investments. Nothing in this Section 19.11 or in
Section 19.12 shall be construed to prevent the Trustee from retaining
in cash or cash equivalents or other short-term investments (i) the
proceeds of any Exempt Loan, until such proceeds are used to acquire
Shares, or to repay all or any portion of an Exempt Loan; (ii) cash
dividends received on Shares held in the ESOP Shares Fund, until such
dividends are applied to repay an Exempt Loan, invested in Shares, or
distributed in accordance with Section 19.16; and (iii) such other
amounts as may be required for the proper administration of the Trust.
(a) Authority To Obtain or Modify an Exempt Loan. The Trustee, acting in accordance with a resolution of the Board of Directors, at the direction of the Fund Advisory Committee, or at the direction of corporate officers authorized by the Board of Directors, may obtain an Exempt Loan from time to time to finance the acquisition of Shares or to refinance a prior Exempt Loan. An Exempt Loan shall be primarily for the benefit of Participants of the ESOP and their beneficiaries and shall satisfy the conditions set forth in this Section 19.12. The Trustee, acting in accordance with a resolution of the Board of Directors, at the direction of the Fund Advisory Committee, or at the direction of corporate officers authorized by the Board of Directors, may extend or renew an Exempt Loan, or may otherwise modify the terms of the Exempt Loan, provided that the Exempt Loan, as extended, renewed, or otherwise modified, continues to satisfy the conditions set forth in this Section 19.12.
(b) Terms of the Exempt Loan. An Exempt Loan shall bear a reasonable rate of interest, shall be for specific term, and shall not be payable on demand except in the event of default. Any collateral pledged to the lender by the Trustee shall consist only of the Financed Shares purchased with the proceeds of the Exempt Loan, or Financed Shares purchased with the proceeds of a prior Exempt Loan that is being refinanced; provided that this sentence shall not be construed to prevent the Company from guaranteeing repayment of the Exempt Loan. Any pledge of Financed Shares shall provide for the release of the Shares so pledged as the Trustee makes payments on the Exempt Loan and allocates the Shares to Participants' ESOP Accounts. Under the terms of the Exempt Loan, the lender shall have no recourse against assets of the ESOP except with respect to (i) the Financed Shares pledged to secure the Exempt Loan, (ii) Employer Contributions (other than contributions of Shares) that are made to the ESOP to meet its obligations under the Exempt Loan, and (iii) earnings attributable to the Financed Shares or to the investment of the Employer Contributions.
(c) Use of Loan Proceeds. The Trustee shall use the proceeds of an Exempt Loan, within a reasonable time after their receipt by the ESOP, only for one or more of the following purposes: (i) to acquire Shares; (ii) to repay the Exempt Loan; or (iii) to repay a prior Exempt Loan. Until the proceeds of an Exempt Loan are used as described in the preceding sentence, the Trustee may invest such proceeds in cash or cash equivalents or other short-term investments in accordance with Section 19.11(c). The Trustee shall pay no more than "adequate consideration" (within the meaning of ERISA section 3(18)) for any Shares acquired with the proceeds of an Exempt Loan.
(d) Suspense Account. Financed Shares acquired by the ESOP with the proceeds of an Exempt Loan shall be allocated to a Suspense Account. The Financed Shares shall be released from the Suspense Account only as the Trustee makes payments on the Exempt Loan and shall be allocated to the ESOP Accounts of Participants or beneficiaries who are eligible under Section 19.04 to
receive an allocation of Employer Contributions or who are eligible under Section 19.10 to receive an allocation to replace dividends that were used to repay the Exempt Loan. The number of Financed Shares to be released from the Suspense Account in each Plan Year for allocation to ESOP Accounts shall be determined according to the method set forth in Section 19.12(d)(1), unless the Fund Advisory Committee expressly provides that the method set forth in Section 19.12(d)(2) shall apply with respect to a particular Exempt Loan.
(1) General Rule. The number of Financed Shares held in the Suspense Account immediately before the release for the current Plan Year shall be multiplied by a fraction, the numerator of which is the amount of principal and interest paid on the Exempt Loan for that Plan Year, and the denominator of which is the sum of the numerator plus the total payments of principal and interest on the Exempt Loan projected to be made for all future Plan Years. The number of future Plan Years under the Exempt Loan shall be determined without regard to possible extensions or renewal periods, and the interest to be paid in future Plan Years shall be computed by using the interest rate in effect as of the end of the current Plan Year.
(2) Special Rule. The Fund Advisory Committee, acting in accordance with a resolution of the Board of Directors, may direct at the time the Exempt Loan is obtained (or the terms of the Exempt Loan may provide) that Financed Shares will be released from the Suspense Account based solely on the ratio that the payments of principal for each Plan Year bear to the total principal amount of the Exempt Loan. This method may be used only to the extent that the following conditions are satisfied: (i) the Exempt Loan provides for annual payments of principal and interest at a cumulative rate that is not less rapid at any time than level annual payments of such amounts for 10 years; (ii) interest included in any payment on the Exempt Loan is disregarded only to the extent that it would be determined to be interest under standard loan amortization tables; and (iii) the entire duration of the Exempt Loan repayment period does not exceed 10 years, even in the event of a renewal, extension, or refinancing of the Exempt Loan.
(e) Repayment of Exempt Loan. The payments of principal and
interest on an Exempt Loan (other than payments made pursuant to
Section 19.12(g), by reason of a default) shall be made by the Trustee
(as directed by the Fund Advisory Committee) only from Employer
Contributions to the ESOP (other than contributions of Shares), from
earnings attributable to such Employer Contributions, and from any
dividends received by the Trust on the Shares held by the ESOP
(including earnings on such dividends), except for dividends received
on Shares held in Participants' ESOP Pre-Split Matching Accounts. The
Trustee shall account separately for such Employer Contributions,
earnings, and dividends until the Exempt Loan is repaid. To the extent
that dividends on Shares are used to repay the Exempt Loan in
accordance with Section 19.10, such
dividends shall be used first to repay the principal amount of the Exempt Loan; dividends shall be used to pay interest on the Exempt Loan only to the extent that the aggregate amount of the dividends used to repay the Exempt Loan in any Plan Year exceeds the amount of the principal payment due on the Exempt Loan for that Plan Year.
(f) Allocations to ESOP Accounts. The Shares that are released from a Suspense Account in any Plan Year shall be allocated to Participants' and beneficiaries' ESOP Accounts as follows:
(1) Each Participant's or beneficiary's ESOP Account shall be credited with
(A) Shares whose fair market value (determined as of the date of allocation to the ESOP Account, based upon the mean between the highest and lowest quoted selling price per share for a 100-Share lot on the composite tape of New York Stock Exchange issues) equals the value of the cash dividends used to repay an Exempt Loan, to the extent that the dividends were paid with respect to the Shares allocated to the Participant's or beneficiary's ESOP Account for the Plan Year; and
(B) Shares whose fair market value (determined as of the date of allocation to the ESOP Account, based upon the mean between the highest and lowest quoted selling price per share for a 100-Share lot on the composite tape of New York Stock Exchange issues) equals the value of the Employer Contribution that the Participant is eligible to receive under the ESOP for the Plan Year (reduced by the amount of any Employer Contribution that the Participant has received or is entitled to receive under the Profit-Sharing Plan for the Plan Year, and by the amount of any Employer Contribution that is allocated directly to the Participant's ESOP Account for the Plan Year).
The order of allocation of Shares pursuant to this Section 19.12(f)(1) shall be determined by the Board of Directors or its designee or the Fund Advisory Committee.
(2) Any Shares remaining after the allocations described in
Section 19.12(f)(1) shall be used to provide an additional
Employer Contribution for the Plan Year, calculated by increasing
the Additional Matching Contribution percentage under Section
19.04(a)(2) to the extent necessary to provide for the allocation
of such Shares to Participants' ESOP Accounts.
Except as provided in the following paragraph, the Shares released from a Suspense Account for any Plan Year shall be allocated to Participants' and beneficiaries' ESOP
Accounts on (or as soon as practicable after) the allocation date for the Minimum Matching Contribution, Additional Matching Contribution, Basic Contribution, or dividend to which the released Shares are attributable. In no event shall Shares released from a Suspense Account be allocated as of a date later than the end of the Plan Year in which the Exempt Loan payment is made.
If the Trustee uses an Employer Contribution to make a payment on an Exempt Loan after the end of a Plan Year but on or before the time prescribed in Code section 404(a)(6), the Fund Advisory Committee may direct that some or all of the Shares released from a Suspense Account by reason of the payment shall be applied to satisfy the Employer Contribution obligation for the Plan Year preceding the Plan Year in which the payment is made, and that the Shares so applied shall be allocated to Participants' ESOP Accounts as of the end of that preceding Plan Year.
If the Shares released from a Suspense Account in any Plan Year are
not sufficient to provide the allocations described in Section 19.12(F)(1)(A) or
(B), the Employers shall make an additional contribution to the ESOP in an
amount sufficient to complete such allocations. The total amount of any
forfeitures arising pursuant to Section 10.01(a) for a Plan Year, to the extent
that those forfeitures have not previously been allocated to a Participant's or
beneficiary's account or used to repay an Exempt Loan, shall be treated as part
of the additional contribution described in the preceding sentence. An
additional contribution made in order to provide the allocation described in
Section 19.12(f)(1)(A), shall be treated as a dividend; an additional
contribution made in order to provide the allocation described in Section
19.12(f)(1)(B), shall be treated as an Employer Contribution, in accordance with
Section 19.04(d).
(g) Requirements in the Event of Default. In the event of default on the Exempt Loan, the value of the ESOP assets transferred in satisfaction of the Exempt Loan shall not exceed the amount of the default. If the lender is a party in interest (as defined in ERISA section 3(14)) or a disqualified person (as defined in Code section 4975(e)(2)), the Exempt Loan shall provide for a transfer of ESOP assets on default only upon and to the extent of the failure of the ESOP to meet the payment schedule of the Exempt Loan; provided that a party in interest or disqualified person shall not be considered a "lender" for the purposes of this sentence solely because such party in interest or disqualified person guaranteed the Exempt Loan.
(h) Put Options. Except as provided in this Section 19.12(h), no
employer security acquired with the proceeds of an Exempt Loan shall
be subject to a put, call, or other option, or to a buy-sell or
similar arrangement, while it is held by and when it is distributed
from the ESOP. If an employer security acquired with the proceeds of
an Exempt Loan is not publicly traded when distributed, or if it is
subject to a trading limitation when distributed, the security shall
be subject to a put option that permits the Participant or beneficiary
to resell the security to the Company during the 15-month period
following the distribution of the security. The provisions of this
Section 19.12(h) shall apply
whether or not the ESOP is an employee stock ownership plan at the time the security is held or distributed.
(1) Amortization and Share Release. If there is more than one Exempt Loan outstanding, the Fund Advisory Committee shall direct the Trustee either (A) to amortize each Exempt Loan separately, or (B) to aggregate the principal and interest payments calculated separately with respect to two or more outstanding Exempt Loans and to amortize the Exempt Loans so aggregated as if they were a single Exempt Loan. If the Fund Advisory Committee elects to amortize two or more outstanding Exempt Loans as if they were a single Exempt Loan, the Fund Advisory Committee shall aggregate the Financed Shares purchased with the proceeds of each Exempt Loan to determine the number of Shares released from the Suspense Account and allocated to Participants' and beneficiaries' ESOP Accounts for any year with respect to the aggregated Exempt Loans.
(2) Share Allocation. The Fund Advisory Committee may allocate the Shares purchased with each Exempt Loan in proportion to the payments of principal and interest made with respect to that Exempt Loan, or the Fund Advisory Committee may direct the Trustee to allocate the Shares purchased with one Exempt Loan more rapidly than the Shares purchased with another Exempt Loan; provided, however, that the Fund Advisory Committee's method of attributing the Shares allocated for a given year to a particular Exempt Loan shall not affect the number of Shares released from the Suspense Account and allocated for that year, which number shall be determined in accordance with Section 19.12(d), and as provided in Section 19.12(i)(1).
(3) Eligible Collateral. To the extent permitted by applicable law, the Fund Advisory Committee may, from time to time, determine the number of Financed Shares remaining in the Suspense Account that are pledged (or that are eligible to be pledged) as collateral for a particular Exempt Loan; provided, however, that the number of Financed Shares that are pledged (or eligible to be pledged) as collateral for a particular Exempt Loan shall not exceed the number of Financed Shares that would be pledged (or eligible to be pledged) if the Fund Advisory Committee had allocated the Shares purchased with each Exempt Loan in proportion to the payments of principal and interest made with respect to the Exempt Loan. When the Fund Advisory Committee makes a determination described in this Section 19.12(i)(3), the Fund Advisory Committee shall communicate the number of Financed Shares pledged (or eligible to be pledged) as collateral for a particular Exempt Loan to the Trustee, and the Trustee may rely on such communications.
(a) General Rule. Upon a Participant's Retirement, death, Disability, or other termination of employment with the Company and its affiliates, the Participant (or, if applicable, the Participant's beneficiary) shall be entitled to receive a distribution of the vested portion of his ESOP Account at the same time and in the same manner as he receives a distribution of the other portions of his Participant's Account under Article X. A Participant shall not be entitled to elect a time or method of distribution, or to designate a beneficiary, with respect to his ESOP Account that is different from the time and method of distribution and beneficiary that are applicable to the other portions of his Participant's Account.
(b) Cash-Outs. For purposes of determining, pursuant to Article X, whether a Participant's vested accrued benefit exceeds $5,000, the Participant's ESOP Account shall not be considered separately, but shall be included with the other portions of his Participant's Account.
(c) Distributions in Shares. A Participant or beneficiary may elect, pursuant to Article XI, to receive the distribution of the Participant's ESOP Account in Shares rather than in cash; provided that the Trustee shall distribute fractional shares in cash rather than in Shares.
(d) Post-Retirement Withdrawals. A Retired Participant who has elected to defer commencement of the distribution of his Participant's Account may make periodic withdrawals from his ESOP Account pursuant to Section 10.01(b)(3).
(a) Withdrawals. A Participant may withdraw his Employer
Contributions (and earnings thereon) from his ESOP Account subject to
the same rules as apply to withdrawals of Employer Contributions (and
earnings thereon) from the Participant's Account under Article VIII. A
Participant may elect to receive any withdrawal described in this
Section 19.14(a) in the form of Shares rather than in cash.
(b) Diversification. In accordance with procedures established by the Employee Benefits Committee, a Participant who,has attained 50 years of age and has 10 or more Years of Service may elect at any time during a Plan Year to diversify his ESOP Account by investing his ESOP Account and the earnings thereon in the investment funds established pursuant to Section 5.01 under the following schedule: (a) a Participant aged 50-54 may diversify a cumulative total of 25 percent of the value of his ESOP Account; (b) a Participant aged 55-59 may diversify a cumulative total of 50 percent of the value of his ESOP Account; (c) a Participant aged 60 or older may diversify a cumulative total of 75 percent of the value of his ESOP Account.
A Participant shall be entitled to vote or tender the Shares allocated to his ESOP Account in accordance with the rules set forth in Sections 14.07 and 14.08.
Notwithstanding any other provision of the Plan to the contrary, effective June 1, 2003, to the extent that any cash dividend is paid with respect to Shares that are allocated to a Participant's or beneficiary's ESOP Account on the ex-date for the dividend (as defined in Section 19.16(c)(8)), and the dividend is not used to make a payment on an Exempt Loan, the dividend shall be subject to the election described in this Section.
(a) Election to Receive or Reinvest Dividend. The Participant or
beneficiary to whose ESOP account the Shares are allocated as of the
dividend ex-date may elect to have 100% of the cash dividend with
respect to those Shares either (1) distributed from the Plan and paid
to him, or (2) retained by the Plan and invested as provided in
Section 19.11. A Participant or beneficiary may make or change an
election at any time in the manner prescribed by the Employee Benefits
Committee, and any election made will remain in effect until the
Participant or beneficiary changes it. The election in effect on the
ex-date for a dividend will apply to that dividend. If no election is
in effect on the ex-date for a dividend, the Participant or
beneficiary will be deemed to have elected to have the dividend
retained by the Plan and invested as provided in Section 19.11.
(b) Receipt of Dividends. If a Participant or beneficiary elects to have a cash dividend distributed from the Plan and paid to him, a check in the amount of the dividend will be mailed to him by United States mail as soon as administratively feasible after the payable date for the dividend.
(c) Dividends 100% Vested. A Participant or beneficiary is 100% vested in any cash dividend that is subject to the election described in this Section.
(d) Treatment of Dividends. Cash dividends subject to the election described in this Section are treated as follows:
(1) Spousal Consent not Required. A Participant or beneficiary need not obtain his spouse's consent to an election described in this Section.
(2) No Offset Against Required Distributions. Dividends distributed from the Plan and paid to a Participant or beneficiary pursuant to an election under this Section shall not reduce the amount of any distribution required to be paid under Code section 401(a)(9).
(3) No Rollovers. Dividends distributed from the Plan and paid to a Participant or
beneficiary pursuant to the Participant's or beneficiary's election under this Section are not considered eligible rollover distributions under Code section 402(f)(2)(A).
(4) Offset Against Hardship Withdrawals. Dividends distributed from the Plan and paid to a Participant pursuant to the Participant's election under this Section shall reduce the amount of any withdrawal paid under Article VII between the dividend ex-date and the payable date for the dividend.
(5) Consideration of Dividends. Dividends subject to the elections described in this Section shall not be considered annual additions, Salary Reduction Contributions, or elective deferrals.
(6) Deceased Participants. A Participant's election will be deemed to be an election to have all cash dividends retained by the Plan and invested as provided in Section 19.11 beginning on the date of his death and ending on the date'his beneficiary changes it.
(7) Compliance With Code Section 404(k). The provisions of this Section comply with Code section 404(k), and the provisions shall be construed accordingly.
(8) Dividend Ex-Date. The dividend ex-date with respect to a dividend is the date that is two business days prior to the record date for the dividend.
This Article XX is adopted to reflect certain provisions of the Economic Growth and Tax Relief Reconciliation Act of 2001 ("EGTRRA"). This Article is intended as good faith compliance with the requirements of EGTRRA and is to be construed in accordance with EGTRRA and guidance issued thereunder. Except as otherwise provided, this Article shall be effective as of the first day of the first Plan Year beginning after December 31, 2001.
This Section shall supersede the provisions of the Plan to the extent those provisions are inconsistent with the provisions of this Article.
(a) Effective Date. This Section shall be effective for limitation years beginning after December 31, 2001.
(b) Maximum Annual Addition. Except to the extent permitted under Section 20.10 and Code section 414(v), if applicable, the annual addition that may
be contributed or allocated to a Participant's account under the Plan for any limitation year shall not exceed the lesser of:
(1) $40,000, as adjusted for increases in the cost-of-living under Code section 415(d), or
(2) 100 percent of the Participant's compensation, within
the meaning of Code section 415(c)(3), for the limitation year.
For purposes of this Article XX, the term "compensation" shall
mean the Participant's wages within the meaning of Code section
3401 (without regard to any rule under Code section 3401 that
limits amounts included in wages based on the nature or location
of the employment) and all other payments for which the Employer
is required to furnish the Participant with a written statement
under Code sections 6041(d) and 6051(a)(3). "Compensation" also
includes amounts that would have been paid to the Employee during
the Plan Year in the absence of a salary redirection agreement
but are excluded from gross income pursuant to Code section 125,
132(f), 457, or 402(g).
The compensation limit referred to in this paragraph shall not apply to any contribution for medical benefits after separation from service (within the meaning of Code sections 401(h) or 419A(f)(2)), which is otherwise treated as an annual addition.
The annual compensation of each Participant taken into account in determining allocations for any Plan Year beginning after December 31, 2001, shall not exceed $200,000, as adjusted for cost-of-living increases in accordance with Code section 401(a)(17)(B). Annual compensation means compensation during the Plan Year or such other consecutive 12-month period over which compensation is otherwise determined under the Plan (the determination period). The cost-of-living adjustment in effect for a calendar year applies to annual compensation for the determination period that begins with or within such calendar year.
(a) Effective Date. This Section shall apply for purposes of determining whether the Plan is a top-heavy Plan under Code section 416(g) for Plan Years beginning after December 31, 2001, and whether the Plan satisfies the minimum benefits requirements of Code section 416(c) for those years. This Section 20.05 amends Article XVII of the Plan.
(1) Key Employee. "Key employee" means any Employee or former Employee (including any deceased Employee) who at any time during the Plan Year that includes the determination date was an officer of the Employer having annual compensation greater than $130,000 (as
adjusted under Code section 416(i)(1) for Plan Years beginning after December 31, 2002), a 5-percent owner of the Employer, or a 1-percent owner of the Employer having annual compensation of more than $150,000. For this purpose, annual compensation means compensation within the meaning of Code section 415(c)(3). The determination of who is a key employee will be made in accordance with Code section 416(i)(1) and the applicable regulations and other guidance of general applicability issued thereunder.
(2) Determination of Present Values and Amounts. This
Section 20.05(b)(2) shall apply for purposes of determining the
present values of accrued benefits and the amounts of account
balances of Employees as of the determination date.
(A) Distributions During Year Ending on the
Determination Date. The present values of accrued benefits
and the amounts of account balances of an Employee as of the
determination date shall be increased by the distributions
made with respect to the Employee under the Plan and any
plan aggregated with the Plan under Code section 416(g)(2)
during the 1-year period ending on the determination date.
The preceding sentence shall also apply to distributions
under a terminated plan which, had it not been terminated,
would have been aggregated with the Plan under Code section
416(g)(2)(A)(i). In the case of a distribution made for a
reason other than separation from service, death, or
disability, this provision shall be applied by substituting
5-year period for 1-year period.
(B) Employees Not Performing Services During Year Ending on the Determination Date. The accrued benefits and accounts of any individual who has not performed services for the Employer during the l-year period ending on the determination date shall not be taken into account.
(A) Matching Contributions. Employer matching contributions shall be taken into account for purposes of satisfying the minimum contribution requirements of Code section 416(c)(2) and the Plan. The preceding sentence shall apply with respect to matching contributions under the Plan or, if the Plan provides that the minimum contribution requirement shall be met in another plan, such other plan. Employer matching contributions that are used to satisfy the minimum contribution requirements shall be treated as matching contributions for purposes of the actual contribution percentage test and other requirements of Code section 401(m).
(B) Contributions Under Other Plans. Non-key Employees who participate in the Guidant Retirement Plan ("Retirement Plan") will receive the product of the Employee's Compensation (as defined in the Retirement Plan) for the Testing Period and the lesser of 2 percent per Year of Minimum Benefit Service (as defined in the Retirement Plan) or 20 percent. For purposes of this Section, "Compensation", "Testing Period" and "Year of Minimum Benefit Service" will have the meaning assigned to them in the Retirement Plan.
(a) Effective Date. This Section 20.06 shall apply to distributions made after December 31, 2001.
(b) Modification of Definition of Eligible Retirement Plan. For purposes of the direct rollover provisions in Section 11.02, an "eligible retirement plan" shall also mean an annuity contract described in Code section 403(b) and an eligible plan under Code section 457(b), which is maintained by a state, political subdivision of a state, or any agency or instrumentality of a state or political subdivision of a state and which agrees to separately account for amounts transferred into such plan from this Plan. The definition of "eligible retirement plan" shall also apply in the case of a distribution to a surviving spouse, or to a spouse or former spouse who is the alternate payee under a qualified domestic relation order, as defined in Code section 414(p).
(c) Modification of Definition of Eligible Rollover Distribution to Exclude Hardship Distributions. For purposes of the direct rollover provisions in Section 11.02, any amount that is distributed on account of hardship shall not be an eligible rollover distribution and the distributee may not elect to have any portion of such a distribution paid directly to an eligible retirement plan.
(a) Applicability and Effective Date. This Section 20.07 shall apply to distributions made after December 31, 2001, regardless of when the Participant separated from service.
(b) Rollovers Disregarded in Determining Value of Account
Balance for Involuntary Distributions. For purposes of Section
10.01(b), the value of a Participant's nonforfeitable account balance
shall be determined without regard to that portion of the account
balance that is attributable to rollover contributions (and earnings
allocable thereto) within the meaning of Code sections 402(c),
403(a)(4), 403(b)(8), 408(d)(3)(A)(ii), and 457(e)(16). If the value
of the Participant's nonforfeitable account balance as so determined
is $5,000 or less, the Plan shall immediately distribute the
Participant's entire nonforfeitable account balance.
The multiple use test described in Treasury Regulation ss. 1.401(m)-2 shall not apply for Plan Years beginning after December 31, 2001.
No Participant shall be permitted to have elective deferrals made
under this Plan, or any other qualified plan maintained by the employer during
any taxable year, in excess of the dollar limitation contained in Code section
402(g) in effect for that taxable year, except to the extent permitted under
Section 20.10 and Code section 414(v), if applicable.
All Employees who are eligible to make elective deferrals under this Plan and who have attained age 50 before the close of the Plan Year shall be eligible to make catch-up contributions in accordance with, and subject to thin limitations of, Code section 414(v). Catch-up contributions shall not be taken into account for purposes of the provisions of the Plan implementing the required limitations of Code sections 402(g) and 415. The Plan shall not be treated as failing to satisfy the provisions of the Plan implementing the requirements of Code section 401(k)(3), 401(k)(11), 401(k)(12), 410(b), or 416, as applicable, by reason of the making of such catch-up contributions. Catch-up contributions shall apply to contributions after December 31, 2001.
A Participant who receives a distribution of elective deferrals after December 31, 2001, on account of hardship shall be prohibited from making elective deferrals and employee contributions under this and all other plans of the Employer for 6 months after receipt of the distribution.
A Participant who receives a distribution of elective deferrals in calendar year 2001 on account of hardship shall be prohibited from making elective deferrals and employee contributions under this and all other plans of the employer for the period specified in the provisions of the Plan relating to suspension of elective deferrals that were in effect prior to this amendment.
(a) Effective Date. The provisions of this Article will apply for purposes of determining required minimum distributions for calendar years beginning with the 2003 calendar year.
(b) Precedence. The requirements of this Article will take precedence over any inconsistent provisions of the Plan.
(c) Requirements of Treasury Regulations Incorporated. All distributions required under this Section will be determined and made in accordance with the Treasury Regulations under Code section 401(a)(9).
(a) Required Beginning Date. The Participant's entire interest will be distributed, or begin to be distributed, to the Participant no later than the Participant's required beginning date.
(b) Death of Participant Before Distributions Begin. Unless a Participant or Beneficiary elects to apply the Five-Year Rule pursuant to Section 21.05, if the Participant dies before distributions begin, the Participant's entire interest will be distributed, or begin to be distributed, no later than as follows:
(1) If the Participant's surviving spouse is the Participant's sole designated beneficiary, then distributions to the surviving spouse will begin by December 31 of the calendar year immediately following the calendar year in which the Participant died, or by December 31 of the calendar year in which the Participant would have attained age 70 1/2, if later.
(2) If the Participant's surviving spouse is not the Participant's sole designated beneficiary, then distributions to the beneficiary will begin by December 31 of the calendar year immediately following the calendar year in which the Participant died.
(3) If there is no designated beneficiary as of September 30 of the year following the year of the Participant's death, the Participant's entire interest will be distributed by December 31 of the calendar year containing the fifth anniversary of the Participant's death.
(4) If the Participant's surviving spouse is the Participant's sole designated beneficiary and the surviving spouse dies after the Participant but before distributions to the surviving spouse begin, this Section 21.02(b), other than Section 21.02(b)(l), will apply as if the surviving spouse were the Participant.
For purposes of this Section 21.02(b) and Section 21.04, unless
Section 21.02(b)(4) applies, distributions are considered to begin on the
Participant's required beginning date. If Section 21.02(b)(4) applies,
distributions are considered to begin on the date distributions are required to
begin to the surviving spouse under Section 21.02(b)(1). If distributions under
an annuity purchased from an insurance company irrevocably commence to the
Participant before the Participant's required beginning date (or to the
Participant's surviving spouse before the date distributions are required to
begin to the surviving spouse under Section 21.02(b)(1), the date distributions
are considered to begin is the date distributions actually commence.
(c) Form of Distribution. Unless the Participant's interest is distributed in the form of an annuity purchased from an insurance company or in a single sum on or before the required beginning date, as of the first distribution calendar year, distributions will be made in accordance with Sections 21.03 and 21.04. If the Participant's interest is distributed in the form of an annuity purchased from an insurance company, distributions thereunder will be made in accordance with the requirements of Code section 401(a)(9) and the Treasury Regulations.
(a) Amount of Required Minimum Distribution For Each Distribution Calendar Year. During the Participant's lifetime, the minimum amount that will be distributed for each distribution calendar year is the lesser of:
(1) The quotient obtained by dividing the Participant's Account balance by the distribution period in the Uniform Lifetime Table set forth in ss. 1.401(a)(9)-9 of the Treasury Regulations, using the Participant's age as of the Participant's birthday in the distribution calendar year; or
(2) If the Participant's sole designated beneficiary for the distribution calendar year is the Participant's spouse, the quotient obtained by dividing the Participant's Account balance by the number in the Joint and Last Survivor Table set forth in ss. 1.401(a)(9)-9 of the Treasury Regulations, using the Participant's and spouse's attained ages as of the Participant's and spouse's birthdays in the distribution calendar year.
(b) Lifetime Required Minimum Distributions Continue Through Year of Participant's Death. Required minimum distributions will be determined under this Section 21.03 beginning with the first distribution calendar year and up to and including the distribution calendar year that includes the Participant's date of death.
(1) Participant Survived by Designated Beneficiary. If the Participant dies on or after the date distributions begin and there is a designated beneficiary, the minimum amount that will be distributed for each distribution calendar year after the year of the Participant's death is the quotient obtained by dividing the Participant's Account balance by the longer of the remaining life expectancy of the Participant or the remaining life expectancy of the Participant's designated Beneficiary, determined as follows:
(A) The Participant's remaining life expectancy is calculated using the age of the Participant in the year of death, reduced by one for each subsequent year.
(B) If the Participant's surviving spouse is the Participant's designated sole beneficiary, the remaining life expectancy of the surviving spouse is calculated for each distribution calendar year after the year of the Participant's death using the surviving spouse's age as of the spouse's birthday in that year. For distribution calendar years after the year of the surviving spouse's death, the remaining life expectancy of the surviving spouse is calculated using the age of the surviving spouse as of the spouse's birthday in the calendar year of the spouse's death, reduced by one for each subsequent calendar year.
(C) If the Participant's surviving spouse is not the Participant's sole designated beneficiary, the designated beneficiary's remaining life expectancy is calculated using the age of the beneficiary in the year following the year of the Participant's death, reduced by one for each subsequent year.
(2) No Designated Beneficiary. If the Participant dies on or after the date distributions begin and there is no designated beneficiary as of September 30 of the year after the year of the Participant's death, the minimum amount that will be distributed for each distribution calendar year after the year of the Participant's death is the quotient obtained by dividing the Participant's Account balance by the Participant's remaining life expectancy calculated using the age of the Participant in the year of death, reduced by one for each subsequent year. (b) Death Before Date Distributions Begin.
Unless a Participant or beneficiary elects to apply the Five-Year Rule pursuant to Section 21.05, the Participant's interest will be distributed as follows:
(1) Participant Survived by Designated Beneficiary. If the Participant dies before the date distributions begin and there is a designated beneficiary, the minimum amount that will be distributed for each distribution calendar year after the year of the Participant's death is the quotient obtained by dividing the Participant's Account balance by the remaining life expectancy of the Participant's designated beneficiary, determined as provided in Section 21.04(a).
(2) No Designated Beneficiary. If the Participant dies before the date distributions begin and there is no designated beneficiary as of September 30 of the year following the year of the Participant's death, distribution of the Participant's entire interest will be completed by
December 31 of the calendar year containing the fifth anniversary of the Participant's death.
(c) Death of Surviving Spouse Before Distributions to Surviving Spouse Are Required to Begin. If the Participant dies before the date distributions begin, the Participant's surviving spouse is the Participant's sole designated beneficiary, and the surviving spouse dies before distributions are required to begin to the surviving spouse under Section 21.02(b)(1), this Section 21.04(b) will apply as if the surviving spouse were the Participant.
A Participant or beneficiary may elect to apply the Five-Year Rule instead of the life expectancy rule of Section 21.02(b) or 21.04(b). The Participant or Beneficiary's election must be made no later than the earlier of September 30 of the calendar year in which distribution would be required to begin under Section 21.02(b); or by September 30 of the calendar year which contains the fifth anniversary of the Participant's (or, if applicable, surviving spouse's) death.
(a) Designated Beneficiary. A "designated beneficiary" is an individual who is designated as the beneficiary under Section 10.02 and is the designated beneficiary under Code section 401(a)(9) and ss. 1.401(a)(9)-1, Q&A-4, of the Treasury Regulations.
(b) Distribution Calendar Year. A "distribution calendar year" is the calendar year for which a minimum distribution is required. For distributions beginning before the Participant's death, the first distribution calendar year is the calendar year immediately preceding the calendar year which contains the Participant's required beginning date. For distributions beginning after the Participant's death, the first distribution calendar year is the calendar year in which distributions are required to begin under Section 21.02(b). The required minimum distribution for the Participant's first distribution calendar year will be made on or before the Participant's required beginning date. The required minimum distribution for other distribution calendar years, including the required minimum distribution for the distribution calendar year in which the Participant's required beginning date occurs, will be made on or before December 31 of that distribution calendar year.
(c) Five-Year Rule. The "Five-Year Rule" requires that a Participant's entire interest be distributed by December 31 of the calendar year containing the fifth anniversary of the Participant's death.
(d) Life Expectancy. "Life expectancy" is the life expectancy computed by use of the Single Life Table in ss. 1.401(a)(9)-9 of the Treasury Regulations.
(e) Participant's Account Balance. A Participant's "Account balance" is the Account balance as of the last valuation date in the calendar year immediately preceding the distribution calendar year (valuation calendar year) increased by the amount of any contributions made and allocated or forfeitures allocated to the Account balance as of dates in the valuation calendar year after the valuation date and decreased by distributions made in the valuation calendar year after the valuation date. The Account balance for the valuation calendar year includes any amounts rolled over or transferred to the Plan either in the valuation calendar y ear or in the distribution calendar year if distributed or transferred in the valuation calendar year.
(f) Required Beginning Date. The date specified in Section 10.01(b).
IN WITNESS WHEREOF, Guidant Corporation has caused this restated Plan document to be executed and adopted, effective January 1, 2003, except as otherwise provided in the Plan, on this day of , 2003.
GUIDANT CORPORATION
Pursuant to Section 5.01 of the Plan, the Fund Advisory Committee has designated the following investment Fund options to be available for the investment of Participant's Salary Reduction Contributions.
The Stable Value Fund. The investment objective of the Stable Value Fund is to preserve principle while seeking a high level of current income. The Fund is designed to provide Participants with a higher return than typically offered by money markets while maintaining liquidity and safety of principle. The Fund generally invests in investment contracts issued by insurance companies, banks, and other financial institutions and will be diversified among many different institutions.
Large Company Value. The investment objective of the Large Company Value Fund is to outperform the Russell 1000 Value Index while maintaining below average volatility. The fund is a large company stock fund that seeks long-term growth and income by investing in a diversified portfolio of stocks that are thought to be under valued relative to their dividend income, the value of the underlying assets of the issuing corporation, and potential future return.
The S&P 500 Index Fund. The investment objective of the S&P 500 Index Fund is to match the investment performance of the U.S. stock market. The Fund invests in the securities that make up the S&P 500 Index, which includes 500 established companies of different sizes and sectors of the U.S. economy, resulting in a broadly diversified, mostly large company U.S. stock fund.
The Large Conwanv Growth Fund. The investment objective of The Large Company Stock Fund is to outperform the S&P 500 Index over a long term. The Fund seeks the highest possible level of consistent, sustainable growth by buying stocks of fundamentally strong, quality companies at prices below their estimated economic or intrinsic value. The strategy is to enhance and protect the fund by combining growth and value disciplines. The Fund is comprised of a select group of both U.S. and international stocks.
The International Stock Fund. The investment objective of The International Stock Fund is to seek long-term growth of capital and future income by investing primarily in the stocks of companies based outside the United States. The Fund normally invests in foreign and U.S./registered securities, as well as companies that target markets outside the United States. The Fund generally emphasizes strong, well-managed companies in Europe, Canada, Australia and the Far East.
Small Company Value Fund. The investment objective of the Small Company Value Fund is to provide superior long-term appreciation through the selection of under valued stocks. The Fund invests primarily in equity securities of small capitalization companies based in the United States. Its strategy is to create a portfolio of undervalued stocks that reflect the characteristics of the Russell 2000 Index.
The Real Estate Fund. The investment objective of The Real Estate Fund is to seek total return with equal emphasis on capital appreciation and current income. The Fund invests primarily in equity securities of real estate companies. Some of the securities include
common stocks, convertible securities, and preferred stocks. The Fund may invest, with limitations, the securities of foreign real estate companies.
Small Company Growth Fund. The investment objective of the Small Company Growth Fund is to provide 100% appreciation over 36 months. It seeks to meet this objective by investing in stocks of small and mid-cap companies that have records of high earnings growth and above average prospects for future earnings growth.
Horizon Portfolio Alternatives. The Horizon Portfolios are four pre-mixed balanced funds, each of which invests in the eight investment Funds described above, but with an asset allocation formula designed to suit a particular time horizon. Horizon Portfolio (A) will have a time horizon of 3 to 6 years; Horizon Portfolio (B) will have a time horizon of 6 to 12 years; Horizon Portfolio (C) will have a time horizon of 12 to 20 years; and Horizon Portfolio (D) will have a time horizon of 20 years. Each Horizon Portfolio will be diversified across and within asset classes. Each Horizon Portfolio will he periodically and automatically rebalanced to the target asset allocations determined by professional investment advisors. Horizon Portfolios are offered as an alternative to individual investment direction among the eight funds. A Participant or Beneficiary who invests in a Horizon Portfolio will not be permitted to invest in any of the eight investment Funds while invested in a Horizon Portfolio. In addition, a Participant or Beneficiary may not invest in more than one Horizon Portfolio at a time.
A. |
The
Company adopted the Plan, originally effective January 1, 1995, and
most
recently restated it in its entirety effective January 1,
2003.
|
B. |
The
Company now wishes to amend the Plan.
|
1. |
Effective
February 9, 2004, Section 1.01(a)(26)(x) is added to read as
follows:
|
2. |
Effective
October 1, 2004, Section 5.08 is amended to read as
follows:
|
5.08 |
Transferred
Participant Loans
.
|
3. |
Effective
October 1, 2004, Section 6.01(a) is amended to read as
follows:
|
(a) |
Salary
Reduction Contributions
.
The Participant’s Salary Reduction Contributions to the Plan, including
amounts attributable to salary reduction contributions under a Prior
Savings Plan or the Endovascular Technologies, Inc. 401(k) Savings
Plan,
the InControl 401(k) Plan, the Sulzer Medica USA Retirement Plan, the
CardioThoracic Systems 401(K) Savings Plan or the AFx 401(k) Plan
transferred to or merged into this Plan, and the earnings
thereon:
|
4. |
Effective
October 1, 2004, the first paragraph of Section 7.01 is amended to
read as
follows:
|
5. |
Effective
October 1, 2004, Section 9.01(a) is amended to read as
follows:
|
(a) |
Subject
to such rules as the Employee Benefits Committee may from time to
time
prescribe, a Participant may make no more than one (1) withdrawal
pursuant
to either Article VII or Article VIII in any Plan Year. Notwithstanding
the preceding sentence, a Participant may make unlimited withdrawals
pursuant to Article VII and Section 8.02(g) from the portion of his
Profit-Sharing Account that is attributable to salary redirection
contributions transferred from the AFx 401(k) Plan to the
Plan.
|
6. |
Effective
October 1, 2004, Section 10.01(a)(1)(A) is amended to read as
follows:
|
A. |
Amount
of Payment
.
A
Participant who resigned or is dismissed from employment and who
has
completed 5 years of Service as of such date shall be entitled to
the
entire value of his Participant’s Account. A Participant shall always be
100 percent vested in his Rollover Contributions Account. A Participant
who has completed less than 5 years of Service shall be entitled
to the
value of his Salary Reduction Contributions and Employee Contributions
to
the Plan, plus the value of his salary reduction contributions and
qualified matching contributions made under the Endovascular Technologies,
Inc. 401(K) Savings Plan transferred to this Plan, plus the value
of any
amounts transferred from the CardioThoracic Systems 401(K) Savings
Plan or
the AFx 401(k) Plan to the Plan, plus his vested interest in the
value of
the Employer Contributions credited to his Participant’s Account. Such
vested interest shall be determined by a percentage equal to 20 percent
for each full year of Service.
|
7. |
Effective
October 1, 2004, a new Section 14.19 is added to the Plan to read as
follows:
|
14.19 |
Transfer
From AFx Plan
.
As soon as practicable on or after October 1, 2004, the Trust shall
accept
a transfer from the trust for the AFx 401(k) Plan (the “AFx Plan”) of
amounts representing all of the assets of the AFx Plan. Amounts credited
to the accounts of an individual under the AFx Plan shall be credited
to a
corresponding Participant Account for that individual under the Plan.
To
the extent required by applicable law, an amount transferred with respect
to an individual, and the earnings accrued thereon following the transfer,
will be separately accounted for under the Plan. Amounts transferred
from
the AFx Plan to this Plan as described in this Section are fully vested
at
all times.
|
8. |
Effective
October 1, 2004, Section 14.20 is added to read as
follows:
|
14.20 |
Blackout
Periods
.
If the Trust accepts a transfer of assets from the trust of another
plan,
the transfer may result in a period of time during which a Participant
may
not obtain a distribution or a loan of the transferred assets or direct
the investment of the transferred assets (“blackout period”). During the
blackout period, the transferred assets will be invested in the funds
designated by the Employee Benefits Committee. The designated funds,
as
well as the date the blackout period is expected to end, shall be
communicated to affected Participants in advance of the commencement
of
the period as required by ERISA. After the blackout period ends, the
transferred assets will be invested in accordance with Article
V.
|
A. |
The
Company adopted the Plan, originally effective January 1, 1995, and
most
recently restated it in its entirety effective January 1,
2003.
|
B. |
The
Plan has been amended by a First
Amendment.
|
C. |
The
Company wishes to amend the Plan further.
|
1. |
Section
10.01(a)(1)(A) is amended to read as
follows:
|
A. |
The
Company adopted the Plan, originally effective January 1, 1995, and
most
recently restated it in its entirety effective January 1,
2003.
|
B. |
The
Plan has been amended by a First Amendment and a Second
Amendment.
|
C. |
The
Company wishes to amend the Plan further.
|
1. |
Effective
July 1, 2005, Section 1.01(a)(27) is amended to read as
follows:
|
2. |
Effective
January 1, 2005, Section 5.06(d) is redesignated as Section 5.06(e),
and a
new Section 5.06(d) is added to read as
follows:
|
3. |
Effective
March 28, 2005, a new Section 10.05 is added to read as
follows:
|
A. |
The
Company adopted the Plan, which was originally effective January
1, 1995,
and most recently restated it in its entirety effective January 1,
2003.
|
B. |
The
Company amended the Plan by a First Amendment, a Second Amendment,
and a
Third Amendment.
|
C. |
The
Company now wishes to amend the Plan further, effective March 18,
2006.
|
GUIDANT
CORPORATION
By:
Printed
Name
Title
|
(ii)
|
An
Employee who received compensation in excess of $80,000 (as adjusted
pursuant to Code section 415(d)) during the preceding Plan Year and
was in the top-paid group of employees for the preceding Plan Year.
|
(i)
|
Qualified
Nonelective Contributions to Correct Excess Salary Reduction
Contributions
.
In lieu of, or in combination with, the distribution of Excess Salary
Reduction Contributions under Section 3.04(b) to satisfy the
limitation described at Section 3.03(a), any Employer may make a
qualified nonelective contribution (“QNEC”) to the Plan on behalf of one
or more Employees who are not highly compensated Employees (as defined
in
Section 3.03) to cause the limitation to be satisfied. The QNEC made
on
behalf of an Employee shall be allocated to the Employee’s Participant’s
Account and shall be considered a Salary Reduction Contribution for
all
Plan purposes, except that an Employee may not withdraw it solely
on
account of a hardship.
|
(1)
|
Hardship
withdrawals shall be approved, on a case-by-case basis and in view
of all
relevant facts and circumstances, only if needed to satisfy an immediate
and heavy financial need that is on account of one of the
following:
|
(A)
|
Expenses
for (or necessary to obtain) medical care that would be deductible
under
Code section 213(d) (determined without regard to whether the expenses
exceed 7.5% of adjusted gross income);
|
(B)
|
Costs
directly related to the purchase of a principal residence for the
Participant (excluding mortgage payments);
|
(C)
|
Payment
of tuition, related educational fees, and room and board expenses,
for up
to the next 12 months of post-secondary education for the Participant,
or
the Participant
’
s
spouse,
children or dependents (as defined in Code section 152 and, for taxable
years beginning on or after January 1, 2005, without regard to Code
sections 152(b)(1), (b)(2) and (d)(1)(B));
|
(D)
|
Payments
necessary to prevent the eviction of the Participant from the
Participant’s principal residence or foreclosure on the mortgage on that
residence;
|
(E)
|
Payments
for burial or funeral expenses for the Participant’s deceased parent,
spouse, children or dependents (as defined in
|
|
Code
section 152 and, for taxable years beginning on or after
January 1, 2005, without regard to Code section 152(d)(1)(B));
or
|
(F)
|
Expenses
for the repair of damage to the Participant’s principal residence that
would qualify for the casualty deduction under Code section 165
(determined without regard to whether the loss exceeds 10% of adjusted
gross income).
|
GUIDANT
CORPORATION
By:
Printed
Name
Title
|
|
||||||||||||||||
|
||||||||||||||||
|
||||||||||||||||
|
||||||||||||||||
(in
millions)
|
2006
|
2005
|
2004
|
2003
|
2002
|
|||||||||||
Fixed
charges
|
||||||||||||||||
Interest
expense and debt issuance costs
|
|
435
|
90
|
64
|
46
|
43
|
||||||||||
Interest
portion of rental expense
|
16
|
13
|
10
|
10
|
11
|
|||||||||||
Total
fixed charges
|
451
|
103
|
74
|
56
|
54
|
|||||||||||
Earnings
|
||||||||||||||||
(Loss)
income before income taxes
|
(3,535
|
)
|
891
|
1,494
|
643
|
549
|
||||||||||
Fixed
charges per above
|
451
|
103
|
74
|
56
|
54
|
|||||||||||
Equity
in losses of equity investees
|
28
|
9
|
3
|
|||||||||||||
Total
(deficit) earnings, adjusted
|
(3,056
|
)
|
1,003
|
1,571
|
699
|
603
|
||||||||||
Ratio
of earnings to fixed charges (a)
|
9.74
|
21.23
|
12.48
|
11.17
|
|
|
/s/
James
R.
Tobin
James
R. Tobin
President
and Chief Executive
Officer
|
|
/s/
Lawrence
C.
Best
Lawrence
C. Best
Executive
Vice President—Finance & Administration and Chief Financial
Officer
|
By:
|
|
/s/
James
R.
Tobin
|
|
|
|
|
James
R. Tobin
President
and Chief Executive Officer
|
|
|
|
|
March
1, 2007
|
|
|
By:
|
|
/s/
Lawrence C.
Best
|
|
|
|
|
Lawrence
C. Best
Executive
Vice President—Finance & Administration
and
Chief Financial Officer
|
|
|
|
|
March
1, 2007
|
|
|